{"meta":{"query_hash":"1fe60c4b3c46","filters":{"venue":"Critical Reviews in Oncology/Hematology"},"cohort_total":164,"direct_labels_cover":1,"predictions_cover":164,"exported":164,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/1fe60c4b3c46","api":"https://metacan.xera.ac/api/v1/cohort?venue=Critical+Reviews+in+Oncology%2FHematology"},"results":[{"id":"W1969110349","doi":"10.1016/j.critrevonc.2013.04.003","title":"CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myeloma","year":2013,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Monoclonal antibody; Multiple myeloma; Immune system; Haematopoiesis; Immunology; Receptor; Biology; Autoimmunity; Cancer research; Antibody; Medicine; Cell biology; Stem cell; Genetics","score_opus":0.1524543527778546,"score_gpt":0.44352341900849934,"score_spread":0.29106906623064477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969110349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010842811,0.9989925,0.00009223436,0.00021816377,0.00015538676,0.0000031343966,0.000017802366,0.0000072123203,0.00040524683],"genre_scores_gemma":[0.00070977537,0.99839264,0.0001500996,0.00019966964,0.00012445604,0.0000041857156,0.00003762721,0.0000010752156,0.00038041893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998466,0.00001737673,0.00002013152,0.000022744702,0.00007373747,0.00001931478],"domain_scores_gemma":[0.99977225,0.000083818646,0.000041603394,0.0000053517692,0.00007206955,0.000024853325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051175104,0.00073315424,0.0013945976,0.0014523094,0.00021760377,0.0008802887,0.00074886315,0.00083394005,0.002623737],"category_scores_gemma":[0.0005559543,0.00021310039,0.00045380497,0.0017248088,0.00035080445,0.0008091126,0.00061192,0.0015654743,0.0015693413],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012492835,0.00005118744,0.00015367211,0.014538663,0.000119274555,0.00013843352,0.000027423472,0.00025626007,0.0037230283,0.0017736886,0.036417313,0.94267625],"study_design_scores_gemma":[0.000050584338,0.000114505114,0.000889099,0.0024550406,0.0002411769,0.00095869845,0.000046110436,0.00009821472,0.001242341,0.0011068255,0.99277556,0.000021759974],"about_ca_topic_score_codex":0.0009586557,"about_ca_topic_score_gemma":0.001810672,"teacher_disagreement_score":0.002623737,"about_ca_system_score_codex":0.0006064435,"about_ca_system_score_gemma":0.0011666907,"threshold_uncertainty_score":0.008777261},"labels":[],"label_agreement":null},{"id":"W1971705000","doi":"10.1016/j.critrevonc.2011.06.001","title":"Combination or sequencing strategies to improve the outcome of metastatic renal cell carcinoma patients: A critical review","year":2011,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Temsirolimus; Medicine; Tolerability; Everolimus; Oncology; Bevacizumab; Renal cell carcinoma; Clinical trial; Internal medicine; Combination therapy; Targeted therapy; Discovery and development of mTOR inhibitors; Intensive care medicine; Cancer; Adverse effect; Chemotherapy; PI3K/AKT/mTOR pathway","score_opus":0.2091943021318495,"score_gpt":0.4524947061415655,"score_spread":0.243300404009716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971705000","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007771158,0.99925464,0.000055337747,0.00025601147,0.00015369442,0.0000051880374,0.000007946857,0.0000017576809,0.00018757062],"genre_scores_gemma":[0.0007866425,0.9982938,0.00019526487,0.00037128534,0.0002364026,0.000010485354,0.000016459573,9.0274096e-7,0.00008876255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996836,0.000093806215,0.00006395533,0.000053180658,0.00008133316,0.000024181683],"domain_scores_gemma":[0.99888116,0.0007805314,0.00011474353,0.000016583776,0.00017314986,0.000033773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013480097,0.0008788719,0.0029457633,0.0012127536,0.0002744144,0.0009315667,0.001363023,0.0010141748,0.0025018323],"category_scores_gemma":[0.0019480351,0.00028672256,0.0011905363,0.0013219367,0.00047173994,0.00096651894,0.0004614787,0.0018390835,0.00060132134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036634458,0.00013110711,0.00028692657,0.03854036,0.0006804897,0.00024506904,0.000047259542,0.00043583414,0.0007928464,0.0016420955,0.033859644,0.9229722],"study_design_scores_gemma":[0.0005040213,0.0010790991,0.0024975992,0.03969191,0.0045544906,0.0031630897,0.0001812759,0.00042461063,0.0011568259,0.00443315,0.94222736,0.00008654662],"about_ca_topic_score_codex":0.0010659995,"about_ca_topic_score_gemma":0.0026906903,"teacher_disagreement_score":0.0029457633,"about_ca_system_score_codex":0.000676544,"about_ca_system_score_gemma":0.0013427014,"threshold_uncertainty_score":0.008369505},"labels":[],"label_agreement":null},{"id":"W1980534817","doi":"10.1016/j.critrevonc.2005.08.002","title":"Cancer screening: The importance of outcome measures","year":2005,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Outcome (game theory); Cancer; Cancer screening; Disease; MEDLINE; Intensive care medicine; Family medicine; Pathology; Internal medicine","score_opus":0.23187728914333075,"score_gpt":0.50424701748236,"score_spread":0.2723697283390293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980534817","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042253905,0.99864846,0.00015336962,0.00070391846,0.0003100599,0.0000062817876,0.00001892859,0.0000022991514,0.0001144969],"genre_scores_gemma":[0.0012121701,0.9967399,0.00061928626,0.00071189535,0.0005896427,0.000025346506,0.000030037581,0.000002998645,0.00006873678],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9905219,0.0041199164,0.0020447678,0.0009123165,0.0022432134,0.00015798978],"domain_scores_gemma":[0.927443,0.062169448,0.0034479802,0.0008431889,0.005709648,0.00038668097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020467475,0.0020435348,0.010070055,0.004137075,0.00047412698,0.0035688404,0.0029114306,0.0027669102,0.0017666246],"category_scores_gemma":[0.04313002,0.00067059684,0.0024103755,0.005089047,0.0023843981,0.003802048,0.0012589738,0.0043116203,0.00062058197],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020960311,0.00006469053,0.0014428147,0.06517374,0.0011032638,0.000071942035,0.00010040719,0.0003377557,0.0002015424,0.0062351176,0.019944822,0.90511435],"study_design_scores_gemma":[0.00035399987,0.00065297715,0.015981175,0.19439578,0.008338053,0.0018043828,0.0006582535,0.0010922864,0.00096477446,0.026836274,0.74862605,0.00029602688],"about_ca_topic_score_codex":0.0043906374,"about_ca_topic_score_gemma":0.0052703507,"teacher_disagreement_score":0.020467475,"about_ca_system_score_codex":0.0028618388,"about_ca_system_score_gemma":0.004643049,"threshold_uncertainty_score":0.108243644},"labels":[],"label_agreement":null},{"id":"W1988787726","doi":"10.1016/j.critrevonc.2014.10.007","title":"Angiogenic factors in chronic lymphocytic leukaemia (CLL): Where do we stand?","year":2014,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Pleiotrophin; Midkine; Angiogenesis; Angiogenin; Cancer research; Basic fibroblast growth factor; Haematopoiesis; Growth factor; Immunology; Vascular endothelial growth factor; Chronic lymphocytic leukemia; Placental growth factor; Medicine; Angiopoietin; Biology; Internal medicine; Leukemia; Stem cell; Cell biology; Receptor; VEGF receptors","score_opus":0.10254896086678436,"score_gpt":0.46684396905452313,"score_spread":0.36429500818773874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988787726","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022005832,0.99940336,0.000017814069,0.00028897074,0.00017154455,0.0000012572173,0.0000056211043,0.0000014374396,0.00008784261],"genre_scores_gemma":[0.00028574734,0.99907804,0.000052763207,0.0002701305,0.00023026842,0.000002678425,0.000008460449,3.6473142e-7,0.000071615],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99953103,0.00011792985,0.000087127264,0.00005861443,0.00015811007,0.000047254947],"domain_scores_gemma":[0.9985905,0.00079977175,0.00019367928,0.000023950219,0.0003004771,0.00009161727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016706533,0.0008643368,0.00235913,0.0021054877,0.00037946357,0.0020683687,0.0010144042,0.0017909775,0.002782319],"category_scores_gemma":[0.002518016,0.00035517628,0.0008723115,0.0026674378,0.0008128362,0.0021126622,0.0010547423,0.0025221498,0.000941835],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018391972,0.00006074522,0.00034608698,0.036860712,0.00029633823,0.0001795974,0.000093381874,0.00022808295,0.0006716644,0.0028953904,0.06188531,0.89629865],"study_design_scores_gemma":[0.000111122055,0.0001666049,0.0011369202,0.02053346,0.00078735035,0.0009286956,0.00019695738,0.00009625245,0.00024912023,0.0027225974,0.9730314,0.000039414022],"about_ca_topic_score_codex":0.0016777008,"about_ca_topic_score_gemma":0.003120753,"teacher_disagreement_score":0.002782319,"about_ca_system_score_codex":0.0008664242,"about_ca_system_score_gemma":0.0024440645,"threshold_uncertainty_score":0.009307742},"labels":[],"label_agreement":null},{"id":"W1989665858","doi":"10.1016/j.critrevonc.2013.01.006","title":"The effect of estrogen on the sexual interest of castrated males: Implications to prostate cancer patients on androgen-deprivation therapy","year":2013,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dalhousie University","funders":"Medical Research Council; Beatrice Hunter Cancer Research Institute","keywords":"Prostate cancer; Estrogen therapy; Androgen deprivation therapy; Estrogen; Medicine; Internal medicine; Androgen; Castration; Oncology; Endocrinology; Gynecology; Cancer; Hormone","score_opus":0.16639744115831975,"score_gpt":0.4974359483198989,"score_spread":0.3310385071615791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989665858","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009184124,0.9995159,0.000010428183,0.00011840339,0.00006936581,0.000001222309,0.000013905191,8.2278075e-7,0.00017812246],"genre_scores_gemma":[0.0006811231,0.9989046,0.00002599285,0.0001519752,0.00009889631,0.0000017840881,0.0000118641665,3.6575793e-7,0.00012344624],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9998017,0.00004519689,0.000035625842,0.00003058014,0.00007202893,0.000014962173],"domain_scores_gemma":[0.9994548,0.00038171574,0.00006778952,0.0000074414493,0.0000655911,0.000022622415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051523425,0.00050925894,0.00171282,0.0010727113,0.00015210292,0.00076420605,0.00063446007,0.0007173592,0.0031277982],"category_scores_gemma":[0.0011320345,0.0002066251,0.0006463462,0.0012742601,0.00041721374,0.000511914,0.00039657048,0.0012394045,0.0005969495],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029311833,0.00006655221,0.0006125346,0.031079775,0.000434638,0.00016478618,0.000049119808,0.00019821769,0.00067762943,0.001216275,0.018878283,0.94632906],"study_design_scores_gemma":[0.00023680295,0.00045581284,0.00939119,0.021139681,0.0015870328,0.0022138902,0.0002598065,0.00012982132,0.00061029696,0.0019345875,0.9619748,0.00006622668],"about_ca_topic_score_codex":0.0025052046,"about_ca_topic_score_gemma":0.005654171,"teacher_disagreement_score":0.0031277982,"about_ca_system_score_codex":0.00044757157,"about_ca_system_score_gemma":0.00093427644,"threshold_uncertainty_score":0.010463476},"labels":[],"label_agreement":null},{"id":"W1993986934","doi":"10.1016/j.critrevonc.2009.09.005","title":"Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults","year":2009,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Geriatric oncology; Comorbidity; Geriatrics; Gerontology; Life expectancy; Activities of daily living; Androgen deprivation therapy; Cancer; Physical therapy; Population; Internal medicine; Psychiatry; Environmental health","score_opus":0.16781836514551474,"score_gpt":0.514269838172044,"score_spread":0.34645147302652923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993986934","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047587336,0.8638204,0.0024459271,0.108631134,0.014602039,0.00046036375,0.000780503,0.00008435684,0.008699376],"genre_scores_gemma":[0.003625472,0.9111318,0.012373629,0.05740695,0.009209052,0.00067796913,0.0014200112,0.000028105365,0.004127077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962196,0.0008970747,0.0010680726,0.0003355003,0.0012487003,0.00023102964],"domain_scores_gemma":[0.9866008,0.005477614,0.0020282313,0.00034346434,0.004812592,0.00073728577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009355381,0.0010655437,0.0018568027,0.0036321676,0.0009651281,0.0018368119,0.002348071,0.0045483373,0.0053598965],"category_scores_gemma":[0.015176993,0.0005976939,0.0020041524,0.0035325564,0.0014538144,0.0018197707,0.0020511125,0.0079673445,0.0024596655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012611126,0.000121767,0.0009215422,0.0300737,0.00020255047,0.0005890919,0.00031325262,0.00073877367,0.0008055038,0.017487189,0.43042523,0.51819533],"study_design_scores_gemma":[0.00005567662,0.00006517798,0.0020852478,0.03492861,0.00023108328,0.00079328404,0.000112084184,0.00011833179,0.00026074596,0.0039116596,0.9573959,0.000042166146],"about_ca_topic_score_codex":0.0070360666,"about_ca_topic_score_gemma":0.011448337,"teacher_disagreement_score":0.009355381,"about_ca_system_score_codex":0.0036749002,"about_ca_system_score_gemma":0.02135551,"threshold_uncertainty_score":0.049476564},"labels":[],"label_agreement":null},{"id":"W2000337004","doi":"10.1016/j.critrevonc.2005.10.002","title":"Adjuvant chemotherapy for completely resected non-small cell lung cancer: A systematic review","year":2006,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; McMaster University; Juravinski Cancer Centre; University Health Network; University of Toronto; Hamilton Health Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Lung cancer; Oncology; Meta-analysis; Randomized controlled trial; Regimen; Internal medicine; Adverse effect; Radiation therapy; Clinical trial; Adjuvant; Stage (stratigraphy); Cancer; Surgery","score_opus":0.07913791823205374,"score_gpt":0.45831428217309583,"score_spread":0.3791763639410421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000337004","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011778115,0.9982778,0.000053358734,0.000100245714,0.00007578766,0.000083263774,0.000105392275,0.000003335293,0.00012309509],"genre_scores_gemma":[0.022448078,0.9764563,0.00033309186,0.00039398906,0.00006195614,0.00011783263,0.00008927438,0.000002582688,0.000096917145],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99863774,0.0005405167,0.00043665353,0.00014386457,0.00018311909,0.000058157537],"domain_scores_gemma":[0.9954177,0.002886709,0.0012511329,0.000064205145,0.00028035446,0.00009980144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002130192,0.00082563865,0.005383623,0.0021071145,0.00021381966,0.0008058528,0.0007707947,0.0008388283,0.0029719707],"category_scores_gemma":[0.007998078,0.0005758837,0.0039915955,0.002675425,0.00038776267,0.00079191895,0.00057910476,0.0007455528,0.00016398363],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016956258,0.00006202755,0.0017492345,0.84412444,0.02457849,0.00020323276,0.00014217706,0.0004217197,0.0006833707,0.00015085774,0.004387771,0.12180108],"study_design_scores_gemma":[0.004667792,0.002469556,0.017655937,0.5402141,0.37096536,0.001280796,0.00032611043,0.0003477528,0.00088058517,0.00041108386,0.060685806,0.00009511534],"about_ca_topic_score_codex":0.004661575,"about_ca_topic_score_gemma":0.022422906,"teacher_disagreement_score":0.005383623,"about_ca_system_score_codex":0.0017555701,"about_ca_system_score_gemma":0.003002851,"threshold_uncertainty_score":0.012737572},"labels":[],"label_agreement":null},{"id":"W2001748120","doi":"10.1016/j.critrevonc.2004.05.001","title":"Exercise issues in older cancer survivors","year":2004,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute on Aging","keywords":"Medicine; Cancer; Gerontology; Cancer survivor; Sports medicine; Cancer survivorship; Population; Physical therapy; Older people; Survivorship curve; Internal medicine","score_opus":0.08199993426541416,"score_gpt":0.47648314449728313,"score_spread":0.39448321023186894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001748120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000865402,0.99915624,0.00001530678,0.00028096707,0.00028419774,0.000003219694,0.000007368758,0.0000011892822,0.00016496849],"genre_scores_gemma":[0.00076415366,0.9979527,0.00007245429,0.00054905243,0.00041489632,0.000012630608,0.000012271122,5.356668e-7,0.00022128003],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99957114,0.00011736349,0.00011360201,0.000054623408,0.00011848279,0.00002483364],"domain_scores_gemma":[0.99857044,0.00085259974,0.00025391977,0.000018402028,0.00023800861,0.00006668222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010337997,0.0009375334,0.0026836197,0.0023610462,0.00032957125,0.0011187418,0.0006610026,0.0016674132,0.0030179392],"category_scores_gemma":[0.0029472148,0.00030132223,0.0008040591,0.0023172363,0.00046517802,0.0010852932,0.00070621306,0.0014069069,0.0005811944],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026527923,0.00013378685,0.0010413108,0.052160617,0.00038820392,0.00025964016,0.00015539674,0.00012627969,0.00029361914,0.0005309925,0.05128773,0.8933572],"study_design_scores_gemma":[0.0002986614,0.00053414283,0.014938997,0.095169924,0.002771374,0.0027868268,0.00066315994,0.000150424,0.00035800273,0.0014410163,0.88081783,0.00006959752],"about_ca_topic_score_codex":0.0028729555,"about_ca_topic_score_gemma":0.007641432,"teacher_disagreement_score":0.0030179392,"about_ca_system_score_codex":0.0005828939,"about_ca_system_score_gemma":0.001370332,"threshold_uncertainty_score":0.010096014},"labels":[],"label_agreement":null},{"id":"W2002497392","doi":"10.1016/j.critrevonc.2010.02.010","title":"Difficulties in decision making regarding chemotherapy for older cancer patients: A census of cancer physicians","year":2010,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Division of Graduate Education; Université de Montréal; McGill University","keywords":"Medicine; Cancer; Geriatric oncology; Family medicine; General partnership; Gerontology; Chemotherapy; Social support; Internal medicine; Psychology","score_opus":0.06441616133795885,"score_gpt":0.47200247292678754,"score_spread":0.4075863115888287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002497392","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014653106,0.9806402,0.00008046302,0.002889195,0.00017644299,0.000016364509,0.0002826249,0.0000045962524,0.0012569728],"genre_scores_gemma":[0.03295447,0.9649927,0.00032535716,0.0010063915,0.00019050084,0.000023652625,0.00027113847,0.0000014984229,0.0002342405],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99917954,0.000177031,0.00019275266,0.000094747746,0.000311944,0.000044021726],"domain_scores_gemma":[0.99500245,0.0019569453,0.0014860915,0.000052591233,0.0012109332,0.000290986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010982224,0.00032440925,0.0007923786,0.0018221855,0.00027440392,0.0007088988,0.00033991013,0.0005915761,0.0011774583],"category_scores_gemma":[0.0069073276,0.00023231884,0.0005824477,0.0034692,0.0001999532,0.0009859077,0.0004888931,0.0006068309,0.0001614642],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017892031,0.00008369463,0.057534892,0.014342942,0.00066259544,0.0003292744,0.0010282705,0.00021015019,0.00017073801,0.0004226268,0.05142294,0.8736129],"study_design_scores_gemma":[0.0001728592,0.00042592132,0.60024035,0.046922337,0.0020603903,0.0049656094,0.006402205,0.00045220126,0.00025244153,0.0009514359,0.3370302,0.00012407803],"about_ca_topic_score_codex":0.015647601,"about_ca_topic_score_gemma":0.040017378,"teacher_disagreement_score":0.015647601,"about_ca_system_score_codex":0.0010048078,"about_ca_system_score_gemma":0.0028132775,"threshold_uncertainty_score":0.031113029},"labels":[],"label_agreement":null},{"id":"W2009230593","doi":"10.1016/j.critrevonc.2004.11.002","title":"Review of hemophagocytic lymphohistiocytosis (HLH) in children with focus on Japanese experiences","year":2004,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children","keywords":"Hemophagocytic lymphohistiocytosis; Immunology; Perforin; Hepatosplenomegaly; Cytotoxic T cell; Missense mutation; Pathogenesis; Medicine; Disease; Biology; Mutation; Immune system; CD8; Gene; Genetics; Internal medicine","score_opus":0.05908053155043523,"score_gpt":0.43244267741001585,"score_spread":0.3733621458595806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009230593","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018075579,0.9991485,0.00003087584,0.000109986424,0.00019922161,0.000003466229,0.000012090922,0.0000021092283,0.00031307095],"genre_scores_gemma":[0.00067094807,0.99867696,0.00010924348,0.00017806784,0.00019467105,0.00000391126,0.000019910964,5.0958744e-7,0.00014571361],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997392,0.000042131687,0.000084366744,0.00004152995,0.00006953041,0.00002329415],"domain_scores_gemma":[0.99955064,0.00018436411,0.00009355788,0.000009035988,0.0001152307,0.000047212805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061732123,0.0007952721,0.0019370845,0.0036074521,0.00032526307,0.00091263937,0.00086498196,0.0008829049,0.0023199816],"category_scores_gemma":[0.00091076223,0.0002809817,0.0005747588,0.004306066,0.00039827157,0.0012079426,0.0006556129,0.00072237843,0.00059687154],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018184971,0.000121656805,0.0016877487,0.0824545,0.00032243825,0.0030628478,0.00041441908,0.00023663316,0.0023804111,0.0013798104,0.06698797,0.8407697],"study_design_scores_gemma":[0.000061694336,0.00021203516,0.008929914,0.02100174,0.0010312115,0.017791655,0.0005625557,0.00006962088,0.00051957887,0.00072241435,0.94904006,0.000057473422],"about_ca_topic_score_codex":0.0025382338,"about_ca_topic_score_gemma":0.004870259,"teacher_disagreement_score":0.0036074521,"about_ca_system_score_codex":0.0005466976,"about_ca_system_score_gemma":0.0015172543,"threshold_uncertainty_score":0.007761121},"labels":[],"label_agreement":null},{"id":"W2009447754","doi":"10.1016/s1040-8428(01)00218-9","title":"Iron chelators as therapeutic agents for the treatment of cancer","year":2002,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Australian Research Council; National Health and Medical Research Council; Medical Research Council Canada; National Medical Research Council; Heart Research Institute","keywords":"Chelation; Chemistry; Pharmacology; In vivo; In vitro; Deferoxamine; Deferiprone; Intracellular; Cancer; Cancer research; Medicine; Biochemistry; Biology; Internal medicine","score_opus":0.1316043607119331,"score_gpt":0.48144355978300624,"score_spread":0.34983919907107314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009447754","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059644866,0.99902,0.00009988788,0.00016401909,0.00027017298,0.0000035441062,0.000003733767,0.0000039447314,0.00037506604],"genre_scores_gemma":[0.00045669364,0.99823594,0.00023021635,0.00020777973,0.00039080513,0.000005603823,0.000011365271,0.0000011004862,0.00046050976],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996941,0.0000639271,0.000047576996,0.000045218192,0.00012887915,0.000020343783],"domain_scores_gemma":[0.99914706,0.00045540064,0.00011522637,0.000023324972,0.00019589173,0.000063104046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009919864,0.0012591297,0.0023047249,0.0031492675,0.00042344574,0.0010383911,0.001323195,0.0014978116,0.0027022748],"category_scores_gemma":[0.0011400866,0.00034368495,0.00055799127,0.002773105,0.00080391776,0.001268124,0.00062417664,0.0023404108,0.0020434638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001583693,0.000121350946,0.00014697867,0.01072483,0.00011372816,0.00036331423,0.00006293131,0.00028471043,0.0021478974,0.00218229,0.0379965,0.9456971],"study_design_scores_gemma":[0.00008369145,0.00014972438,0.00063290674,0.002380526,0.00021177987,0.0024408272,0.000056617722,0.0000956639,0.00085676345,0.0015382112,0.9915319,0.000021342386],"about_ca_topic_score_codex":0.0012517466,"about_ca_topic_score_gemma":0.0026285555,"teacher_disagreement_score":0.0031492675,"about_ca_system_score_codex":0.0006627028,"about_ca_system_score_gemma":0.0011173093,"threshold_uncertainty_score":0.009039998},"labels":[],"label_agreement":null},{"id":"W2012142584","doi":"10.1016/j.critrevonc.2009.04.005","title":"Clinical experience of cancer specialists and geriatricians involved in cancer care of older patients: A qualitative study","year":2009,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; McGill University","funders":"National Cancer Institute; McGill University","keywords":"Cancer; Geriatric oncology; Medicine; Qualitative research; Geriatrics; Family medicine; Grounded theory; Older people; Gerontology; Health care; Internal medicine; Psychiatry","score_opus":0.09402092157403291,"score_gpt":0.5330545663960128,"score_spread":0.4390336448219799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012142584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966425,0.0005303124,0.0001471351,0.0012501286,0.00003294567,0.00006864824,0.00006731629,0.0000026312696,0.001258434],"genre_scores_gemma":[0.9970516,0.00061140535,0.0001941938,0.0012123635,0.000019292775,0.000109795794,0.000044479362,0.00000670775,0.00075017643],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9893924,0.0072900457,0.00051227835,0.0004615474,0.0008155305,0.0015281896],"domain_scores_gemma":[0.9637858,0.0209585,0.004339936,0.00041957948,0.003806243,0.006689861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013188026,0.00039594775,0.0009278149,0.0014780528,0.0077684415,0.0043786014,0.0013192752,0.0021514907,0.0027274045],"category_scores_gemma":[0.030352755,0.0008153582,0.00053762755,0.0012593181,0.0046463115,0.003754035,0.0056497706,0.0031932888,0.00022145377],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054790475,0.00011141381,0.022079831,0.00010969152,0.000012605896,0.00033173885,0.9749843,0.0000122354495,0.00019228048,0.00019612393,0.00041731077,0.0014976226],"study_design_scores_gemma":[0.0000061829633,0.000058021422,0.0066121775,0.000082183375,0.0000044633107,0.00010141374,0.9918646,0.000016609312,0.000031744607,0.000032181535,0.0011818948,0.000008357806],"about_ca_topic_score_codex":0.020725595,"about_ca_topic_score_gemma":0.043405224,"teacher_disagreement_score":0.020725595,"about_ca_system_score_codex":0.00609953,"about_ca_system_score_gemma":0.008388303,"threshold_uncertainty_score":0.06974572},"labels":[],"label_agreement":null},{"id":"W2012173045","doi":"10.1016/j.critrevonc.2014.11.002","title":"Biologicals, platelet apoptosis and human diseases: An outlook","year":2014,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Platelet; Medicine; Hemostasis; Apoptosis; Thrombosis; Pathophysiology; Immunology; Inflammation; Pharmacology; Cancer research; Bioinformatics; Internal medicine; Biology","score_opus":0.09548755128177946,"score_gpt":0.46330080389559064,"score_spread":0.36781325261381115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012173045","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034563094,0.9989784,0.000056259498,0.00035168373,0.00026825062,0.0000017083844,0.000007328387,0.0000034183902,0.0002985127],"genre_scores_gemma":[0.00026147263,0.9984486,0.00011516823,0.00032763754,0.00053062127,0.0000038696844,0.000013278321,6.174017e-7,0.00029866383],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997795,0.000044473298,0.000032130025,0.00003315993,0.000083704945,0.000027039272],"domain_scores_gemma":[0.99951017,0.00025531708,0.00005917497,0.000012385355,0.00011508689,0.000047800626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008221905,0.001043726,0.0016612113,0.0023678152,0.00039772992,0.0018039356,0.0009188219,0.00180349,0.0042908476],"category_scores_gemma":[0.0010035617,0.00033051017,0.0006226318,0.0025464334,0.00079364365,0.0020438763,0.0010109528,0.0026514046,0.0017414172],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017903605,0.00011917969,0.00027562358,0.020126557,0.0001249382,0.0003047929,0.00006757397,0.00036641356,0.0020611412,0.005957445,0.07494102,0.8954763],"study_design_scores_gemma":[0.000038357364,0.00012356616,0.000710922,0.004927824,0.00017385703,0.001138289,0.00010840813,0.00011670371,0.000256037,0.004008971,0.98837495,0.00002217605],"about_ca_topic_score_codex":0.00090000744,"about_ca_topic_score_gemma":0.0021699942,"teacher_disagreement_score":0.0042908476,"about_ca_system_score_codex":0.0007271899,"about_ca_system_score_gemma":0.0014011279,"threshold_uncertainty_score":0.014354348},"labels":[],"label_agreement":null},{"id":"W2017989710","doi":"10.1016/j.critrevonc.2007.08.002","title":"Neoadjuvant treatment for pancreatic cancer—A review","year":2007,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Neoadjuvant therapy; Pancreatic cancer; Adjuvant therapy; Disease; Surgery; Population; Cancer; Oncology; Chemotherapy; Internal medicine; Breast cancer","score_opus":0.30927968592112004,"score_gpt":0.585018553739542,"score_spread":0.275738867818422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017989710","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006199904,0.999368,0.000035662826,0.00017021589,0.00016904516,0.0000041700487,0.000008616004,0.000002546449,0.00017971764],"genre_scores_gemma":[0.0004827217,0.99867296,0.000110249675,0.0003598726,0.00023076344,0.000008399933,0.000017005104,8.2818457e-7,0.00011714716],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997764,0.000049738563,0.000062985375,0.000040433,0.00005577535,0.000014701414],"domain_scores_gemma":[0.99933416,0.00039017075,0.00013577506,0.000012761499,0.000088345376,0.0000387385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007164938,0.00085459964,0.0023369128,0.0018301315,0.000246981,0.00096321554,0.00088382704,0.0008935457,0.0031267623],"category_scores_gemma":[0.00127036,0.000379594,0.0007136559,0.0020322015,0.0004285897,0.0012303517,0.0005733775,0.0015549288,0.0009882782],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003305715,0.0001084311,0.00030288534,0.045746766,0.00037457352,0.00038223408,0.000041218653,0.0002869834,0.0016204687,0.0005786189,0.048504286,0.90172297],"study_design_scores_gemma":[0.00031748522,0.00064956356,0.0023292748,0.023595324,0.0020778007,0.0036888882,0.0001255261,0.00015860682,0.0009289093,0.0009633388,0.9651115,0.000053874854],"about_ca_topic_score_codex":0.0006796719,"about_ca_topic_score_gemma":0.0023671857,"teacher_disagreement_score":0.0031267623,"about_ca_system_score_codex":0.00052698544,"about_ca_system_score_gemma":0.0011929611,"threshold_uncertainty_score":0.010460079},"labels":[],"label_agreement":null},{"id":"W2024714098","doi":"10.1016/j.critrevonc.2007.06.001","title":"Cognitive function after chemotherapy in adults with solid tumours","year":2007,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cognition; Medicine; Chemotherapy; Cognitive impairment; Cancer; Confounding; Etiology; Incidence (geometry); Oncology; Internal medicine; Clinical psychology; Psychiatry","score_opus":0.06126936250480111,"score_gpt":0.44898116214656203,"score_spread":0.38771179964176095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024714098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013495103,0.9982589,0.000013953005,0.00006782681,0.00006237263,0.0000057875004,0.00003625387,0.0000011775638,0.00020416299],"genre_scores_gemma":[0.015995983,0.98327935,0.0000951964,0.00032833722,0.00010587698,0.000024148927,0.000071069226,6.027593e-7,0.000099479184],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961096,0.00011481248,0.00011294874,0.00005047504,0.0000907329,0.000020139007],"domain_scores_gemma":[0.99857926,0.00083430344,0.0003641656,0.00002279156,0.00016006386,0.000039365117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001001305,0.0006436985,0.002284374,0.0013809799,0.00017933447,0.0006876896,0.00062778103,0.0004450387,0.0011683083],"category_scores_gemma":[0.00383769,0.00015931106,0.0013190799,0.001963666,0.0002655524,0.00037813938,0.00036943305,0.0005706259,0.000108566994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013653714,0.0002074735,0.010731722,0.11462648,0.008187535,0.00032555964,0.00014998896,0.00028194257,0.0005588336,0.00023374663,0.010496352,0.852835],"study_design_scores_gemma":[0.0031769767,0.006448117,0.31593695,0.20474857,0.10244941,0.007162979,0.0012456309,0.0004786629,0.0034755103,0.002543919,0.35203817,0.00029510242],"about_ca_topic_score_codex":0.005381236,"about_ca_topic_score_gemma":0.010614927,"teacher_disagreement_score":0.005381236,"about_ca_system_score_codex":0.0006246167,"about_ca_system_score_gemma":0.0012455615,"threshold_uncertainty_score":0.010699809},"labels":[],"label_agreement":null},{"id":"W2025490583","doi":"10.1016/s1040-8428(03)00095-7","title":"The importance of parenting concerns among patients with cancer","year":2003,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Family Support in Illness","field":"Social Sciences","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Cancer; Childhood cancer; Quality of life (healthcare); Medicine; Cancer treatment; Psychology; Family medicine; Nursing","score_opus":0.10138859431815475,"score_gpt":0.4596896178503047,"score_spread":0.35830102353215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025490583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032914372,0.9985032,0.000020491809,0.00058763515,0.00027409868,0.0000023437926,0.00000503325,7.78434e-7,0.00027731803],"genre_scores_gemma":[0.0044575497,0.99454135,0.00010283782,0.0004781092,0.00029767497,0.000009492128,0.000008538129,5.981391e-7,0.000103864244],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9994006,0.00029183022,0.00008852694,0.00004961566,0.00014295394,0.000026429048],"domain_scores_gemma":[0.9964586,0.0026780567,0.00036651557,0.0000319351,0.00035366925,0.00011127752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012839265,0.00056775927,0.0012855766,0.0012650567,0.0003482319,0.00094349164,0.00039556687,0.0010678835,0.0013420103],"category_scores_gemma":[0.005986286,0.00017361333,0.0005468321,0.0016930278,0.0005376906,0.0007025081,0.0005679246,0.0011541954,0.00015244719],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001491116,0.00005749329,0.0038625887,0.034246087,0.00046648306,0.00054732553,0.000521537,0.00010228537,0.00030855768,0.0007916234,0.026009915,0.93293697],"study_design_scores_gemma":[0.0002790022,0.0006515578,0.04986997,0.08869666,0.0034732206,0.009612936,0.0032837004,0.00018591812,0.0006085779,0.0025623604,0.8406763,0.00009974721],"about_ca_topic_score_codex":0.0020416784,"about_ca_topic_score_gemma":0.0069217477,"teacher_disagreement_score":0.0020416784,"about_ca_system_score_codex":0.0005905874,"about_ca_system_score_gemma":0.001763526,"threshold_uncertainty_score":0.006790161},"labels":[],"label_agreement":null},{"id":"W2027012209","doi":"10.1016/j.critrevonc.2007.04.011","title":"Structure–function relationships of the variable domains of monoclonal antibodies approved for cancer treatment","year":2007,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Garron Family Cancer Centre","keywords":"Monoclonal antibody; Epitope; Paratope; Cetuximab; Recombinant DNA; Antibody; Antigen; Immunogenicity; Computational biology; Medicine; Biology; Immunology; Genetics; Gene","score_opus":0.22997501949382906,"score_gpt":0.499674365523765,"score_spread":0.26969934602993595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027012209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001123741,0.9969952,0.00046441532,0.0002064955,0.0001234268,0.000009579831,0.00002262378,0.00000767835,0.0010467926],"genre_scores_gemma":[0.0069888597,0.99056035,0.0009154154,0.00033301229,0.00016455601,0.000014038254,0.00010128386,0.00000259417,0.0009198838],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968576,0.000057930185,0.000034056957,0.00004150738,0.0001399208,0.000040814793],"domain_scores_gemma":[0.9995993,0.00020010665,0.00009142288,0.000012219081,0.00007937293,0.000017688348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009986887,0.00090234954,0.0012892516,0.001189655,0.0001778082,0.0011128098,0.0013093008,0.0010530154,0.0012533297],"category_scores_gemma":[0.0009879397,0.00033337218,0.0006582594,0.0014225602,0.0005241603,0.00079501176,0.00035481332,0.0013642112,0.0008779504],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000192068,0.00007174381,0.0007504764,0.0077091856,0.00015647111,0.000577778,0.000061481536,0.0014013806,0.02596817,0.0059207077,0.01443804,0.9427526],"study_design_scores_gemma":[0.000076881,0.00030703782,0.003883797,0.0017684071,0.0005021424,0.0045667095,0.000058911406,0.000631384,0.017018707,0.003279743,0.96786946,0.000036805537],"about_ca_topic_score_codex":0.0008093486,"about_ca_topic_score_gemma":0.00094398606,"teacher_disagreement_score":0.0013093008,"about_ca_system_score_codex":0.0010353191,"about_ca_system_score_gemma":0.00075693434,"threshold_uncertainty_score":0.0075117946},"labels":[],"label_agreement":null},{"id":"W2028588327","doi":"10.1016/j.critrevonc.2010.10.004","title":"Cancer cachexia: A systematic literature review of items and domains associated with involuntary weight loss in cancer","year":2011,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cachexia; Weight loss; Anorexia; Cancer cachexia; Cancer; Medicine; Psychosocial; Bioinformatics; Internal medicine; Obesity; Biology; Psychiatry","score_opus":0.10541733335297397,"score_gpt":0.46813371465139136,"score_spread":0.3627163812984174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028588327","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018378557,0.99720395,0.000074338765,0.0001457363,0.000072204166,0.00013286056,0.00040943993,0.0000044796666,0.000119099175],"genre_scores_gemma":[0.021674912,0.97647786,0.0007958086,0.0004437451,0.00005198284,0.0002266318,0.00025676144,0.000003664591,0.00006857483],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99466753,0.001529255,0.0024097892,0.00047657007,0.00076207187,0.00015481676],"domain_scores_gemma":[0.98416245,0.010010563,0.004187423,0.00021969317,0.0012116062,0.00020829312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005959326,0.0013981741,0.00820613,0.008496034,0.00051425764,0.0018238297,0.0011111854,0.0012686532,0.0023749245],"category_scores_gemma":[0.025071057,0.0009436665,0.009035838,0.010911124,0.00080855726,0.0016896043,0.0016940411,0.0010594861,0.00016717959],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038773566,0.000040662937,0.007003078,0.8946382,0.025448106,0.00014314255,0.00033689453,0.00015145102,0.00021364373,0.00015050764,0.002037327,0.069449246],"study_design_scores_gemma":[0.0006244706,0.00047683922,0.03797859,0.6815978,0.25326803,0.0008899198,0.00063474756,0.00014803423,0.00025239773,0.00033845502,0.02367845,0.000112197944],"about_ca_topic_score_codex":0.011143352,"about_ca_topic_score_gemma":0.041228227,"teacher_disagreement_score":0.011143352,"about_ca_system_score_codex":0.002777835,"about_ca_system_score_gemma":0.008129364,"threshold_uncertainty_score":0.031516314},"labels":[],"label_agreement":null},{"id":"W2029225153","doi":"10.1016/s1040-8428(00)00087-1","title":"Overview of autologous stem cell transplantation","year":2000,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Stem cell; Multiple myeloma; Transplantation; Bone marrow; Autologous stem-cell transplantation; Surgery; Immunology; Biology","score_opus":0.1334675622002062,"score_gpt":0.44358331696603615,"score_spread":0.31011575476583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029225153","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030210947,0.99835205,0.00010672994,0.00020532162,0.0005347649,0.0000050872086,0.000011308315,0.0000062611102,0.0007482321],"genre_scores_gemma":[0.00025642852,0.9976482,0.00023247166,0.00050450745,0.0007564764,0.00000938602,0.00002680543,0.0000013575803,0.00056433113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996464,0.000069521375,0.00005431117,0.000058428916,0.00014361365,0.000027639822],"domain_scores_gemma":[0.9993593,0.0003216058,0.00008106443,0.000015378902,0.00016087416,0.00006189724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009893501,0.0014194571,0.002493579,0.003875925,0.00039456753,0.0016454197,0.0012952257,0.0016945783,0.0062667066],"category_scores_gemma":[0.0012873712,0.0004459639,0.0007957819,0.0036893934,0.00062853505,0.0021207188,0.0008715342,0.0025608805,0.0031385275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015734487,0.00012025018,0.00017363833,0.023061689,0.00012835966,0.00040255225,0.000041273568,0.00036371674,0.0013570846,0.0033669742,0.11082598,0.8600011],"study_design_scores_gemma":[0.000050090992,0.00009632345,0.00055790687,0.0043473537,0.00017098579,0.0014687958,0.00003601607,0.00007736367,0.00020841553,0.0011302934,0.9918407,0.000015739659],"about_ca_topic_score_codex":0.0014227573,"about_ca_topic_score_gemma":0.0029691928,"teacher_disagreement_score":0.0062667066,"about_ca_system_score_codex":0.001015169,"about_ca_system_score_gemma":0.0018683687,"threshold_uncertainty_score":0.020964265},"labels":[],"label_agreement":null},{"id":"W2036568229","doi":"10.1016/j.critrevonc.2009.03.001","title":"Adjuvant bisphosphonate therapy for breast cancer patients: Standard of care or future direction?","year":2009,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Bone health and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Oncology; Adjuvant therapy; Adjuvant; Clinical trial; Cancer; Internal medicine; Metastatic breast cancer; Randomized controlled trial; Disease","score_opus":0.052923977268484586,"score_gpt":0.46855957400646975,"score_spread":0.41563559673798517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036568229","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011290274,0.9967283,0.00009095475,0.002040502,0.00056099676,0.000004384374,0.000018024617,0.0000042247993,0.00043964727],"genre_scores_gemma":[0.001353477,0.9963678,0.00032681882,0.0010785767,0.0005555766,0.00000794408,0.000032512162,0.0000011215749,0.0002761092],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99941075,0.00015227262,0.00013974134,0.0000706518,0.00018616523,0.000040315692],"domain_scores_gemma":[0.9987012,0.00059060554,0.00028017652,0.0000291008,0.00033089516,0.00006809088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002164977,0.00061755866,0.002621083,0.0011571744,0.00020530756,0.0013050217,0.0011356431,0.0014507399,0.0037400671],"category_scores_gemma":[0.0032082868,0.00028770202,0.00068128057,0.0018684808,0.0005663799,0.0015000092,0.00045623808,0.002336276,0.0012408983],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002602387,0.000074026626,0.00033332035,0.015282009,0.00021307118,0.00012430748,0.000025405263,0.0002602139,0.00047000466,0.0020524221,0.041111242,0.9397938],"study_design_scores_gemma":[0.000514047,0.00044551806,0.0029085719,0.025801545,0.0013973686,0.0018186448,0.00017531935,0.00039398807,0.0005091306,0.0036395225,0.96235454,0.00004185229],"about_ca_topic_score_codex":0.0017923216,"about_ca_topic_score_gemma":0.0060372925,"teacher_disagreement_score":0.0037400671,"about_ca_system_score_codex":0.001136419,"about_ca_system_score_gemma":0.0027755639,"threshold_uncertainty_score":0.01251179},"labels":[],"label_agreement":null},{"id":"W2036755924","doi":"10.1016/j.critrevonc.2013.05.007","title":"Geographic differences in approach to advanced gastric cancer: Is there a standard approach?","year":2013,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Irinotecan; Cancer; Internal medicine; Oncology; Chemotherapy; Disease; Colorectal cancer","score_opus":0.10869819486598088,"score_gpt":0.42253776119236824,"score_spread":0.3138395663263874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036755924","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001625578,0.9968569,0.00006138024,0.002365024,0.0002896,0.000003674728,0.000017350849,0.0000019963245,0.00024145351],"genre_scores_gemma":[0.0031780843,0.99462587,0.00025724186,0.0013546777,0.0004784,0.000012572354,0.000029530116,0.0000012534456,0.00006230562],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99857724,0.00050743564,0.00035287888,0.00017014431,0.00032205944,0.00007038173],"domain_scores_gemma":[0.9952938,0.0026369337,0.0009956615,0.00007584832,0.00084403,0.000153596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040611904,0.00058532454,0.0023371796,0.002073943,0.00025804355,0.0014646016,0.0011424044,0.0010175413,0.0019553069],"category_scores_gemma":[0.011327587,0.00024317975,0.0011016116,0.00336501,0.001038967,0.0017800234,0.0010877008,0.0019751687,0.00027897625],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017189521,0.00005919519,0.0047468403,0.051782858,0.0013680074,0.000152947,0.000269919,0.00033838445,0.0001497399,0.003794567,0.03479536,0.90237033],"study_design_scores_gemma":[0.00033660242,0.00039768,0.024921175,0.13197666,0.0068548624,0.0016545177,0.0018472518,0.0002466248,0.00032009964,0.008019923,0.82332295,0.00010165835],"about_ca_topic_score_codex":0.004944634,"about_ca_topic_score_gemma":0.009872838,"teacher_disagreement_score":0.004944634,"about_ca_system_score_codex":0.00199627,"about_ca_system_score_gemma":0.0043362263,"threshold_uncertainty_score":0.021477878},"labels":[],"label_agreement":null},{"id":"W2042675162","doi":"10.1016/s1040-8428(02)00007-0","title":"Copper and carcinogenesis","year":2002,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Trace Elements in Health","field":"Nursing","cited_by":352,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kootenay Association for Science & Technology","funders":"","keywords":"Deoxyribose; Reactive oxygen species; Chemistry; Copper; Carcinogenesis; Radical; Catalysis; DNA damage; Redox; Reactive intermediate; Metal; DNA; Biochemistry; Inorganic chemistry; Organic chemistry","score_opus":0.17513654691434463,"score_gpt":0.4877557359682859,"score_spread":0.31261918905394126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042675162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001937669,0.99528116,0.00020568176,0.00088960974,0.0019085335,0.0000063578755,0.0000124969665,0.000014803212,0.001487482],"genre_scores_gemma":[0.0023178132,0.98905784,0.00027837016,0.0007252567,0.0014051668,0.000013730873,0.000030619594,0.0000034142847,0.006167811],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996075,0.00009966213,0.000048645103,0.000059987164,0.0001507732,0.000033477063],"domain_scores_gemma":[0.9996259,0.00010291034,0.00006197767,0.000030298866,0.00014493735,0.000034016717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072291394,0.0012771982,0.001549607,0.0027965074,0.00060248334,0.0012840134,0.0009887664,0.0015312372,0.0055068973],"category_scores_gemma":[0.0009361967,0.00036992555,0.00050777063,0.002790068,0.00083256763,0.0011867632,0.0012912891,0.0011666773,0.001997263],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016279811,0.00007758554,0.00034603968,0.012239775,0.00015475409,0.0003962553,0.00013374382,0.0002504867,0.0035496731,0.0034204018,0.1103168,0.86895174],"study_design_scores_gemma":[0.000026392376,0.00011230925,0.00061327487,0.002065363,0.0001757021,0.0010503144,0.00010249169,0.00004101801,0.0018443589,0.0020925063,0.9918616,0.000014603456],"about_ca_topic_score_codex":0.0028167833,"about_ca_topic_score_gemma":0.005415192,"teacher_disagreement_score":0.0055068973,"about_ca_system_score_codex":0.0009653382,"about_ca_system_score_gemma":0.002491239,"threshold_uncertainty_score":0.018422425},"labels":[],"label_agreement":null},{"id":"W2043247151","doi":"10.1016/s1040-8428(01)00139-1","title":"Ethics of rural health care","year":2001,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Jessie Ball duPont Fund","keywords":"Outreach; Confidentiality; Rural area; Medicine; Health care; Alliance; Nursing; Economic Justice; Quarter (Canadian coin); Family medicine; Political science; Law","score_opus":0.1608137104597912,"score_gpt":0.5248876162937445,"score_spread":0.36407390583395327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043247151","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003164147,0.96572024,0.00022283921,0.028559553,0.0009359678,0.000012870361,0.000006736969,0.0000041916533,0.0042212526],"genre_scores_gemma":[0.013357941,0.96975434,0.00056334713,0.013037564,0.0013310037,0.000059488462,0.00001306499,0.000003962939,0.0018792489],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934011,0.0047995145,0.00032323904,0.00019759529,0.0010739309,0.00020454457],"domain_scores_gemma":[0.9867511,0.009818749,0.0012641931,0.000324829,0.0014574913,0.00038371718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072192075,0.0005163429,0.00097501546,0.0019248136,0.0012755546,0.003294163,0.0007947239,0.0031747057,0.0036128773],"category_scores_gemma":[0.01832926,0.00032077255,0.00030003168,0.0027974586,0.004176562,0.0025014195,0.0024034944,0.0034271372,0.00042969093],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006858341,0.00009766371,0.0008560973,0.02438012,0.00011888205,0.0005991178,0.0037815964,0.00045699126,0.0003940399,0.10551558,0.17370085,0.6900304],"study_design_scores_gemma":[0.000028317687,0.000034785342,0.0015191868,0.022291757,0.00004454632,0.00065081636,0.001695388,0.00006214686,0.000123224,0.020297362,0.9532381,0.0000142623485],"about_ca_topic_score_codex":0.0039151916,"about_ca_topic_score_gemma":0.009602302,"teacher_disagreement_score":0.0072192075,"about_ca_system_score_codex":0.004584941,"about_ca_system_score_gemma":0.015377552,"threshold_uncertainty_score":0.03817928},"labels":[],"label_agreement":null},{"id":"W2046364242","doi":"10.1016/j.critrevonc.2012.07.003","title":"The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: A clinical practice guideline","year":2012,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital; Jewish General Hospital; McGill University Health Centre; Sunnybrook Health Science Centre; St. Paul's Hospital; Health Sciences Centre; University of British Columbia","funders":"","keywords":"Lenalidomide; Thalidomide; Myelodysplastic syndromes; Guideline; Medicine; Intensive care medicine; Oncology; Internal medicine; Multiple myeloma; Pathology; Bone marrow","score_opus":0.2543962427450863,"score_gpt":0.5526891098308602,"score_spread":0.29829286708577385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046364242","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000077146266,0.99653023,0.00023626938,0.0012858717,0.00052768394,0.000036848167,0.00008468094,0.000013074697,0.001208259],"genre_scores_gemma":[0.00042069625,0.9965933,0.000958157,0.0009968397,0.00022230923,0.000032363223,0.00013392081,0.0000026889415,0.0006397831],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99940276,0.000113513895,0.00015516931,0.00005596162,0.00024128627,0.000031396896],"domain_scores_gemma":[0.99874794,0.00056246977,0.00022368594,0.000021216803,0.00038035892,0.00006423824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014250918,0.0010026371,0.0021465109,0.0026128204,0.00028663428,0.0010665145,0.0019730004,0.0019816454,0.0028751378],"category_scores_gemma":[0.002238397,0.00037311972,0.0014895323,0.0023657198,0.00040138,0.0010534031,0.00063464936,0.0024646781,0.0017045676],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010964766,0.000081035934,0.00020287857,0.030486641,0.0003086954,0.00021655236,0.0000462808,0.000300354,0.0010056071,0.001912739,0.1409519,0.8243777],"study_design_scores_gemma":[0.00015199825,0.00009228185,0.0010083123,0.020671485,0.0007822047,0.0008544078,0.000047947753,0.00013868415,0.00030389318,0.001295142,0.9746276,0.000026013062],"about_ca_topic_score_codex":0.004225149,"about_ca_topic_score_gemma":0.009394609,"teacher_disagreement_score":0.004225149,"about_ca_system_score_codex":0.00097087334,"about_ca_system_score_gemma":0.0028840757,"threshold_uncertainty_score":0.009618342},"labels":[],"label_agreement":null},{"id":"W2049829884","doi":"10.1016/j.critrevonc.2014.07.004","title":"Reproductive factors and non-Hodgkin lymphoma: A systematic review","year":2014,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Universitat de Barcelona","keywords":"Etiology; Medicine; Estrogen; Lymphoma; Hormone; Hodgkin lymphoma; Oncology; Bioinformatics; Gynecology; Internal medicine; Biology","score_opus":0.07690594790914243,"score_gpt":0.45548752257723996,"score_spread":0.3785815746680975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049829884","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004251522,0.99917704,0.000026460506,0.00010264608,0.000060167888,0.000045450077,0.000105550615,0.0000019241186,0.00005548595],"genre_scores_gemma":[0.010319318,0.98873246,0.00020846994,0.00046779227,0.00006633813,0.00009094237,0.000058202448,0.0000015652187,0.00005487883],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99649054,0.0011180285,0.0013617193,0.00033978972,0.0005259593,0.00016389036],"domain_scores_gemma":[0.98566806,0.009652704,0.0035696856,0.00015800078,0.00072595285,0.00022567197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004397523,0.0015847574,0.006475682,0.007578119,0.00044757177,0.0021022232,0.0010620008,0.0019634024,0.0052367942],"category_scores_gemma":[0.019011032,0.0011955604,0.007136019,0.008038901,0.0008243073,0.0017279306,0.0014869757,0.0012804784,0.00022927835],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030178428,0.00002808512,0.0022911776,0.9365736,0.025966411,0.0001538127,0.00015067193,0.000097134915,0.00014367346,0.00012520004,0.0018949395,0.03227355],"study_design_scores_gemma":[0.0007463294,0.00032584634,0.010550649,0.66559225,0.29450488,0.0008258719,0.00040355246,0.000079103535,0.0001714076,0.00035237602,0.026377812,0.000070007765],"about_ca_topic_score_codex":0.008324851,"about_ca_topic_score_gemma":0.03271843,"teacher_disagreement_score":0.008324851,"about_ca_system_score_codex":0.0025137868,"about_ca_system_score_gemma":0.0069672125,"threshold_uncertainty_score":0.0232566},"labels":[],"label_agreement":null},{"id":"W2053115200","doi":"10.1016/j.critrevonc.2011.05.009","title":"Could targeting bone delay cancer progression? Potential mechanisms of action of bisphosphonates","year":2011,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Bone health and treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Zoledronic acid; Medicine; Bone marrow; Cancer; Breast cancer; Multiple myeloma; Cancer research; Tumor progression; Oncology; Cancer cell; Tumor microenvironment; Internal medicine","score_opus":0.12128708839131158,"score_gpt":0.5000773647743756,"score_spread":0.378790276383064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053115200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000090016714,0.9987005,0.0000811566,0.00041109067,0.00019073412,0.000003486102,0.000010945875,0.000003958315,0.000508188],"genre_scores_gemma":[0.0006013227,0.9986136,0.00013323831,0.0001980457,0.000108170134,0.0000054416805,0.000014033094,6.90851e-7,0.00032548717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974555,0.000046435758,0.00003328954,0.000037920512,0.00010399971,0.00003283779],"domain_scores_gemma":[0.99966955,0.00016609223,0.000048174345,0.000008738888,0.000086821565,0.000020598087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008139571,0.0010212269,0.0019979854,0.0014340394,0.00030041093,0.0012047035,0.0012512673,0.0015990562,0.0039554355],"category_scores_gemma":[0.0009102486,0.00031309662,0.0007401702,0.0015453913,0.0007005569,0.0011767481,0.0006444179,0.0021602435,0.0017104506],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002735843,0.00011500258,0.00014676712,0.015952235,0.000163984,0.00025292137,0.000043689448,0.00042436327,0.0041334983,0.006744582,0.030166889,0.94158244],"study_design_scores_gemma":[0.00012628845,0.00022735889,0.0007735021,0.00379458,0.00025788773,0.0013140697,0.00006928231,0.00012480382,0.001615089,0.0035962372,0.9880746,0.000026382782],"about_ca_topic_score_codex":0.0015017786,"about_ca_topic_score_gemma":0.0034150132,"teacher_disagreement_score":0.0039554355,"about_ca_system_score_codex":0.000855497,"about_ca_system_score_gemma":0.0013554565,"threshold_uncertainty_score":0.013232231},"labels":[],"label_agreement":null},{"id":"W2058243111","doi":"10.1016/j.critrevonc.2009.03.005","title":"Levels of sex hormones have limited effect on cognition in older men with or without prostate cancer","year":2009,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Rehabilitation Institute; University of Toronto","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Toronto Rehabilitation Institute; University Health Network; Cancer Research Institute","keywords":"Testosterone (patch); Prostate cancer; Cognition; Hormone; Androgen; Androgen deprivation therapy; Internal medicine; Affect (linguistics); Medicine; Psychology; Endocrinology; Oncology; Cancer; Neuroscience","score_opus":0.059537684602260964,"score_gpt":0.4201733202279859,"score_spread":0.360635635625725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058243111","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96047026,0.036112536,0.000065643566,0.0004666427,0.00014168657,0.00000939119,0.00047170653,0.000006061697,0.002256143],"genre_scores_gemma":[0.99458295,0.0042913905,0.000058044097,0.0003087564,0.00018343348,0.000005328557,0.000223135,0.0000030410408,0.00034387386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958366,0.0001500189,0.00005417957,0.00008028325,0.00007905494,0.000052836047],"domain_scores_gemma":[0.99609345,0.0018435786,0.0009266887,0.00030771265,0.0004384351,0.0003901332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011874479,0.0005674333,0.0011609321,0.0008874303,0.0004001866,0.001010234,0.0004510201,0.00066719076,0.0015079554],"category_scores_gemma":[0.007540533,0.000291367,0.0008783684,0.001194107,0.00063833914,0.0005454588,0.0004125139,0.00075149,0.0001557477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064801937,0.00022620481,0.9633208,0.000539823,0.002558824,0.00037414563,0.0006319186,0.00007278206,0.0010208386,0.00007644251,0.00061201124,0.024086094],"study_design_scores_gemma":[0.00004943988,0.00041705256,0.9982191,0.000030621224,0.00061112613,0.000111806825,0.00013230949,0.000015996698,0.000055151595,0.00009227412,0.0002596653,0.000005397221],"about_ca_topic_score_codex":0.013539624,"about_ca_topic_score_gemma":0.016714035,"teacher_disagreement_score":0.013539624,"about_ca_system_score_codex":0.00037872617,"about_ca_system_score_gemma":0.0004025046,"threshold_uncertainty_score":0.02692163},"labels":[],"label_agreement":null},{"id":"W2059330989","doi":"10.1016/j.critrevonc.2010.04.003","title":"Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study","year":2010,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital; University of Toronto","funders":"","keywords":"Medicine; Grip strength; Logistic regression; Toxicity; Geriatric oncology; Prospective cohort study; Proportional hazards model; Performance status; Internal medicine; Cancer; Gerontology; Physical therapy","score_opus":0.08229290768159514,"score_gpt":0.4132758791085545,"score_spread":0.33098297142695937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059330989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99900705,0.00039772192,0.00011516803,0.00006529379,0.000015756465,0.00004071472,0.00018781678,0.0000021304786,0.00016839802],"genre_scores_gemma":[0.9988972,0.00021390269,0.00020630013,0.00010190687,0.000036446898,0.00005816144,0.00034689248,0.0000023756982,0.00013669353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988551,0.0006494044,0.000093119685,0.00017569782,0.00010455907,0.00012216863],"domain_scores_gemma":[0.9929476,0.0028317992,0.0016798949,0.00078083447,0.0008175333,0.0009422992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047771693,0.00097060186,0.0012974747,0.0004378097,0.00068710296,0.0013970168,0.0006375599,0.0010641416,0.0013372558],"category_scores_gemma":[0.008769504,0.00054668065,0.001347028,0.0009063131,0.0007390312,0.0012802265,0.0005734436,0.0014543039,0.0003950442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016254306,0.0013596953,0.97449476,0.00005180138,0.0006646119,0.000089061235,0.000351609,0.0000969354,0.00065445126,0.000029420635,0.00020857232,0.005744835],"study_design_scores_gemma":[0.0016619758,0.012551492,0.983192,0.00003282209,0.00095407973,0.0001879674,0.00036984676,0.0003536049,0.00022626646,0.00007543485,0.00036903447,0.000025320336],"about_ca_topic_score_codex":0.0032395532,"about_ca_topic_score_gemma":0.003512106,"teacher_disagreement_score":0.0047771693,"about_ca_system_score_codex":0.00038670932,"about_ca_system_score_gemma":0.0006006326,"threshold_uncertainty_score":0.025264382},"labels":[],"label_agreement":null},{"id":"W2059784303","doi":"10.1016/j.critrevonc.2015.01.007","title":"Patients’ satisfaction in early breast cancer treatment: Change in treatment over time and impact of HER2-targeted therapy","year":2015,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Research Society; American Society for Radiation Oncology; American Association for Cancer Research","keywords":"Breast cancer; Medicine; Quality of life (healthcare); Oncology; Adjuvant; Targeted therapy; Adjuvant therapy; Cancer; Internal medicine; Human Epidermal Growth Factor Receptor 2; Nursing","score_opus":0.13091745782011374,"score_gpt":0.5000722111753172,"score_spread":0.3691547533552034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059784303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007607755,0.9984346,0.000042701635,0.00035803523,0.00008399446,0.0000050536246,0.00003549508,0.0000014722955,0.000278015],"genre_scores_gemma":[0.0069928113,0.99195063,0.00018764334,0.00046067222,0.00015212175,0.0000139487975,0.000053338586,0.0000011339984,0.00018771851],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9993649,0.00023050199,0.000091564674,0.000068105925,0.00020145487,0.000043413587],"domain_scores_gemma":[0.99866307,0.0008793771,0.00025562992,0.000011420319,0.00014332386,0.00004718825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013974194,0.00041499166,0.0018088096,0.0007574788,0.00013404666,0.00084551086,0.0006362501,0.0007317042,0.0021534837],"category_scores_gemma":[0.002541232,0.00016255496,0.0010938549,0.0015603134,0.00026953156,0.00062265585,0.00041226856,0.0012176504,0.00023924415],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032846944,0.00013898367,0.0024710847,0.035737075,0.0011402526,0.00007704332,0.00012771532,0.00023112631,0.00029344103,0.00087596447,0.012538862,0.94604003],"study_design_scores_gemma":[0.0007693373,0.0022151768,0.12149033,0.10183285,0.007759842,0.0041025765,0.0016212934,0.0009325224,0.0011023954,0.0040049516,0.7539015,0.00026728632],"about_ca_topic_score_codex":0.0017088188,"about_ca_topic_score_gemma":0.004007904,"teacher_disagreement_score":0.0021534837,"about_ca_system_score_codex":0.00080047175,"about_ca_system_score_gemma":0.0009098684,"threshold_uncertainty_score":0.0073903203},"labels":[],"label_agreement":null},{"id":"W2060481687","doi":"10.1016/j.critrevonc.2014.08.001","title":"Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis","year":2014,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministero dell’Istruzione, dell’Università e della Ricerca","keywords":"Benchmarking; Renal cell carcinoma; Medicine; Oncology; Clinical endpoint; Internal medicine; Progression-free survival; Clinical trial; Overall survival; Randomized controlled trial","score_opus":0.12207618892468768,"score_gpt":0.48118485976249337,"score_spread":0.3591086708378057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060481687","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033693985,0.998609,0.00046039265,0.00022059008,0.00008851572,0.000041707328,0.000045024695,0.0000046979844,0.00019320045],"genre_scores_gemma":[0.016011802,0.98024344,0.0021601517,0.0006536277,0.00037925027,0.00024632926,0.00013924784,0.000012369716,0.0001538097],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9897003,0.0061546573,0.0019713258,0.0006200536,0.0014361124,0.00011752318],"domain_scores_gemma":[0.95355386,0.041867074,0.0028087574,0.00043779172,0.0011880393,0.00014456845],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.019883182,0.00088615646,0.0068873516,0.00159254,0.00013887283,0.0014215065,0.0019927637,0.0011241239,0.0017427065],"category_scores_gemma":[0.03636642,0.0004454173,0.0038108174,0.0021877934,0.00074184657,0.0010828158,0.00058320677,0.002078466,0.00029756414],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027232775,0.000073697,0.00096266763,0.13485254,0.009077621,0.00004527041,0.00006508329,0.0017093589,0.00047320325,0.0029035467,0.007156043,0.8399577],"study_design_scores_gemma":[0.014830899,0.011334978,0.033857856,0.2657864,0.13056782,0.0030470185,0.00051288656,0.00848499,0.0045406376,0.04932245,0.47722003,0.00049399893],"about_ca_topic_score_codex":0.0007138345,"about_ca_topic_score_gemma":0.001632419,"teacher_disagreement_score":0.98011684,"about_ca_system_score_codex":0.001198093,"about_ca_system_score_gemma":0.0014665973,"threshold_uncertainty_score":0.10515362},"labels":[],"label_agreement":null},{"id":"W2066047258","doi":"10.1016/j.critrevonc.2012.02.004","title":"Multitargeted anti-angiogenic agents and NSCLC: Clinical update and future directions","year":2012,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Sunitinib; Axitinib; Bevacizumab; Medicine; Angiogenesis; Vascular endothelial growth factor; Sorafenib; Fibroblast growth factor; Lung cancer; Cancer research; Oncology; Platelet-derived growth factor receptor; Growth factor; Pharmacology; Internal medicine; Chemotherapy; Cancer; VEGF receptors; Receptor; Hepatocellular carcinoma","score_opus":0.12314918485587871,"score_gpt":0.5226966903665233,"score_spread":0.3995475055106446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066047258","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010889615,0.99888533,0.00007249946,0.00039044375,0.00017630655,0.0000036009021,0.000018340526,0.000006033586,0.00033849227],"genre_scores_gemma":[0.0006567313,0.9981394,0.000201616,0.00042364173,0.00027387784,0.000005628297,0.000030848627,0.0000013393937,0.00026689612],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979216,0.00003577899,0.000037306232,0.000032793465,0.000079293204,0.000022680695],"domain_scores_gemma":[0.9993036,0.00034759523,0.00011517476,0.000012792752,0.00016568201,0.00005518372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009317798,0.0007894566,0.0018324519,0.0015298183,0.00020803676,0.001270525,0.00090265257,0.0010835197,0.003481693],"category_scores_gemma":[0.0011495267,0.00032292164,0.00068096496,0.0018241848,0.00042779208,0.0015162844,0.00057991955,0.0023606014,0.001386629],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019232543,0.00011579858,0.00028622922,0.01287506,0.00016100901,0.00018156484,0.000036530335,0.00036960116,0.0015107031,0.0012490383,0.049735297,0.93328696],"study_design_scores_gemma":[0.00014251699,0.00030108646,0.0014005981,0.0044312,0.0005953092,0.0015331624,0.0000730866,0.00029214323,0.0007089882,0.0013682165,0.9891165,0.000037311896],"about_ca_topic_score_codex":0.0008323868,"about_ca_topic_score_gemma":0.0027317659,"teacher_disagreement_score":0.003481693,"about_ca_system_score_codex":0.0005036619,"about_ca_system_score_gemma":0.001291481,"threshold_uncertainty_score":0.011647403},"labels":[],"label_agreement":null},{"id":"W2068016036","doi":"10.1016/j.critrevonc.2013.12.003","title":"A critical appraisal of systemic treatment options for metastatic non-clear cell renal cell carcinoma","year":2013,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Temsirolimus; Sunitinib; Sorafenib; Medicine; Oncology; Renal cell carcinoma; Internal medicine; Discovery and development of mTOR inhibitors; Biology","score_opus":0.13347212915148227,"score_gpt":0.4518256693344538,"score_spread":0.3183535401829715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068016036","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041687792,0.9991499,0.000038804857,0.00034577242,0.00018008122,0.0000031720917,0.000010840605,0.0000022590625,0.0002273988],"genre_scores_gemma":[0.00065552024,0.99805367,0.00012471422,0.0006797399,0.0003197434,0.0000068743634,0.00001954527,0.000001098197,0.00013916168],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99962676,0.00010360446,0.00009359187,0.00004739578,0.0001025494,0.000026097341],"domain_scores_gemma":[0.99869233,0.0008257909,0.00020988968,0.00001741608,0.00021041295,0.000044250726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013055326,0.0007625267,0.0024378307,0.0018825433,0.00027195073,0.0011225336,0.0008771895,0.0010785008,0.0034453084],"category_scores_gemma":[0.0022662857,0.000336642,0.0012517357,0.0017901949,0.00048503093,0.0013889141,0.0005625367,0.0020688658,0.0006548745],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024717575,0.000051496474,0.00017150224,0.05921376,0.00042214157,0.00022012273,0.00006954109,0.00036787658,0.000792948,0.0017060577,0.058256175,0.8784811],"study_design_scores_gemma":[0.00020070629,0.00041815027,0.0012512512,0.034601185,0.001885561,0.0015780028,0.000106672094,0.0002120461,0.00041969138,0.0015569911,0.9577286,0.000041174495],"about_ca_topic_score_codex":0.0010906387,"about_ca_topic_score_gemma":0.0033532318,"teacher_disagreement_score":0.0034453084,"about_ca_system_score_codex":0.00090954814,"about_ca_system_score_gemma":0.0014834214,"threshold_uncertainty_score":0.011525691},"labels":[],"label_agreement":null},{"id":"W2070432051","doi":"10.1016/j.critrevonc.2010.05.004","title":"Potential drug interactions in elderly cancer patients","year":2010,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Concomitant; Contraindication; Medicine; Drug; Cancer; Intensive care medicine; Drug interaction; Internal medicine; Pharmacology; Alternative medicine; Pathology","score_opus":0.2005661983127204,"score_gpt":0.557114383883131,"score_spread":0.35654818557041057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070432051","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00069337676,0.9985617,0.00004890999,0.0002301154,0.00007439683,0.0000058017913,0.000022017724,0.0000025129532,0.00036119536],"genre_scores_gemma":[0.0053617847,0.993573,0.00021289023,0.00040121138,0.00017847543,0.000011601866,0.000028805955,8.4295846e-7,0.0002313861],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993794,0.00019666756,0.0001736817,0.000059767124,0.00016731505,0.000023211267],"domain_scores_gemma":[0.9977658,0.0013327185,0.0006195563,0.000020121568,0.00021230865,0.000049495866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087246235,0.00057335536,0.0017961345,0.0014858228,0.00019286621,0.0006867569,0.00041244252,0.0006980035,0.0019120278],"category_scores_gemma":[0.0030290529,0.00020857283,0.0009832995,0.0015314238,0.00019354101,0.0006315991,0.00041060834,0.00071416446,0.0002760197],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004028953,0.00012411333,0.0042164293,0.040630873,0.001460659,0.0005432915,0.00007628962,0.00021810483,0.00060137373,0.00038084638,0.014577756,0.9367674],"study_design_scores_gemma":[0.0008085702,0.0016701145,0.059255052,0.06460639,0.018385325,0.015309612,0.0005127981,0.0009332503,0.0025424685,0.0025065853,0.8333366,0.00013309137],"about_ca_topic_score_codex":0.00092262187,"about_ca_topic_score_gemma":0.0034006354,"teacher_disagreement_score":0.0019120278,"about_ca_system_score_codex":0.00041968309,"about_ca_system_score_gemma":0.0008855048,"threshold_uncertainty_score":0.0063963532},"labels":[],"label_agreement":null},{"id":"W2071995956","doi":"10.1016/j.critrevonc.2010.07.007","title":"Peripheral T-cell lymphoma – Not otherwise specified","year":2010,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Peripheral T-cell lymphoma; Lymphoma; CD5; International Prognostic Index; CD8; Not Otherwise Specified; Medicine; Pathology; Lymph node; B symptoms; Bone marrow; Cytotoxic T cell; Generalized lymphadenopathy; T cell; Biology; Immunology; Diffuse large B-cell lymphoma; Immune system","score_opus":0.0986027842196142,"score_gpt":0.43288626105203254,"score_spread":0.3342834768324183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071995956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008417788,0.9983626,0.000082155166,0.00021648452,0.00043265964,0.000005560145,0.000014732391,0.0000062340787,0.00079534855],"genre_scores_gemma":[0.001331541,0.996655,0.00021094231,0.00055103377,0.00049686676,0.0000107332935,0.000052405743,0.0000016284588,0.00068983476],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974483,0.000055511184,0.000059221045,0.000036247908,0.000079301935,0.000024885183],"domain_scores_gemma":[0.9994779,0.00022770242,0.00013408756,0.000016327667,0.000104039114,0.000040006857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005361052,0.0009123029,0.001804031,0.0019280217,0.00019399864,0.0007145052,0.0007133523,0.00064780744,0.0033992704],"category_scores_gemma":[0.0012349808,0.00023148285,0.00039892644,0.002032097,0.0004817248,0.0009782028,0.00056263455,0.0012104771,0.0013244798],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012491408,0.000039695056,0.0003047756,0.017856535,0.00012954975,0.00037445824,0.00002101943,0.0002170467,0.00098675,0.0008312426,0.06528922,0.91382486],"study_design_scores_gemma":[0.000104455394,0.00012090778,0.001355395,0.008720653,0.00059986726,0.0050184326,0.000058389338,0.000094743074,0.0005772477,0.0010136149,0.98231655,0.00001962801],"about_ca_topic_score_codex":0.00092371734,"about_ca_topic_score_gemma":0.002475273,"teacher_disagreement_score":0.0033992704,"about_ca_system_score_codex":0.00064316497,"about_ca_system_score_gemma":0.0014254602,"threshold_uncertainty_score":0.011371732},"labels":[],"label_agreement":null},{"id":"W2072037526","doi":"10.1016/j.critrevonc.2012.02.005","title":"Anaplastic large cell lymphoma, ALK-positive","year":2012,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; CD30; Medicine; Lymphoma; CHOP; Internal medicine; Oncology; International Prognostic Index; Large cell; Chemotherapy; Autologous stem-cell transplantation; Vincristine; Pathology; Cancer research; Cyclophosphamide; Diffuse large B-cell lymphoma; Cancer; Adenocarcinoma","score_opus":0.0786741343386865,"score_gpt":0.42814028940004256,"score_spread":0.34946615506135603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072037526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057460984,0.9991554,0.00003454803,0.00012997918,0.00016999524,0.0000024008154,0.000009390809,0.0000031991235,0.0004376841],"genre_scores_gemma":[0.0007212146,0.99820733,0.00010171497,0.00027303092,0.00030638525,0.000003947191,0.000029672536,8.1672226e-7,0.0003559572],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997707,0.000033854052,0.00004457439,0.00004264861,0.0000893877,0.000018870618],"domain_scores_gemma":[0.99957305,0.00019235838,0.00009242862,0.000010570726,0.00008985613,0.000041676023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004526661,0.0008655141,0.0014778655,0.0024879102,0.00022935795,0.0009324614,0.000775374,0.00070662476,0.0030541455],"category_scores_gemma":[0.0010208183,0.0002823074,0.000414188,0.0023329074,0.00045016452,0.0011241415,0.0005064165,0.001278749,0.00141831],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008873525,0.00004242361,0.00035079345,0.016100407,0.00011528766,0.00034912289,0.000021127546,0.00016355533,0.0011639106,0.0007139162,0.046382602,0.9345082],"study_design_scores_gemma":[0.000090449386,0.0001081057,0.0023740563,0.008647875,0.0005755749,0.0067581506,0.00009146576,0.00010524231,0.00056153385,0.0015275073,0.9791252,0.00003481064],"about_ca_topic_score_codex":0.0011697893,"about_ca_topic_score_gemma":0.0034364006,"teacher_disagreement_score":0.0030541455,"about_ca_system_score_codex":0.0005779196,"about_ca_system_score_gemma":0.0011398369,"threshold_uncertainty_score":0.01021713},"labels":[],"label_agreement":null},{"id":"W2072606968","doi":"10.1016/j.critrevonc.2007.04.014","title":"A comprehensive systematic review of testicular germ cell tumor surveillance","year":2007,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Germ cell; Germ; Medicine; Biology; Cell biology; Genetics","score_opus":0.09061410456637124,"score_gpt":0.45929676956395243,"score_spread":0.3686826649975812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072606968","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029368777,0.99898046,0.00005540704,0.00019177613,0.0000829867,0.00006982405,0.00018078952,0.000004034973,0.0001410276],"genre_scores_gemma":[0.0063644773,0.9924143,0.00039471796,0.00045140652,0.00007542879,0.00011268853,0.00011292672,0.0000021703393,0.0000718175],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99505216,0.0016466819,0.0020549458,0.00039160423,0.0007057883,0.00014883974],"domain_scores_gemma":[0.98592234,0.008188168,0.0040817354,0.00021095258,0.0013632514,0.0002335344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006004042,0.0014744182,0.007735333,0.010149148,0.0004070344,0.0016460725,0.001300548,0.0012864775,0.0035107057],"category_scores_gemma":[0.020108817,0.0009206618,0.0050168564,0.009788427,0.00063899346,0.0015355562,0.0013034646,0.0008802733,0.00028172205],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003056806,0.00002514437,0.00116033,0.84658086,0.014116765,0.00020073634,0.00022665552,0.0002072544,0.0003332346,0.00026097195,0.006071383,0.13051097],"study_design_scores_gemma":[0.0005709149,0.0005455767,0.008197893,0.76501817,0.14262804,0.0010056264,0.00031552106,0.00011814416,0.0004643522,0.0003888859,0.08067737,0.00006951765],"about_ca_topic_score_codex":0.008163087,"about_ca_topic_score_gemma":0.031391136,"teacher_disagreement_score":0.010149148,"about_ca_system_score_codex":0.0029508995,"about_ca_system_score_gemma":0.011189416,"threshold_uncertainty_score":0.031752765},"labels":[],"label_agreement":null},{"id":"W2073309188","doi":"10.1016/j.critrevonc.2011.02.005","title":"Consensus on the utility of bone markers in the malignant bone disease setting","year":2011,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Bone health and treatments","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; University of Waterloo; Centre Hospitalier de l’Université de Montréal","funders":"Cancer Research UK","keywords":"Disease; Medicine; Pathology","score_opus":0.16574590685762466,"score_gpt":0.45947597047575384,"score_spread":0.29373006361812914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073309188","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003225934,0.99653995,0.00014455372,0.0024140147,0.00048831804,0.000004097019,0.000018028033,0.0000030964165,0.00035576936],"genre_scores_gemma":[0.00049461005,0.9962114,0.0004325372,0.0020565276,0.0006054099,0.000010130207,0.000028942228,0.00000202654,0.0001585042],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9976146,0.00055953494,0.00063192396,0.00033614162,0.0007302383,0.00012755218],"domain_scores_gemma":[0.9861834,0.009203598,0.0010368968,0.00020917118,0.0030675046,0.0002993768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077783973,0.0012533683,0.0041414406,0.0041571776,0.0005186368,0.0032613766,0.002967632,0.004363546,0.002824639],"category_scores_gemma":[0.013915283,0.00061699626,0.0020470133,0.0040487717,0.0017030095,0.0039887265,0.0018904516,0.0059709097,0.0015982372],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022926588,0.000048789596,0.0003576838,0.03936105,0.00043603798,0.00040179357,0.00014066641,0.00032300665,0.0007530584,0.0066230693,0.08016055,0.8711651],"study_design_scores_gemma":[0.00009488997,0.00010056741,0.00090975256,0.035644647,0.0008631344,0.001245319,0.00020269852,0.00012268191,0.0005255148,0.0050104107,0.9552229,0.000057533587],"about_ca_topic_score_codex":0.0031815777,"about_ca_topic_score_gemma":0.00521691,"teacher_disagreement_score":0.0077783973,"about_ca_system_score_codex":0.0018413102,"about_ca_system_score_gemma":0.006560979,"threshold_uncertainty_score":0.041136563},"labels":[],"label_agreement":null},{"id":"W2073595456","doi":"10.1016/j.critrevonc.2008.07.015","title":"Quality of life beyond 6 months after diagnosis in older adults with acute myeloid leukemia","year":2008,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Quality of life (healthcare); Myeloid leukemia; Cognition; Pediatrics; Adverse effect; Gerontology; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.04108414178077232,"score_gpt":0.38816088368181106,"score_spread":0.34707674190103877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073595456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9526567,0.04121757,0.000079949365,0.0021938565,0.000236109,0.000024694162,0.0007336069,0.00000365774,0.002853892],"genre_scores_gemma":[0.99131197,0.007183741,0.00007468626,0.00044087827,0.00018790885,0.000018022987,0.0005500503,0.0000010334361,0.00023162081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995553,0.00014152209,0.00007138131,0.000048589056,0.00008226037,0.00010103311],"domain_scores_gemma":[0.99766636,0.00040165382,0.0010656579,0.000041111834,0.00032544,0.0004999175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009454916,0.00023411306,0.0006833412,0.00057687535,0.00036289092,0.0006927533,0.0002086331,0.0006490311,0.0009305395],"category_scores_gemma":[0.0052709705,0.00009026696,0.00080795574,0.0009334566,0.00021863403,0.00066581654,0.00050383864,0.00088444573,0.00009599379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006519179,0.00016149748,0.9643898,0.00030217372,0.00043304326,0.00028596845,0.00045162372,0.00011874216,0.00012740996,0.0000976926,0.0012621401,0.031717855],"study_design_scores_gemma":[0.000021391148,0.00031283696,0.99785334,0.000106989704,0.00017266549,0.00019006303,0.00031083374,0.00006707938,0.000020079817,0.00010058664,0.00083638466,0.000007778416],"about_ca_topic_score_codex":0.004439692,"about_ca_topic_score_gemma":0.007489855,"teacher_disagreement_score":0.004439692,"about_ca_system_score_codex":0.0005851745,"about_ca_system_score_gemma":0.00044019718,"threshold_uncertainty_score":0.008827686},"labels":[],"label_agreement":null},{"id":"W2073945008","doi":"10.1016/j.critrevonc.2013.06.003","title":"Malnutrition assessment in patients with cancers of the head and neck: A call to action and consensus","year":2013,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; Alberta Health Services; University of Alberta","funders":"Canadian Institutes of Health Research; Canadian Nutrition Society; Alberta Health Services","keywords":"Malnutrition; Medicine; Action (physics); Head and neck; Call to action; Head and neck cancer; Intensive care medicine; Head (geology); Internal medicine; Surgery; Radiation therapy; Biology","score_opus":0.1476131765603573,"score_gpt":0.5086713834653993,"score_spread":0.361058206905042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073945008","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011074309,0.98811764,0.0001736744,0.010292508,0.0010791137,0.0000059421195,0.000025745994,0.0000066026223,0.00018812396],"genre_scores_gemma":[0.0023642937,0.9875644,0.0014318661,0.0067683,0.0016273977,0.000030520256,0.00007318832,0.0000046073947,0.0001353904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99680895,0.0008795447,0.00097013015,0.00042652502,0.0007689925,0.00014592595],"domain_scores_gemma":[0.9862483,0.008004591,0.0011942028,0.00018361863,0.00391932,0.0004499895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009426307,0.0012136817,0.0060320813,0.0023937318,0.0006152956,0.003423101,0.0027617011,0.0045952983,0.0016777664],"category_scores_gemma":[0.01526963,0.00051125477,0.002821106,0.002401548,0.0013927958,0.0049480395,0.002007879,0.008308538,0.00067865796],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036108136,0.00013110817,0.003445482,0.03804358,0.0009052013,0.00027985347,0.00026949565,0.00039873342,0.0004661746,0.0030395372,0.10550579,0.8471539],"study_design_scores_gemma":[0.00037230333,0.0003486443,0.012905225,0.15585116,0.0038545413,0.0020219604,0.0020629237,0.0008801077,0.0006226208,0.014676633,0.80616987,0.00023403346],"about_ca_topic_score_codex":0.0064056846,"about_ca_topic_score_gemma":0.0102284085,"teacher_disagreement_score":0.009426307,"about_ca_system_score_codex":0.0021935364,"about_ca_system_score_gemma":0.007822847,"threshold_uncertainty_score":0.049851716},"labels":[],"label_agreement":null},{"id":"W2074862947","doi":"10.1016/j.critrevonc.2012.12.010","title":"Erythropoiesis-stimulating agents (ESAs): Do they still have a role in chemotherapy-induced anemia (CIA)?","year":2013,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Sunnybrook Health Science Centre; Queen Elizabeth II Health Sciences Centre; Juravinski Hospital; Regional Municipality of Durham; University of Toronto; Health Sciences Centre; Ottawa Regional Cancer Foundation; BC Cancer Agency; Ottawa Hospital","funders":"Public Health Agency of Canada","keywords":"Medicine; Anemia; Erythropoiesis; Chemotherapy; Intensive care medicine; Cancer; Oncology; Internal medicine","score_opus":0.10825598706274397,"score_gpt":0.4510804286726588,"score_spread":0.3428244416099148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074862947","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004965949,0.99936444,0.000028116918,0.0002575953,0.00010336157,0.0000016534672,0.000008345761,0.0000015742685,0.00018531914],"genre_scores_gemma":[0.00050794764,0.99886537,0.00009963535,0.0002625357,0.00013089702,0.000003756152,0.000012816885,5.512433e-7,0.00011652441],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971634,0.000059176396,0.000063525105,0.000041359915,0.00009850264,0.000021044387],"domain_scores_gemma":[0.9990227,0.00062593806,0.00014901102,0.000017673729,0.00014205326,0.000042563333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010131955,0.00054550666,0.0017250706,0.0011760421,0.00022287511,0.0009683878,0.0008080093,0.0010395482,0.0033724078],"category_scores_gemma":[0.00184855,0.00024433204,0.0007227038,0.001562368,0.0004817962,0.0010540306,0.0005051322,0.001981863,0.0008848462],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001654865,0.000068752604,0.00024129152,0.021424295,0.00022106372,0.00009319933,0.000033281674,0.00017401636,0.0006166345,0.0027568687,0.024802499,0.9494025],"study_design_scores_gemma":[0.0001631198,0.00020874485,0.0013458835,0.01336712,0.0007679876,0.001132602,0.00007653237,0.000113670474,0.00047509972,0.0021933615,0.9801327,0.000023205177],"about_ca_topic_score_codex":0.0012844305,"about_ca_topic_score_gemma":0.0029744217,"teacher_disagreement_score":0.0033724078,"about_ca_system_score_codex":0.00045842343,"about_ca_system_score_gemma":0.0013089366,"threshold_uncertainty_score":0.011281788},"labels":[],"label_agreement":null},{"id":"W2076179156","doi":"10.1016/j.critrevonc.2008.01.005","title":"Conformal radiotherapy for hepatocellular carcinoma","year":2008,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; University of Michigan","keywords":"Medicine; Hepatocellular carcinoma; Radiation therapy; Toxicity; Carcinoma; Oncology; Limiting; Internal medicine","score_opus":0.20987471570514496,"score_gpt":0.4231530574531787,"score_spread":0.21327834174803376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076179156","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007831817,0.9988201,0.000089802146,0.00017796077,0.00026906663,0.00000456843,0.000010446018,0.0000053481003,0.00054428086],"genre_scores_gemma":[0.00091630366,0.9978264,0.00013696449,0.00033025458,0.00035310417,0.000007733192,0.000020229272,0.0000018635466,0.000407169],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981695,0.00005357036,0.000034911995,0.00003065258,0.000052164076,0.000011777546],"domain_scores_gemma":[0.99962866,0.00018198346,0.00008482604,0.000019599782,0.00006449231,0.000020419186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053505664,0.0006931426,0.001510604,0.0016212312,0.00019815302,0.0006324668,0.00065151154,0.0005941171,0.0032643713],"category_scores_gemma":[0.0012371129,0.00027513402,0.00046112842,0.0020489574,0.00038897037,0.0007799054,0.0005396128,0.0010035201,0.0012353313],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007426319,0.00002634465,0.0001424257,0.015848255,0.00013673663,0.00013406582,0.000029281953,0.0002850847,0.0007683731,0.00072822615,0.041021038,0.94080585],"study_design_scores_gemma":[0.000089377056,0.00019822815,0.0017959516,0.0069699762,0.0005605171,0.003591583,0.00004258128,0.00012792237,0.0008581696,0.001093146,0.9846436,0.000029013938],"about_ca_topic_score_codex":0.0011491368,"about_ca_topic_score_gemma":0.0022640345,"teacher_disagreement_score":0.0032643713,"about_ca_system_score_codex":0.00064189493,"about_ca_system_score_gemma":0.00081145635,"threshold_uncertainty_score":0.010920405},"labels":[],"label_agreement":null},{"id":"W2078205539","doi":"10.1016/s1040-8428(01)00126-3","title":"The use of Shiga-like toxin 1 in cancer therapy","year":2001,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"University of Toronto","keywords":"Shiga toxin; Cancer research; Biology; Context (archaeology); Immunotoxin; Immunology; Antibody; Monoclonal antibody; Gene","score_opus":0.18327446621127189,"score_gpt":0.434008883629548,"score_spread":0.25073441741827607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078205539","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001488842,0.9979279,0.00025409932,0.0004990743,0.00055774924,0.000004524236,0.00000555276,0.0000074034083,0.0005948171],"genre_scores_gemma":[0.0009674953,0.99702734,0.00030116257,0.00042783385,0.00063726,0.000007929304,0.00001749576,0.0000016871984,0.00061181677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976534,0.000057836256,0.0000283603,0.00003385387,0.00009107515,0.000023508579],"domain_scores_gemma":[0.9994987,0.00027190542,0.00005312951,0.000018731707,0.000112108384,0.000045358476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011481746,0.0010031315,0.0017917695,0.0015817124,0.00042341868,0.0011680946,0.0009912027,0.0018322495,0.0023334858],"category_scores_gemma":[0.0009222224,0.00029847166,0.0005740408,0.0015279993,0.00084714557,0.0016144256,0.00065080257,0.0029498055,0.0016110068],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023858984,0.000129175,0.00022096193,0.0059923967,0.00009069072,0.00046744567,0.000057877452,0.0006346155,0.0045099943,0.005126966,0.046790928,0.93574035],"study_design_scores_gemma":[0.00009569288,0.0002689984,0.00066631363,0.0014043344,0.00011000767,0.0024059894,0.00005673802,0.0001716025,0.0012981017,0.0029600062,0.99054,0.000022325896],"about_ca_topic_score_codex":0.0007451469,"about_ca_topic_score_gemma":0.0016190505,"teacher_disagreement_score":0.0023334858,"about_ca_system_score_codex":0.0008180033,"about_ca_system_score_gemma":0.0009331044,"threshold_uncertainty_score":0.007806301},"labels":[],"label_agreement":null},{"id":"W2079589100","doi":"10.1016/j.critrevonc.2009.08.005","title":"Treatment for metastatic malignant melanoma: Old drugs and new strategies","year":2009,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Directorate for Biological Sciences","keywords":"Medicine; Dacarbazine; Melanoma; Metastatic melanoma; Immunotherapy; Clinical trial; Oncology; Chemotherapy; First line; Refractory (planetary science); Cancer; Internal medicine; Cancer research","score_opus":0.2065223788696071,"score_gpt":0.5077436865363419,"score_spread":0.3012213076667348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079589100","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000086492415,0.9983437,0.00014174943,0.0005013267,0.0003263857,0.000004556928,0.000009673642,0.0000067683973,0.0005794261],"genre_scores_gemma":[0.00066563074,0.9975569,0.00025781867,0.0005629819,0.00039659202,0.000007587531,0.000021726424,0.000002044179,0.00052864634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997719,0.00004713705,0.000025220348,0.00004099519,0.00009301059,0.000021754406],"domain_scores_gemma":[0.99964094,0.00019007169,0.000040951763,0.000012569857,0.00008415747,0.000031258118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083284057,0.0009940658,0.002157735,0.001696681,0.00033967983,0.0010524056,0.0011388942,0.0012838073,0.003211121],"category_scores_gemma":[0.00076683774,0.0003014202,0.0006609018,0.0014212169,0.0007271023,0.0017448098,0.00059366884,0.0029909485,0.0018844097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012123578,0.00010651914,0.00011693641,0.006730667,0.000098646284,0.00019925613,0.000035347195,0.00041696551,0.0014651684,0.0025199845,0.055310067,0.93287927],"study_design_scores_gemma":[0.0000911512,0.0001847812,0.000527711,0.0024679329,0.00016334852,0.001205615,0.000050583425,0.00019966543,0.00045242632,0.0020299682,0.9926052,0.000021680144],"about_ca_topic_score_codex":0.0010029285,"about_ca_topic_score_gemma":0.0027331468,"teacher_disagreement_score":0.003211121,"about_ca_system_score_codex":0.0006814756,"about_ca_system_score_gemma":0.0007929497,"threshold_uncertainty_score":0.010742247},"labels":[],"label_agreement":null},{"id":"W2088100021","doi":"10.1016/j.critrevonc.2009.10.006","title":"Does frailty predict hospitalization, emergency department visits, and visits to the general practitioner in older newly-diagnosed cancer patients? Results of a prospective pilot study","year":2009,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; University of Toronto; Jewish General Hospital","funders":"Jewish General Hospital; McGill University","keywords":"Medicine; Emergency department; Prospective cohort study; Cancer; Odds ratio; Health care; Emergency medicine; Internal medicine; Psychiatry","score_opus":0.028648932510621613,"score_gpt":0.3904657639378036,"score_spread":0.36181683142718196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088100021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994722,0.00014464624,0.000023317729,0.000034028937,0.0000061600144,0.000013959882,0.00015626404,7.4432927e-7,0.00014872475],"genre_scores_gemma":[0.9994468,0.000106189225,0.000055929297,0.000047816513,0.000017344239,0.00001705861,0.0002022634,9.2911563e-7,0.000105614665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926406,0.000317044,0.00007381627,0.00012238906,0.000093327464,0.00012939527],"domain_scores_gemma":[0.99624544,0.0010486123,0.0011713168,0.00028065717,0.00039251905,0.00086140254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016773824,0.00054566894,0.0008346381,0.000578418,0.00067849597,0.0009301619,0.00048060084,0.0010736648,0.0012990265],"category_scores_gemma":[0.005787455,0.000506166,0.0012019612,0.0011207263,0.00043570038,0.0008640959,0.0005597899,0.0013650118,0.00029567847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008166319,0.00027130972,0.9977247,0.00000956496,0.00007942364,0.000042043866,0.00015533497,0.00001744706,0.00007570242,0.0000052744504,0.000053808777,0.000748841],"study_design_scores_gemma":[0.00006861505,0.0008407185,0.9985262,0.0000060791335,0.00008075952,0.000068963665,0.00024161255,0.00007534208,0.000018935858,0.00000983827,0.000057686233,0.00000509924],"about_ca_topic_score_codex":0.013473295,"about_ca_topic_score_gemma":0.015150929,"teacher_disagreement_score":0.013473295,"about_ca_system_score_codex":0.00041617203,"about_ca_system_score_gemma":0.00057278347,"threshold_uncertainty_score":0.026789784},"labels":[],"label_agreement":null},{"id":"W2088500044","doi":"10.1016/j.critrevonc.2012.07.006","title":"Treatment of metastatic cervical cancer: Future directions involving targeted agents","year":2012,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cervical cancer; Clinical trial; Disease; Oncology; Targeted therapy; Chemotherapy; Cancer; Radiation therapy; Internal medicine; Intensive care medicine","score_opus":0.13359325886132045,"score_gpt":0.5007791000466785,"score_spread":0.367185841185358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088500044","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000086814216,0.99857986,0.00016588253,0.00039370754,0.00019231447,0.0000054573215,0.00001697141,0.000008492972,0.0005504669],"genre_scores_gemma":[0.00066198007,0.9981104,0.00027103646,0.00037718524,0.00020043823,0.000006652738,0.000028247334,0.0000016684668,0.00034233282],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998204,0.000035556855,0.000023337578,0.000036069017,0.00006185113,0.000022809098],"domain_scores_gemma":[0.99965775,0.00018459342,0.000044286153,0.000008712099,0.00007948939,0.000025105983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006419686,0.00092943275,0.0016873403,0.001442548,0.00025181985,0.0010483769,0.0009678344,0.0010676846,0.004308027],"category_scores_gemma":[0.00076978945,0.00026230735,0.00077412004,0.0013851171,0.00047037244,0.0013525023,0.0004971514,0.0022020473,0.0014803121],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010373297,0.00010217287,0.00015297033,0.011845367,0.00010441573,0.0001607604,0.00002754021,0.00051863515,0.0020962912,0.0018033673,0.037620716,0.94546396],"study_design_scores_gemma":[0.00008579055,0.0002523112,0.0008757473,0.004015534,0.00038500797,0.0013337057,0.000057142177,0.0002637736,0.00085716747,0.0019436977,0.98990333,0.00002686583],"about_ca_topic_score_codex":0.0012018192,"about_ca_topic_score_gemma":0.0032345485,"teacher_disagreement_score":0.004308027,"about_ca_system_score_codex":0.00073614647,"about_ca_system_score_gemma":0.0010592554,"threshold_uncertainty_score":0.014411747},"labels":[],"label_agreement":null},{"id":"W2093173796","doi":"10.1016/j.critrevonc.2010.08.004","title":"Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients","year":2010,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer","keywords":"Medicine; Geriatric oncology; Depression (economics); Malnutrition; Cancer; Geriatric Depression Scale; Geriatrics; Population; Activities of daily living; Internal medicine; Physical therapy; Cognition; Psychiatry; Depressive symptoms","score_opus":0.07266032070785503,"score_gpt":0.458234214218081,"score_spread":0.385573893510226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093173796","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028436314,0.9962334,0.000043709508,0.00029808504,0.00014021085,0.000007212891,0.000018356737,0.0000017478785,0.00041357786],"genre_scores_gemma":[0.038132347,0.96038055,0.00038741587,0.0005053641,0.000362572,0.00002350158,0.000073470495,0.0000016643761,0.0001331351],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99928015,0.00029463862,0.00014772767,0.00007159316,0.00016913688,0.00003674533],"domain_scores_gemma":[0.99710816,0.0020071752,0.00039092638,0.000022590142,0.0003771237,0.000094014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012282741,0.0004713554,0.0017344912,0.0007734958,0.00020836391,0.0007022249,0.00062357425,0.0005725747,0.0014504243],"category_scores_gemma":[0.007732629,0.00017854554,0.0010318588,0.0010361568,0.00019914078,0.00046446713,0.00031047995,0.00076691114,0.00014211575],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010725934,0.00019608295,0.018639067,0.043885853,0.002641989,0.00044974496,0.00021716808,0.0003620388,0.000306339,0.0002814725,0.013104808,0.91884285],"study_design_scores_gemma":[0.0029332035,0.003645261,0.3161529,0.1832352,0.05991949,0.010005515,0.001842822,0.0023873674,0.0018726101,0.002430281,0.41524842,0.00032690575],"about_ca_topic_score_codex":0.0033064205,"about_ca_topic_score_gemma":0.007864141,"teacher_disagreement_score":0.0033064205,"about_ca_system_score_codex":0.00064682745,"about_ca_system_score_gemma":0.0015891478,"threshold_uncertainty_score":0.0065743327},"labels":[],"label_agreement":null},{"id":"W2093960755","doi":"10.1016/j.critrevonc.2008.07.019","title":"Optimizing treatment for men with advanced prostate cancer: Expert recommendations and the multidisciplinary approach","year":2008,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Cancer Research UK","keywords":"Multidisciplinary approach; Medicine; Prostate cancer; Docetaxel; Disease; Multidisciplinary team; Cancer; Palliative care; Intensive care medicine; Oncology; Family medicine; Medical physics; Gynecology; Internal medicine; Nursing","score_opus":0.15436456547267305,"score_gpt":0.5045686602154852,"score_spread":0.3502040947428121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093960755","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006176666,0.9913446,0.0003765982,0.0067805946,0.0009066263,0.000015106101,0.000017950268,0.00000901115,0.00048776792],"genre_scores_gemma":[0.0007195086,0.9933744,0.0016640957,0.00301125,0.00088562036,0.00002511696,0.00003369178,0.0000026918376,0.00028359925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99842143,0.0005638464,0.00024071052,0.0001635144,0.00053265056,0.00007797024],"domain_scores_gemma":[0.9964904,0.0019848263,0.0003734973,0.000050876864,0.0009447451,0.0001556057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004544793,0.0013791288,0.0034446782,0.0018242005,0.0005452626,0.0016466547,0.0026004482,0.0034750937,0.003049132],"category_scores_gemma":[0.005524484,0.00046876085,0.0017419652,0.0017775969,0.0008279963,0.0022261029,0.0011156359,0.00554843,0.0011792375],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011180764,0.00013703167,0.0004898474,0.018548382,0.00048173542,0.00021744787,0.000094123374,0.00087688013,0.00035609302,0.0030430825,0.13850239,0.8371412],"study_design_scores_gemma":[0.0002693665,0.00021563131,0.0027568727,0.056678962,0.001487032,0.0015805073,0.00034491127,0.0007349116,0.000427778,0.01119951,0.92421484,0.00008955865],"about_ca_topic_score_codex":0.0038635286,"about_ca_topic_score_gemma":0.0090521965,"teacher_disagreement_score":0.004544793,"about_ca_system_score_codex":0.001756549,"about_ca_system_score_gemma":0.004245488,"threshold_uncertainty_score":0.024035454},"labels":[],"label_agreement":null},{"id":"W2096582651","doi":"10.1016/j.critrevonc.2006.06.006","title":"Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: A systematic literature review","year":2006,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University Health Network; University of Toronto; Toronto Rehabilitation Institute","funders":"","keywords":"Androgen deprivation therapy; Prostate cancer; Medicine; Sexual function; Adverse effect; Quality of life (healthcare); Disease; Bone mineral; Oncology; Sexual dysfunction; Randomized controlled trial; Internal medicine; Cancer; Physical therapy; Osteoporosis","score_opus":0.04513563591893599,"score_gpt":0.4416818956491786,"score_spread":0.3965462597302426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096582651","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009303905,0.99872005,0.00003413638,0.000065271546,0.00003961949,0.00003093934,0.00010725945,0.0000016754112,0.00007073756],"genre_scores_gemma":[0.01358081,0.9857099,0.00023841861,0.00022305697,0.000047822527,0.000055847853,0.00008423779,0.0000014967725,0.000058469133],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9972114,0.00081211334,0.0011148097,0.0002603653,0.0005232061,0.00007810408],"domain_scores_gemma":[0.9838268,0.010964609,0.004029404,0.00016525439,0.00082376285,0.00019018087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041803755,0.00083272514,0.0056861523,0.0034216943,0.0003127079,0.0012412659,0.0010465618,0.0011069746,0.002643894],"category_scores_gemma":[0.016330443,0.0006570904,0.0059902593,0.0046073236,0.00045440104,0.0010186015,0.00079287187,0.0009020585,0.00014252261],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097389816,0.00005301692,0.004405256,0.84557694,0.033958822,0.0002689037,0.00020419087,0.00022919099,0.00024528155,0.00013103521,0.0023473108,0.11160606],"study_design_scores_gemma":[0.0011705081,0.0011242692,0.042574972,0.6084543,0.3026022,0.001876843,0.0005025567,0.00020930158,0.00039087047,0.0003991607,0.040578473,0.000116595074],"about_ca_topic_score_codex":0.006220567,"about_ca_topic_score_gemma":0.026220439,"teacher_disagreement_score":0.006220567,"about_ca_system_score_codex":0.0017613315,"about_ca_system_score_gemma":0.0036362542,"threshold_uncertainty_score":0.022108197},"labels":[],"label_agreement":null},{"id":"W2096984260","doi":"10.1016/j.critrevonc.2004.12.004","title":"Multi-dysfunctional pathophysiology in ITP","year":2005,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Science and Technology of the People's Republic of China; University of Calgary","keywords":"Autoantibody; Immunology; Pathophysiology; Medicine; Megakaryocytopoiesis; Disease; Platelet; Thrombopoietin; Antibody; Biology; Haematopoiesis; Stem cell; Internal medicine","score_opus":0.11643709893329297,"score_gpt":0.46576395480221006,"score_spread":0.3493268558689171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096984260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008863974,0.9986111,0.00016325188,0.00032961057,0.000411165,0.0000037795553,0.0000048846287,0.000005171018,0.0003823823],"genre_scores_gemma":[0.0008450291,0.99738413,0.0002527824,0.00037424287,0.0007786046,0.000008319665,0.000015932792,8.438725e-7,0.00034008795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973065,0.000058506273,0.000060349936,0.000039782535,0.00008744821,0.000023271034],"domain_scores_gemma":[0.99953365,0.00025282396,0.0000722807,0.000014654917,0.00009471248,0.000031844953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008456664,0.0012473126,0.0020040122,0.0021886046,0.0003040785,0.0013263867,0.0009215355,0.0015878471,0.0022025262],"category_scores_gemma":[0.0010404235,0.0003628624,0.00052000576,0.0018333907,0.0006625983,0.0016023489,0.00080592505,0.001998942,0.0012632812],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016454262,0.00010425356,0.00048603542,0.015055944,0.00020640099,0.0018580776,0.00007790217,0.0004444257,0.0020199618,0.0049909693,0.04638727,0.92820436],"study_design_scores_gemma":[0.000127667,0.00020256577,0.0015484404,0.0059676324,0.00048305286,0.010721249,0.000114341114,0.0003132984,0.0011235677,0.0062054093,0.9731531,0.000039574516],"about_ca_topic_score_codex":0.00049153395,"about_ca_topic_score_gemma":0.00094117917,"teacher_disagreement_score":0.0022025262,"about_ca_system_score_codex":0.00055940135,"about_ca_system_score_gemma":0.0014245476,"threshold_uncertainty_score":0.007368207},"labels":[],"label_agreement":null},{"id":"W2112249236","doi":"10.1016/j.critrevonc.2013.03.002","title":"Mismatch repair status and clinical outcome in endometrial cancer: A systematic review and meta-analysis","year":2013,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Endometrial cancer; Meta-analysis; Medicine; Oncology; Outcome (game theory); Internal medicine; Cancer","score_opus":0.31325222125291924,"score_gpt":0.5481715933611923,"score_spread":0.23491937210827302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112249236","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043905354,0.9949239,0.0001607134,0.00009208633,0.00007444254,0.000047201735,0.00022473549,0.0000067644996,0.00007969719],"genre_scores_gemma":[0.13878046,0.8585452,0.0010526957,0.00061529747,0.00017343086,0.00018474193,0.0004105116,0.000011243931,0.00022639504],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.996855,0.0011524201,0.001035537,0.0004659023,0.00033573,0.00015541463],"domain_scores_gemma":[0.9925107,0.00527575,0.0014118013,0.00022480206,0.00044214108,0.00013486521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053399494,0.0019566882,0.010466567,0.0032031971,0.00043373276,0.0017408503,0.0016819984,0.0017006586,0.0030806107],"category_scores_gemma":[0.0140195545,0.0012643184,0.019861568,0.0050101723,0.00054094405,0.0012908346,0.0013210047,0.001417132,0.00022480785],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021065106,0.000046756646,0.012482675,0.37197322,0.59173006,0.00023362676,0.00012604143,0.00044131998,0.00037606974,0.00011715158,0.001027555,0.01933909],"study_design_scores_gemma":[0.00046078538,0.00018881472,0.008149857,0.0148075875,0.9738641,0.00014844214,0.00007339265,0.00010058456,0.000088790715,0.00013430147,0.0019526593,0.000030630166],"about_ca_topic_score_codex":0.005914009,"about_ca_topic_score_gemma":0.01859114,"teacher_disagreement_score":0.010466567,"about_ca_system_score_codex":0.0013685119,"about_ca_system_score_gemma":0.002156136,"threshold_uncertainty_score":0.02824068},"labels":[],"label_agreement":null},{"id":"W2124808968","doi":"10.1016/j.critrevonc.2006.09.006","title":"Pharmacogenetics of paclitaxel metabolism","year":2006,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Paclitaxel; Pharmacogenetics; Medicine; Pharmacology; Chemotherapy; Drug metabolism; Drug; Oncology; Internal medicine; Biology; Genotype; Genetics","score_opus":0.3217679777041367,"score_gpt":0.5847237841736879,"score_spread":0.2629558064695512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124808968","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00083698216,0.9942715,0.0013684022,0.0006939531,0.0002845745,0.000009539475,0.00005119066,0.0000335212,0.0024503586],"genre_scores_gemma":[0.0067591416,0.98857236,0.0012739158,0.00055341213,0.0006570738,0.000019352414,0.00011874932,0.0000059549143,0.0020399455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998036,0.000062064166,0.000023944485,0.00003328087,0.00006423087,0.000012834369],"domain_scores_gemma":[0.99975795,0.00013307766,0.00004482627,0.000011918719,0.000040602114,0.000011549925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004249016,0.0007196643,0.001136366,0.0010656391,0.000119754586,0.00071613997,0.00044924478,0.0005649514,0.0021560828],"category_scores_gemma":[0.00060175505,0.0002066925,0.0004050601,0.0010313075,0.00022907778,0.00039918153,0.00029953066,0.0008164541,0.0010964302],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014675522,0.00007276407,0.0009597753,0.0023454966,0.00012648679,0.000607633,0.000014424395,0.00053797837,0.0046927603,0.0021756978,0.019186998,0.96913314],"study_design_scores_gemma":[0.00011803339,0.00036253198,0.007326187,0.002084183,0.0006078446,0.009270279,0.00004090999,0.0008072551,0.010496355,0.0065249563,0.96231747,0.000044029704],"about_ca_topic_score_codex":0.0006379329,"about_ca_topic_score_gemma":0.0011368878,"teacher_disagreement_score":0.0021560828,"about_ca_system_score_codex":0.00041183532,"about_ca_system_score_gemma":0.0006980517,"threshold_uncertainty_score":0.0072128177},"labels":[],"label_agreement":null},{"id":"W2131932756","doi":"10.1016/j.critrevonc.2011.03.003","title":"Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumors","year":2011,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Ottawa Hospital","funders":"University of Melbourne; Amgen","keywords":"Medicine; Neutropenia; Antibiotics; Febrile neutropenia; Incidence (geometry); Intensive care medicine; Clinical trial; Internal medicine; Chemotherapy","score_opus":0.1792675953964135,"score_gpt":0.4809735508662515,"score_spread":0.301705955469838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131932756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001882553,0.99896073,0.00010251157,0.0001917557,0.0001233535,0.0000050471913,0.000023679446,0.0000034258917,0.00040122334],"genre_scores_gemma":[0.0015823315,0.9974837,0.00022173784,0.00031066258,0.00019454435,0.0000051379816,0.00004096804,0.0000014808202,0.00015954081],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9991116,0.0001900082,0.00024984757,0.000103233964,0.00030970178,0.000035602472],"domain_scores_gemma":[0.99708444,0.0014502876,0.00080770603,0.00006675835,0.00053065276,0.00006020506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015652969,0.0006924318,0.0014952637,0.0028834108,0.00020683305,0.0010455148,0.0010789308,0.0011231124,0.0016363115],"category_scores_gemma":[0.00370287,0.0002614791,0.0008077869,0.0031256508,0.0005479094,0.0009849764,0.0006317367,0.001165963,0.00049541245],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010600254,0.000029183631,0.000779529,0.034015972,0.00026736042,0.00060908054,0.000094673625,0.00026714354,0.001676732,0.0009921906,0.021151597,0.94001055],"study_design_scores_gemma":[0.00006323195,0.0002830462,0.0059875464,0.027770728,0.0013510662,0.011804609,0.00017810601,0.00017034652,0.0028507796,0.0011119245,0.9483746,0.000053986576],"about_ca_topic_score_codex":0.0013110009,"about_ca_topic_score_gemma":0.0029142685,"teacher_disagreement_score":0.0028834108,"about_ca_system_score_codex":0.00063768757,"about_ca_system_score_gemma":0.0016691445,"threshold_uncertainty_score":0.0082781315},"labels":[],"label_agreement":null},{"id":"W2141368398","doi":"10.1016/j.critrevonc.2007.07.003","title":"The impact of acute myeloid leukemia and its treatment on quality of life and functional status in older adults","year":2007,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network; Toronto Rehabilitation Institute; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research; Toronto Rehabilitation Institute","keywords":"Medicine; Myeloid leukemia; Quality of life (healthcare); Activities of daily living; Performance status; Internal medicine; Palliative care; Gerontology; Chemotherapy; Oncology; Physical therapy","score_opus":0.06820022062710904,"score_gpt":0.4493297000785055,"score_spread":0.3811294794513964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141368398","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51750994,0.4640866,0.00013469912,0.0077437456,0.0006912112,0.00003184007,0.0005462799,0.000005182425,0.009250609],"genre_scores_gemma":[0.91571105,0.080950335,0.00018078224,0.0012036511,0.0011466878,0.00002396078,0.00027419277,0.0000017333591,0.0005076424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947494,0.00024813128,0.00005350216,0.000032527074,0.00013004601,0.00006088593],"domain_scores_gemma":[0.99815506,0.0008771077,0.0004462601,0.00003458794,0.00025323968,0.00023377863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009378855,0.00021495309,0.0007351538,0.0004636631,0.00025215308,0.00063678663,0.00023560037,0.0006016653,0.0013087173],"category_scores_gemma":[0.0039601666,0.00008540138,0.00076974096,0.0006269696,0.0002791505,0.00035403567,0.00029017165,0.0006671978,0.00011215246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003006263,0.0006267007,0.6810887,0.0019643335,0.002264173,0.00082316366,0.00040176176,0.00060900726,0.0008112263,0.0009480688,0.006986968,0.3004696],"study_design_scores_gemma":[0.00007283021,0.001165658,0.9918503,0.00034770678,0.0007210976,0.0006002468,0.0002905027,0.00013058254,0.00010204374,0.0003553976,0.0043492643,0.000014234809],"about_ca_topic_score_codex":0.002978813,"about_ca_topic_score_gemma":0.006429851,"teacher_disagreement_score":0.002978813,"about_ca_system_score_codex":0.00054480333,"about_ca_system_score_gemma":0.00050256826,"threshold_uncertainty_score":0.0059229136},"labels":[],"label_agreement":null},{"id":"W2145906267","doi":"10.1016/s1040-8428(08)70003-9","title":"Understanding and meeting the needs of the older population: a global challenge","year":2008,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Migration, Aging, and Tourism Studies","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Waterloo","funders":"","keywords":"Livelihood; Population ageing; Relevance (law); Economic growth; Older people; Population; Development economics; Gerontology; Political science; Sociology; Economics; Geography; Medicine; Demography","score_opus":0.16626104376205575,"score_gpt":0.4084801668687963,"score_spread":0.24221912310674054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145906267","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004717899,0.37854993,0.00081766356,0.6054233,0.0057428,0.000018340566,0.000067911344,0.000019732328,0.0046424163],"genre_scores_gemma":[0.048033677,0.7961603,0.0019797517,0.12226384,0.02890578,0.000094915486,0.00009995718,0.000038415543,0.0024233973],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99785334,0.0010789309,0.00018469317,0.00016923784,0.00042379161,0.00028990718],"domain_scores_gemma":[0.98243356,0.009767464,0.0015446785,0.00037696993,0.0032736803,0.0026036513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076488773,0.0012635003,0.002561961,0.0018760641,0.0024251149,0.005312006,0.0013571273,0.008295625,0.00646935],"category_scores_gemma":[0.0132206455,0.00027756084,0.0009596395,0.0020492433,0.0060317665,0.008802402,0.0047245,0.008365567,0.0010838179],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016250052,0.00039015376,0.010933032,0.009072667,0.00038456373,0.0011806418,0.013272462,0.0009144552,0.0010601698,0.036342565,0.2955204,0.63076633],"study_design_scores_gemma":[0.00006765186,0.00038824973,0.014429515,0.007817542,0.00035764155,0.001752682,0.054407,0.00036324657,0.00030973135,0.08539278,0.83461434,0.000099570476],"about_ca_topic_score_codex":0.005721603,"about_ca_topic_score_gemma":0.011211691,"teacher_disagreement_score":0.008295625,"about_ca_system_score_codex":0.002163595,"about_ca_system_score_gemma":0.011619887,"threshold_uncertainty_score":0.040451586},"labels":[],"label_agreement":null},{"id":"W2146532066","doi":"10.1016/j.critrevonc.2014.01.007","title":"Detection methods of circulating tumor cells in cutaneous melanoma: A systematic review","year":2014,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Melanoma; Medicine; Circulating tumor cell; Malignancy; Disease; Oncology; Peripheral blood; Biomarker; Primary tumor; Stage (stratigraphy); Cancer; Internal medicine; Pathology; Cancer research; Metastasis; Biology","score_opus":0.08296916132267225,"score_gpt":0.4777881327860845,"score_spread":0.39481897146341227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146532066","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022539312,0.9995048,0.00004935126,0.000048367558,0.000037710564,0.00003089864,0.000052268086,0.000001670511,0.000049578874],"genre_scores_gemma":[0.004550298,0.9945997,0.00034273535,0.00029614352,0.000053568314,0.000051460902,0.000057413657,0.0000018058438,0.0000468682],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99744,0.00066580856,0.0010070961,0.00034241917,0.0004615428,0.000083121406],"domain_scores_gemma":[0.98921937,0.008165127,0.0016005519,0.00014105154,0.0007829552,0.000090974405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043535703,0.0013805466,0.007179121,0.004888439,0.0003576492,0.0021368188,0.0017303753,0.001972671,0.0035851642],"category_scores_gemma":[0.017392125,0.0008953873,0.0075266967,0.004197099,0.0007453706,0.001925959,0.0010742765,0.0011917657,0.00030604898],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046663228,0.000039717987,0.0012465061,0.85088414,0.013608788,0.0000908495,0.00013880506,0.00012268337,0.00033564985,0.00019145456,0.0023753282,0.13049948],"study_design_scores_gemma":[0.00080964563,0.00070878677,0.011138851,0.6802301,0.24830276,0.0010229625,0.00048177093,0.00024586174,0.0006751881,0.00076647557,0.055462535,0.00015509514],"about_ca_topic_score_codex":0.004709423,"about_ca_topic_score_gemma":0.013846508,"teacher_disagreement_score":0.007179121,"about_ca_system_score_codex":0.0012069863,"about_ca_system_score_gemma":0.0036749018,"threshold_uncertainty_score":0.023024142},"labels":[],"label_agreement":null},{"id":"W2164110159","doi":"10.1016/j.critrevonc.2005.04.006","title":"Management of patients with higher risk myelodysplastic syndromes","year":2005,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"York University; University of Southern California","keywords":"Myelodysplastic syndromes; Medicine; International Prognostic Scoring System; Oncology; Internal medicine; Hematopoietic stem cell transplantation; Azacitidine; Disease; Radiation therapy; Intensive care medicine; Bone marrow","score_opus":0.0678892869649371,"score_gpt":0.4310722778615204,"score_spread":0.36318299089658335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164110159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00057831913,0.9974598,0.00030790712,0.0005951249,0.0002194404,0.000007998606,0.000012015737,0.000008274883,0.0008110573],"genre_scores_gemma":[0.005939875,0.9913932,0.00093364954,0.0007734456,0.0005321208,0.0000141962755,0.000060974588,0.0000021351484,0.0003503527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997055,0.00008429023,0.000043610627,0.000034717636,0.00011048772,0.000021413998],"domain_scores_gemma":[0.99945825,0.00030180675,0.000113535134,0.000009849905,0.00008195024,0.00003462194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005398793,0.0006051458,0.0014316794,0.0010790598,0.00019237309,0.00064341753,0.00087430107,0.00077632547,0.0016208497],"category_scores_gemma":[0.0021436573,0.00013366845,0.0005522428,0.00077336835,0.00024926293,0.0005681474,0.00040115122,0.0011759537,0.00051751756],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010069023,0.00006403765,0.0020107583,0.0055517703,0.00018586295,0.0010213599,0.00006841984,0.00031132303,0.0008929938,0.0007171798,0.02405098,0.96502465],"study_design_scores_gemma":[0.00048422866,0.0007291716,0.025606738,0.023676034,0.0018979991,0.037805595,0.00045430523,0.00059769716,0.0016868046,0.0054928283,0.90147704,0.00009164261],"about_ca_topic_score_codex":0.0006016716,"about_ca_topic_score_gemma":0.0015480836,"teacher_disagreement_score":0.0016208497,"about_ca_system_score_codex":0.00027598944,"about_ca_system_score_gemma":0.00065897626,"threshold_uncertainty_score":0.005422294},"labels":[],"label_agreement":null},{"id":"W2168814113","doi":"10.1016/j.critrevonc.2006.11.009","title":"Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?","year":2007,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Carboplatin; Medicine; Ovarian cancer; Paclitaxel; Regimen; Chemotherapy; Oncology; Internal medicine; Randomized controlled trial; Stage (stratigraphy); Cancer; Cisplatin","score_opus":0.19755678368570986,"score_gpt":0.5193243633535761,"score_spread":0.3217675796678663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168814113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052836904,0.99317026,0.00017665536,0.0040088226,0.0009410735,0.000005751819,0.00002757092,0.000008966893,0.001132494],"genre_scores_gemma":[0.0071638864,0.98480266,0.0006625421,0.0045220177,0.0019962545,0.000017684612,0.00007607525,0.0000051163993,0.00075378857],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997359,0.00008583743,0.000049475024,0.0000416759,0.000067032204,0.00002016472],"domain_scores_gemma":[0.9992644,0.0003824913,0.00013379796,0.000021837315,0.00014410951,0.000053375523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009803828,0.00039377317,0.0021332705,0.0005529238,0.00023333933,0.0008157118,0.00060970866,0.0011727359,0.0027735601],"category_scores_gemma":[0.0024687496,0.00018020987,0.00063007016,0.0008737265,0.00045416222,0.0010808974,0.00029083193,0.0025269948,0.0009434597],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005305927,0.00006733838,0.0012106093,0.008287389,0.00021027868,0.00037301518,0.000036811503,0.00031280945,0.0006992811,0.0014521667,0.048150416,0.9386693],"study_design_scores_gemma":[0.00078968704,0.0008902549,0.011023249,0.016626008,0.001481775,0.006447073,0.00020875172,0.00041077103,0.0010068121,0.00458857,0.95647293,0.000054090568],"about_ca_topic_score_codex":0.0012342064,"about_ca_topic_score_gemma":0.0038759818,"teacher_disagreement_score":0.0027735601,"about_ca_system_score_codex":0.00054766174,"about_ca_system_score_gemma":0.0013825676,"threshold_uncertainty_score":0.009278476},"labels":[],"label_agreement":null},{"id":"W2213935416","doi":"10.1016/j.critrevonc.2015.12.008","title":"Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilisation: A systematic review","year":2015,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Technology Assessment international; Università Bocconi; Helsinn","keywords":"Anorexia; Cachexia; Quality of life (healthcare); Medicine; Resource (disambiguation); Cancer cachexia; Cancer; Intensive care medicine; Gerontology; Internal medicine; Nursing; Computer science","score_opus":0.3282251994536354,"score_gpt":0.5772138258584952,"score_spread":0.24898862640485986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2213935416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00081450434,0.9986777,0.000037965794,0.00008110569,0.00005840832,0.000048711958,0.00019729209,0.0000024862022,0.000081904116],"genre_scores_gemma":[0.013639499,0.9854844,0.00025911312,0.00031510481,0.000052286938,0.00007599525,0.00011407063,0.0000022541806,0.000057294186],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9978275,0.00056594255,0.0007909352,0.00026886872,0.00042845943,0.00011837429],"domain_scores_gemma":[0.9927301,0.005035437,0.0014650868,0.00008174124,0.0005647621,0.0001229132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033980815,0.0013408911,0.006857134,0.0045968564,0.00040790718,0.0021233512,0.0012261576,0.0014069967,0.0037080597],"category_scores_gemma":[0.015357724,0.000898515,0.009066995,0.0065977396,0.00049665215,0.0014674789,0.0014438857,0.001386402,0.00020240464],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033862158,0.000034282624,0.0029657003,0.9099362,0.039914075,0.00011467203,0.00013717798,0.00016270942,0.000115511706,0.00017117462,0.0021101364,0.043999735],"study_design_scores_gemma":[0.00058422744,0.0003034628,0.022578074,0.57085747,0.37979138,0.00067328545,0.00048575818,0.00019807661,0.0001566661,0.00049626164,0.023761619,0.00011365106],"about_ca_topic_score_codex":0.013850447,"about_ca_topic_score_gemma":0.046470895,"teacher_disagreement_score":0.013850447,"about_ca_system_score_codex":0.0021768152,"about_ca_system_score_gemma":0.0052605504,"threshold_uncertainty_score":0.02753967},"labels":[],"label_agreement":null},{"id":"W2292869747","doi":"10.1016/j.critrevonc.2016.03.002","title":"Diagnostic accuracy of serum biomarkers for head and neck cancer: A systematic review and meta-analysis","year":2016,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Head and neck squamous-cell carcinoma; Biomarker; Meta-analysis; Oncology; Internal medicine; Cancer; Head and neck cancer; Diagnostic biomarker; Biomarker discovery; Pathology; Proteomics; Biology","score_opus":0.15278933483028087,"score_gpt":0.49711508965559925,"score_spread":0.34432575482531835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292869747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004734596,0.99447614,0.0002674951,0.00009698838,0.00009771468,0.000059313934,0.00017243727,0.000008889409,0.00008653656],"genre_scores_gemma":[0.19966239,0.79571325,0.0022279292,0.0010531815,0.00030345915,0.00022987905,0.000557375,0.000020494232,0.00023210973],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9942616,0.0021871415,0.0018856371,0.0007793386,0.0006851351,0.00020114957],"domain_scores_gemma":[0.98670876,0.009656212,0.0022296137,0.00044718842,0.00081082305,0.00014751407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009129032,0.0024428105,0.014485353,0.0036331012,0.0004474986,0.0023262503,0.0016104945,0.0019079562,0.002047019],"category_scores_gemma":[0.022826688,0.0012913015,0.025308363,0.0045569246,0.00068701326,0.0016813307,0.0013727008,0.0016446093,0.00020485488],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034098995,0.000050467184,0.009586973,0.2630808,0.69862324,0.00015693781,0.0000971617,0.0004480602,0.000446463,0.000103440405,0.0006723172,0.023324285],"study_design_scores_gemma":[0.00059262547,0.00022257178,0.0047660703,0.00845226,0.9841485,0.00011621044,0.000046243087,0.00013016253,0.00014015716,0.00014032848,0.0012163451,0.000028526514],"about_ca_topic_score_codex":0.0035137166,"about_ca_topic_score_gemma":0.009360805,"teacher_disagreement_score":0.014485353,"about_ca_system_score_codex":0.0013172514,"about_ca_system_score_gemma":0.0021303897,"threshold_uncertainty_score":0.048279524},"labels":[],"label_agreement":null},{"id":"W2333897154","doi":"10.1016/s1040-8428(13)70021-0","title":"IIIB.1 Adjuvant chemotherapy in elderly patients: an analysis of National Cancer Institute of Canada Clinical Trials Group and Intergroup JBR.10","year":2006,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Axitinib; Medicine; Proteinuria; Discontinuation; Internal medicine; Adverse effect; Hazard ratio; Renal cell carcinoma; Urology; Gastroenterology; Renal function; Oncology; Kidney; Confidence interval; Sunitinib","score_opus":0.10382160704737768,"score_gpt":0.46543353735548804,"score_spread":0.36161193030811034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333897154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82781184,0.10249526,0.0012634237,0.003229396,0.0003552822,0.0029848977,0.04719065,0.00009850759,0.014570702],"genre_scores_gemma":[0.9314642,0.03197506,0.0017969231,0.0028331766,0.00037931837,0.0011765817,0.026238708,0.00009017354,0.0040458986],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9975407,0.0012130068,0.00019134911,0.00020928627,0.0005278748,0.00031783083],"domain_scores_gemma":[0.9945997,0.0015788095,0.0017932508,0.00044420853,0.00069126417,0.00089272694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054849703,0.0007085297,0.002191837,0.00065113074,0.000498467,0.00096811564,0.00071408553,0.00054588687,0.0023959808],"category_scores_gemma":[0.0056060557,0.0003341196,0.0025370957,0.0019039332,0.00038926917,0.0003480892,0.00032779956,0.0012121616,0.0002921116],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5892898,0.0010435134,0.19919659,0.0044674673,0.025427105,0.0002017914,0.00019791596,0.003517729,0.0039156447,0.00073085434,0.033937033,0.13807449],"study_design_scores_gemma":[0.12378582,0.016433198,0.7850881,0.0013541417,0.040997703,0.00045074112,0.0001753467,0.0016996199,0.0011203652,0.00070121564,0.028079832,0.00011376964],"about_ca_topic_score_codex":0.078025594,"about_ca_topic_score_gemma":0.32113346,"teacher_disagreement_score":0.078025594,"about_ca_system_score_codex":0.0038194892,"about_ca_system_score_gemma":0.0059042363,"threshold_uncertainty_score":0.15514284},"labels":[],"label_agreement":null},{"id":"W2394579054","doi":"10.1016/j.critrevonc.2016.05.011","title":"The role of aspirin in colorectal cancer chemoprevention","year":2016,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Upper River Valley Hospital; Dalhousie University; Memorial University of Newfoundland","funders":"","keywords":"Aspirin; Medicine; Disease; Colorectal cancer; Cyclooxygenase; Cancer; Intensive care medicine; Low dose aspirin; Clinical trial; Cancer prevention; Oncology; Internal medicine; Bioinformatics; Biology","score_opus":0.03925139523658195,"score_gpt":0.4389904786052342,"score_spread":0.39973908336865227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2394579054","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006622162,0.9994325,0.000028310926,0.00014182867,0.00012714254,0.0000018805613,0.000009794899,0.0000016430854,0.0001906798],"genre_scores_gemma":[0.00058032357,0.99894124,0.000067629066,0.00011782733,0.00015839576,0.0000023273744,0.0000099511435,4.0543765e-7,0.00012181732],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99974173,0.00004872653,0.00006070543,0.000039854218,0.000090050184,0.000018958151],"domain_scores_gemma":[0.99928904,0.00037343832,0.00013577618,0.000018947901,0.00014525873,0.000037529982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074638845,0.00077173987,0.0015945619,0.002019773,0.00021742872,0.0011045675,0.0006656548,0.0010827415,0.0032648337],"category_scores_gemma":[0.0015181097,0.0002939908,0.00079575187,0.0021130133,0.00044671548,0.0010070523,0.00069943245,0.0016307817,0.0009095554],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021487307,0.00008750383,0.00044726205,0.03674224,0.00043036242,0.0002225688,0.00006231827,0.00025839615,0.0014044076,0.0017862947,0.016919728,0.9414241],"study_design_scores_gemma":[0.00013400089,0.00037449322,0.0031440447,0.013781211,0.0016615412,0.0012578276,0.00014698142,0.00019232965,0.0008264666,0.0026468467,0.97578716,0.000047035108],"about_ca_topic_score_codex":0.0011873535,"about_ca_topic_score_gemma":0.0028375052,"teacher_disagreement_score":0.0032648337,"about_ca_system_score_codex":0.00035808398,"about_ca_system_score_gemma":0.0012608843,"threshold_uncertainty_score":0.010922015},"labels":[],"label_agreement":null},{"id":"W2397619099","doi":"10.1016/j.critrevonc.2016.04.019","title":"Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma: An updated review of published data from the named patient program","year":2016,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Takeda Oncology","keywords":"Brentuximab vedotin; Tolerability; Medicine; Internal medicine; Oncology; Refractory (planetary science); Anaplastic large-cell lymphoma; Lymphoma; Clinical trial; Hodgkin lymphoma; Adverse effect","score_opus":0.09861715029883955,"score_gpt":0.4469495262259395,"score_spread":0.3483323759270999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397619099","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015556952,0.9995161,0.00002188746,0.0001093213,0.000042407984,0.0000059913614,0.000035248333,0.0000021796504,0.00011126559],"genre_scores_gemma":[0.00095335464,0.9986524,0.000108484164,0.00015083383,0.000033846383,0.000009492023,0.000041600808,0.0000010133324,0.000048907437],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990157,0.0002334564,0.00037463708,0.0001048358,0.00023127718,0.00004001021],"domain_scores_gemma":[0.996469,0.0020693678,0.0008099979,0.00005132832,0.0005293198,0.00007100426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022811312,0.00076702336,0.0027199606,0.0059871026,0.00025660612,0.001243345,0.0010488529,0.0008065305,0.0021688403],"category_scores_gemma":[0.004722411,0.00040357694,0.0016173143,0.0069007752,0.00036808453,0.0013407584,0.0006668313,0.0008051662,0.00040814542],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020670585,0.000036936504,0.000526936,0.4018661,0.0014977751,0.00023124847,0.00025691112,0.0001772342,0.00084139564,0.0006488573,0.015447416,0.57826245],"study_design_scores_gemma":[0.00018591325,0.0004552454,0.007764369,0.33829042,0.016974099,0.0032179975,0.0005276398,0.00016744522,0.00089445146,0.0011774504,0.630268,0.00007692772],"about_ca_topic_score_codex":0.0022825294,"about_ca_topic_score_gemma":0.00529579,"teacher_disagreement_score":0.0059871026,"about_ca_system_score_codex":0.00095711154,"about_ca_system_score_gemma":0.0030198381,"threshold_uncertainty_score":0.0120639205},"labels":[],"label_agreement":null},{"id":"W2406868600","doi":"10.1016/j.critrevonc.2010.04.010","title":"Editorial","year":2010,"lang":"en","type":"editorial","venue":"Critical Reviews in Oncology/Hematology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"European Society for Medical Oncology; European School of Oncology","keywords":"Medicine; Quality of life (healthcare); Prospective cohort study; Cohort; Activities of daily living; Mental health; Cancer; Gerontology; Internal medicine; Physical therapy; Psychiatry","score_opus":0.030418805447440956,"score_gpt":0.4148811962739988,"score_spread":0.3844623908265578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406868600","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030985957,0.0043485817,0.00006522929,0.03996834,0.9520323,0.000028085176,0.000052920794,0.00005507171,0.003418458],"genre_scores_gemma":[0.00057002326,0.004047268,0.00013898322,0.05194671,0.91799086,0.00005614926,0.00006547083,0.000054160057,0.025130397],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931037,0.0015915787,0.0007039466,0.00073014246,0.003202839,0.0006677496],"domain_scores_gemma":[0.9751244,0.005399431,0.002870069,0.00092381524,0.011190239,0.0044920677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007258457,0.0035213851,0.0035371769,0.0040597576,0.0031538457,0.0076520992,0.003551014,0.017229296,0.03819708],"category_scores_gemma":[0.0338005,0.0011563187,0.0025735558,0.0014010479,0.0018744494,0.0032377692,0.0025113309,0.01530841,0.031393882],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000151427475,0.000004193831,0.00000958077,0.000072877585,0.0000073752785,0.000058390488,0.0000043972145,0.0000056139475,0.000017752205,0.00007154623,0.99701214,0.0027208822],"study_design_scores_gemma":[0.00008190332,0.000021064181,0.00012323001,0.0003772858,0.00004801509,0.00022493117,0.000024629531,0.00005484902,0.00008019464,0.00047796,0.99847275,0.000013288055],"about_ca_topic_score_codex":0.0018878012,"about_ca_topic_score_gemma":0.0049536116,"teacher_disagreement_score":0.03819708,"about_ca_system_score_codex":0.0039666803,"about_ca_system_score_gemma":0.0048643667,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2517435317","doi":"10.1016/j.critrevonc.2012.06.004","title":"Anaplastic large cell lymphoma, ALK-negative","year":2012,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Anaplastic large-cell lymphoma; Anaplastic lymphoma kinase; Lymphoma; Medicine; CD30; Internal medicine; Pathology; Large cell; B symptoms; Oncology; Cancer; Adenocarcinoma; Lung cancer","score_opus":0.09508870384681826,"score_gpt":0.4356182006152879,"score_spread":0.3405294967684696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517435317","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43834737,0.10685498,0.009952353,0.0048311646,0.0014228652,0.0012224151,0.0077519477,0.0012433871,0.42837355],"genre_scores_gemma":[0.879307,0.024697388,0.006350114,0.0033412972,0.0007319888,0.00022690157,0.0061046006,0.00012986305,0.079110965],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975246,0.000027808808,0.000026952473,0.000054459208,0.00008236516,0.000055988676],"domain_scores_gemma":[0.99974686,0.000042945783,0.00005235973,0.000026594887,0.00007395751,0.000057323196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025677326,0.00048203257,0.000335899,0.0014125832,0.0004649748,0.0006741269,0.00037365808,0.00049156277,0.014553671],"category_scores_gemma":[0.0009921277,0.00012320657,0.00027991916,0.001031396,0.00032645726,0.00073477905,0.00034319825,0.00045305915,0.008338565],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016288833,0.0005078308,0.29631802,0.0013835944,0.00015238165,0.20248348,0.00048826856,0.00039643666,0.05949539,0.005778468,0.070258535,0.3611087],"study_design_scores_gemma":[0.00015110456,0.00043917546,0.14283077,0.0005985333,0.00017818226,0.53579736,0.0005478292,0.00063726027,0.0059766946,0.0045137336,0.30828008,0.000049281312],"about_ca_topic_score_codex":0.0014097622,"about_ca_topic_score_gemma":0.0020849411,"teacher_disagreement_score":0.014553671,"about_ca_system_score_codex":0.0003650269,"about_ca_system_score_gemma":0.00038613667,"threshold_uncertainty_score":0.048686862},"labels":[],"label_agreement":null},{"id":"W2518785689","doi":"10.1016/j.critrevonc.2016.09.001","title":"Adverse neuropsychological effects associated with cumulative doses of corticosteroids to treat childhood acute lymphoblastic leukemia: A literature review","year":2016,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Neurocognitive; Neuropsychology; Medicine; Adverse effect; Clinical psychology; Pediatrics; Psychiatry; Cognition; Internal medicine","score_opus":0.04423018214970691,"score_gpt":0.4246406758221332,"score_spread":0.3804104936724263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518785689","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012687531,0.9996488,0.000015559424,0.000057953956,0.00004002965,0.0000050674585,0.000022761162,0.0000010114292,0.00008189194],"genre_scores_gemma":[0.0011133491,0.9985726,0.00007418764,0.00013099189,0.00005685002,0.0000066914663,0.00001612532,3.9830354e-7,0.00002884183],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9993457,0.00013423205,0.0002674497,0.000074736825,0.0001501863,0.000027646482],"domain_scores_gemma":[0.9968244,0.0019709817,0.00084152014,0.000034646873,0.00027783038,0.000050632396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011579302,0.00086016266,0.002274773,0.0028444119,0.00024970633,0.0010748053,0.0010199439,0.00075576996,0.0026482919],"category_scores_gemma":[0.0045548985,0.00030924246,0.0016587419,0.0033744741,0.00040465462,0.0008829786,0.00069809763,0.00087675167,0.00020630915],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035161094,0.000089491776,0.001918831,0.3274132,0.0029738175,0.00044083476,0.00016394258,0.0003032053,0.0007589387,0.00058979884,0.011685014,0.6533113],"study_design_scores_gemma":[0.0004396054,0.00085466634,0.021691425,0.3442852,0.03679308,0.0072775027,0.0008320729,0.00024786856,0.0013029701,0.0019458684,0.58414125,0.00018856757],"about_ca_topic_score_codex":0.0029783216,"about_ca_topic_score_gemma":0.0073132277,"teacher_disagreement_score":0.0029783216,"about_ca_system_score_codex":0.0006631849,"about_ca_system_score_gemma":0.0022348769,"threshold_uncertainty_score":0.008859456},"labels":[],"label_agreement":null},{"id":"W2528978902","doi":"10.1016/j.critrevonc.2016.09.003","title":"A critical review of treatment modalities for blastic plasmacytoid dendritic cell neoplasm","year":2016,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bone marrow; Neoplasm; Haematopoiesis; Disease; Plasmacytoid dendritic cell; Leukemia; Stem cell; Complete remission; Cancer research; Immunology; Dendritic cell; Oncology; Pathology; Chemotherapy; Internal medicine; Biology; Immune system","score_opus":0.13979330534355452,"score_gpt":0.4921211483401748,"score_spread":0.35232784299662023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528978902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060537484,0.9990145,0.00007756031,0.00027131275,0.0002278466,0.000004383907,0.00001398693,0.000003721326,0.0003261608],"genre_scores_gemma":[0.00067680684,0.99785477,0.00025451722,0.00057182275,0.00040289006,0.000007829968,0.00002911834,0.0000014755113,0.0002006215],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997389,0.000055135464,0.00007265218,0.00004331406,0.000071262395,0.000018712191],"domain_scores_gemma":[0.9993493,0.00039818804,0.000098544726,0.000014677976,0.00010988731,0.000029511531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066354586,0.00065959635,0.0018112996,0.0021648223,0.00028889635,0.0009476299,0.0009012844,0.0010206379,0.0035655706],"category_scores_gemma":[0.001490109,0.00030133198,0.00089870155,0.0016545778,0.00044006627,0.0014102175,0.0005140562,0.001791975,0.0008605033],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012102971,0.000071527626,0.00021823257,0.038933173,0.00022550386,0.00042050748,0.000060085145,0.0002447429,0.0010551594,0.0016865138,0.0476492,0.9093143],"study_design_scores_gemma":[0.000085965534,0.0002119413,0.0011793727,0.01785948,0.00085419265,0.004328518,0.00008788874,0.00015291465,0.00052171544,0.0017497068,0.9729234,0.000044810517],"about_ca_topic_score_codex":0.00084066787,"about_ca_topic_score_gemma":0.0018481885,"teacher_disagreement_score":0.0035655706,"about_ca_system_score_codex":0.0005208436,"about_ca_system_score_gemma":0.0011740202,"threshold_uncertainty_score":0.0119280815},"labels":[],"label_agreement":null},{"id":"W2561725509","doi":"10.1016/j.critrevonc.2016.12.009","title":"Salivary biomarkers in the diagnosis of breast cancer: A review","year":2016,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Breast cancer; Biomarker; Medicine; Oncology; Cancer; Internal medicine; Saliva; Stage (stratigraphy); Biology","score_opus":0.10194319096818653,"score_gpt":0.4640668575290022,"score_spread":0.3621236665608156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561725509","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040310624,0.99952626,0.000047873935,0.00016997647,0.000105422994,0.0000021224052,0.000009398632,0.0000020538243,0.00009656433],"genre_scores_gemma":[0.00052970904,0.9987446,0.00014226488,0.00020479698,0.0002753567,0.000003862218,0.000016215667,6.0183675e-7,0.000082624814],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99949944,0.00010162513,0.000112832364,0.00009508462,0.00015630812,0.000034662313],"domain_scores_gemma":[0.99810934,0.0011328027,0.0002486563,0.000029748386,0.00040160745,0.00007785048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014040559,0.0010487575,0.002190042,0.003335458,0.0002916655,0.0015842166,0.0010935008,0.0015293661,0.0025175058],"category_scores_gemma":[0.0029129607,0.0004387744,0.0010687897,0.002659659,0.0006598221,0.0017778802,0.0009989885,0.0017916885,0.00097309914],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017146979,0.00007582501,0.0010125438,0.029150145,0.00032119543,0.0003675794,0.00007666878,0.00026419858,0.0014403028,0.0012816556,0.028489808,0.93734866],"study_design_scores_gemma":[0.000090334375,0.00027707138,0.0042942804,0.024742322,0.0015648056,0.004670299,0.00028993693,0.00030979578,0.0012304024,0.0028026886,0.959624,0.00010393358],"about_ca_topic_score_codex":0.001530372,"about_ca_topic_score_gemma":0.0026460045,"teacher_disagreement_score":0.003335458,"about_ca_system_score_codex":0.0006435954,"about_ca_system_score_gemma":0.001718276,"threshold_uncertainty_score":0.008421838},"labels":[],"label_agreement":null},{"id":"W2586486297","doi":"10.1016/j.critrevonc.2017.02.003","title":"Enzastaurin: A lesson in drug development","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Cancer Society","keywords":"Medicine; Drug development; Drug; Clinical trial; Pharmacology; MAPK/ERK pathway; Oncology; Kinase; Internal medicine; Biology","score_opus":0.17130075587845123,"score_gpt":0.466556597083607,"score_spread":0.2952558412051558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586486297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008721026,0.99525297,0.00018543,0.0021820695,0.0011728957,0.0000034274335,0.0000265331,0.000015536438,0.0010739298],"genre_scores_gemma":[0.0011100821,0.99327326,0.0003214027,0.0023681447,0.0013293016,0.000007449413,0.00004909683,0.000005179596,0.0015360797],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998036,0.000038884198,0.0000275664,0.000034087003,0.000071213195,0.000024760018],"domain_scores_gemma":[0.99961627,0.00018716062,0.000037802096,0.000017412718,0.00009020037,0.000051180094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081519276,0.0007813277,0.0011791195,0.0009845945,0.00028805473,0.0012621051,0.0009241276,0.0015577014,0.004134251],"category_scores_gemma":[0.0011200337,0.0002743788,0.00048764187,0.000981451,0.0008695029,0.0021062372,0.00078022026,0.0048902943,0.002457728],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017203201,0.00007553786,0.0001671303,0.005268843,0.0000722931,0.00023420685,0.00003850649,0.0003402841,0.0012739279,0.0074428697,0.13442631,0.8504882],"study_design_scores_gemma":[0.00004444779,0.000053846954,0.00016894088,0.0010338004,0.000042580974,0.00043895218,0.000018681896,0.00005157366,0.00028099772,0.0024584003,0.99539787,0.000009844273],"about_ca_topic_score_codex":0.0007753603,"about_ca_topic_score_gemma":0.002385334,"teacher_disagreement_score":0.004134251,"about_ca_system_score_codex":0.000717285,"about_ca_system_score_gemma":0.0012959463,"threshold_uncertainty_score":0.013830423},"labels":[],"label_agreement":null},{"id":"W2589167545","doi":"10.1016/j.critrevonc.2017.02.020","title":"Adjuvant nodal radiotherapy in the era of sentinel node biopsy staging of breast cancer: A review of published guidelines and prospective trials and their implications on clinical practice","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Sentinel node; Medicine; Breast cancer; Radiation therapy; Adjuvant radiotherapy; Biopsy; Adjuvant; Clinical Practice; Oncology; Cancer; NODAL; Medical physics; General surgery; Internal medicine; Family medicine","score_opus":0.20305275812832801,"score_gpt":0.5545317272133716,"score_spread":0.3514789690850436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589167545","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000072336414,0.9993629,0.00004866818,0.00029008253,0.00008550195,0.000007581922,0.000025766602,0.0000017107624,0.000105434316],"genre_scores_gemma":[0.0008442171,0.99812776,0.00027500352,0.0005392017,0.000116448464,0.000015522568,0.00003463885,0.000001588044,0.000045731005],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9988399,0.00035481615,0.0003625254,0.00015224228,0.00024633875,0.000044083965],"domain_scores_gemma":[0.99452716,0.0041015106,0.0006684855,0.00008080899,0.00053518935,0.00008681461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004525116,0.00073977734,0.0028744845,0.0022393141,0.0002517891,0.0014954831,0.0017042283,0.0013002873,0.0023067445],"category_scores_gemma":[0.008550149,0.0003668565,0.001783095,0.0026286268,0.0006363283,0.001405304,0.000746926,0.0017655828,0.0004596979],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052149675,0.000061993596,0.00092793244,0.12836912,0.0013158973,0.000093636816,0.00007405375,0.00042294586,0.0005626152,0.0016383816,0.019082393,0.8469296],"study_design_scores_gemma":[0.00067724043,0.0007384491,0.0071061146,0.2024006,0.012856423,0.0014831765,0.00028909976,0.00039375311,0.0009155987,0.005132581,0.76788294,0.00012404534],"about_ca_topic_score_codex":0.0017312091,"about_ca_topic_score_gemma":0.0054839826,"teacher_disagreement_score":0.004525116,"about_ca_system_score_codex":0.0010726219,"about_ca_system_score_gemma":0.0029530565,"threshold_uncertainty_score":0.023931384},"labels":[],"label_agreement":null},{"id":"W2593675800","doi":"10.1016/j.critrevonc.2017.02.026","title":"A comprehensive review of immunotherapies in prostate cancer","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick; Princess Margaret Cancer Centre; Canada Research Chairs; University of Toronto","funders":"","keywords":"Prostate cancer; Medicine; Immunotherapy; Clinical trial; Cancer; Disease; Oncology; Immune system; Cancer immunotherapy; Internal medicine; Immunology","score_opus":0.25979385975926067,"score_gpt":0.5697634065239928,"score_spread":0.30996954676473215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593675800","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003742441,0.99942636,0.000050081686,0.00012036391,0.00012756187,0.000005624381,0.000018546276,0.0000034658144,0.00021065678],"genre_scores_gemma":[0.00027556485,0.9990965,0.00012378063,0.00020998024,0.00013665186,0.000006004069,0.000024306953,7.614022e-7,0.00012651207],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995951,0.0000871149,0.00009782829,0.000056908942,0.00013059039,0.000032449214],"domain_scores_gemma":[0.99916935,0.0004828808,0.00013066056,0.000017594484,0.00015856496,0.000040975523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010780687,0.00096707075,0.00228675,0.0031533958,0.00029641486,0.0012268937,0.0011059142,0.0010883419,0.0045460686],"category_scores_gemma":[0.0018994008,0.00039527947,0.0012130413,0.0028613827,0.00038633455,0.0013476472,0.0007589007,0.0019257683,0.0011125099],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013870938,0.00009569729,0.0001738845,0.07943034,0.0003705544,0.00013135871,0.0000546166,0.00029489942,0.0013905435,0.0015605685,0.039285704,0.8770731],"study_design_scores_gemma":[0.00009585491,0.00027522948,0.0011074119,0.024659272,0.0012912604,0.0010907621,0.0000667278,0.00012267084,0.0005033105,0.0014450719,0.9692983,0.000044197182],"about_ca_topic_score_codex":0.001358209,"about_ca_topic_score_gemma":0.0031774624,"teacher_disagreement_score":0.0045460686,"about_ca_system_score_codex":0.0006353638,"about_ca_system_score_gemma":0.0019833199,"threshold_uncertainty_score":0.015208125},"labels":[],"label_agreement":null},{"id":"W2594173744","doi":"10.1016/j.critrevonc.2012.07.005","title":"Active surveillance for low-risk prostate cancer","year":2012,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre; Mount Sinai Hospital","funders":"","keywords":"Overdiagnosis; Prostate cancer; Medicine; Cancer; Asymptomatic; Disease; Gynecology; Internal medicine; Intensive care medicine; Family medicine; Oncology","score_opus":0.10824038319028571,"score_gpt":0.4795322791321462,"score_spread":0.37129189594186046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594173744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041090658,0.9995117,0.000031394684,0.00012393628,0.0001094269,0.00000296076,0.00000750545,0.0000017561188,0.00017016003],"genre_scores_gemma":[0.0010578353,0.9980317,0.00011620906,0.00037137532,0.0002550476,0.0000072706343,0.000018382772,9.225643e-7,0.00014125826],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9994931,0.00014108814,0.00011744704,0.00008497104,0.00013623406,0.00002712537],"domain_scores_gemma":[0.9981654,0.0011556436,0.0003607051,0.00003165941,0.00021990892,0.000066713306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010875382,0.0008445164,0.001991483,0.0024070265,0.00021880232,0.00092108035,0.0008325708,0.0008017825,0.0031236766],"category_scores_gemma":[0.0034368918,0.00033325367,0.000972442,0.0016318363,0.00044844724,0.0009778995,0.0005800453,0.0014510349,0.00058206473],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011472731,0.000040705927,0.0003438068,0.03696232,0.00032774426,0.00008161362,0.000030729556,0.00012885821,0.00029857008,0.00050525094,0.018002177,0.94316345],"study_design_scores_gemma":[0.0002928071,0.0006077736,0.0063478732,0.072360545,0.0047014873,0.0034350394,0.00015657954,0.00025189703,0.0009287065,0.0020343668,0.90881115,0.000071751485],"about_ca_topic_score_codex":0.0013951045,"about_ca_topic_score_gemma":0.0044253203,"teacher_disagreement_score":0.0031236766,"about_ca_system_score_codex":0.00071663386,"about_ca_system_score_gemma":0.0014987633,"threshold_uncertainty_score":0.0104497075},"labels":[],"label_agreement":null},{"id":"W2595537928","doi":"10.1016/j.critrevonc.2017.03.002","title":"Toxicity of iron overload and iron overload reduction in the setting of hematopoietic stem cell transplantation for hematologic malignancies","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Transferrin saturation; Ferritin; Pathological; Hematopoietic stem cell; Stem cell; Haematopoiesis; Transplantation; Anemia; Internal medicine; Iron deficiency; Gastroenterology; Intensive care medicine; Biology","score_opus":0.07102304695229372,"score_gpt":0.40060935867777275,"score_spread":0.32958631172547903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595537928","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009210872,0.99923515,0.000057409645,0.00018235997,0.00011479744,0.0000030800798,0.000009819637,0.0000026114985,0.00030257617],"genre_scores_gemma":[0.0009108188,0.99823713,0.00014570668,0.00029594498,0.00020782299,0.000005819686,0.000020550846,0.0000010642372,0.00017506142],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997154,0.00007281147,0.000060182396,0.000032106796,0.00009918549,0.000020363841],"domain_scores_gemma":[0.9993548,0.0003891296,0.00010938864,0.000011946611,0.000109254564,0.00002557568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007445393,0.0006389825,0.001627842,0.0013386881,0.00019348453,0.00088754314,0.0007718321,0.0008772622,0.002176637],"category_scores_gemma":[0.0015225795,0.00017634266,0.00069931254,0.0011536666,0.00036980037,0.0007294532,0.0005308348,0.0013893342,0.00058354624],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014838655,0.000061630955,0.00028147246,0.030219318,0.00026768868,0.00034581777,0.000056764966,0.0002492726,0.00094308495,0.0019140028,0.02978401,0.93572855],"study_design_scores_gemma":[0.000102062,0.00024738788,0.0020354432,0.017646443,0.0008790289,0.0043774233,0.00011753943,0.00014380715,0.0009174996,0.003043258,0.97044206,0.00004789484],"about_ca_topic_score_codex":0.0008057637,"about_ca_topic_score_gemma":0.0017886508,"teacher_disagreement_score":0.002176637,"about_ca_system_score_codex":0.00046037344,"about_ca_system_score_gemma":0.0011100665,"threshold_uncertainty_score":0.0072816014},"labels":[],"label_agreement":null},{"id":"W2595812558","doi":"10.1016/j.critrevonc.2017.03.017","title":"Prognostic and predictive biomarkers in neuroendocrine tumours","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Chromogranin A; Nomogram; Medicine; Biomarker; Neuroendocrine tumors; Oncology; Internal medicine; Bioinformatics; Pathology; Biology; Immunohistochemistry","score_opus":0.13984485539374347,"score_gpt":0.5008886420537874,"score_spread":0.3610437866600439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595812558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006318958,0.9988912,0.000114195245,0.00042096412,0.00024313932,0.0000031963227,0.00002245391,0.000004712803,0.00023692832],"genre_scores_gemma":[0.0009222217,0.9974497,0.0002453881,0.00047931142,0.0006267825,0.0000073402716,0.00005322511,0.0000015738498,0.0002144287],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995043,0.00010387649,0.00009175605,0.00008082807,0.00017603178,0.00004323004],"domain_scores_gemma":[0.99857926,0.0008167489,0.00020535228,0.000036382346,0.00029719464,0.00006507303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001870059,0.0010631128,0.0023399966,0.0019818386,0.00022446386,0.0017966289,0.0011746292,0.0011775156,0.0018631021],"category_scores_gemma":[0.0037674552,0.00036942374,0.00087034836,0.0019533685,0.0007217602,0.0016133769,0.0009055302,0.0027100772,0.0009168337],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012654794,0.000048274513,0.00089706277,0.011558244,0.00022657259,0.00014639889,0.00004059442,0.0003516822,0.00061380333,0.0021547254,0.03378327,0.9500529],"study_design_scores_gemma":[0.00008453811,0.00020239527,0.0038118272,0.012692901,0.001096208,0.0016365962,0.00012737999,0.00038047883,0.00079987757,0.006673206,0.972423,0.00007152269],"about_ca_topic_score_codex":0.00094657054,"about_ca_topic_score_gemma":0.0015886244,"teacher_disagreement_score":0.0023399966,"about_ca_system_score_codex":0.00076644646,"about_ca_system_score_gemma":0.0016001391,"threshold_uncertainty_score":0.00988996},"labels":[],"label_agreement":null},{"id":"W2621173929","doi":"10.1016/j.critrevonc.2017.05.010","title":"Azacitidine in adult patients with acute myeloid leukemia","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Celgene","keywords":"Azacitidine; Myeloid leukemia; Medicine; Clinical trial; Oncology; Internal medicine; Biology","score_opus":0.08975523865005734,"score_gpt":0.4533416505009695,"score_spread":0.3635864118509121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621173929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005403282,0.999191,0.000018444996,0.0002615433,0.00016281898,0.0000022237357,0.000014055704,0.0000024530011,0.0002934923],"genre_scores_gemma":[0.000953601,0.9977665,0.00007424428,0.0006260722,0.00034208142,0.0000055525925,0.000028870485,7.3784616e-7,0.00020228242],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960595,0.00010421292,0.00011672473,0.00005661799,0.00009464501,0.000021838363],"domain_scores_gemma":[0.99906665,0.0005171266,0.00021658058,0.000020504272,0.00013350193,0.000045604786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000815345,0.0006074139,0.0018614216,0.0017434218,0.00021538947,0.0009847076,0.00072004774,0.0009969273,0.00374858],"category_scores_gemma":[0.0024338563,0.0002471339,0.0006496849,0.001522573,0.00037050596,0.0009648077,0.0006430434,0.0016557628,0.00078828016],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021686997,0.000037098576,0.00043087007,0.035102833,0.00042902233,0.0001526517,0.000052592313,0.00016879046,0.0005898815,0.00096468313,0.043647178,0.9182075],"study_design_scores_gemma":[0.0002956778,0.00028586586,0.0025066487,0.024281587,0.0024811728,0.0019450617,0.00009316754,0.00010915213,0.0006140174,0.0012370988,0.9661183,0.00003227993],"about_ca_topic_score_codex":0.00097278116,"about_ca_topic_score_gemma":0.0031854138,"teacher_disagreement_score":0.00374858,"about_ca_system_score_codex":0.0005954973,"about_ca_system_score_gemma":0.0012611486,"threshold_uncertainty_score":0.012540221},"labels":[],"label_agreement":null},{"id":"W2621587943","doi":"10.1016/j.critrevonc.2017.06.001","title":"Biomarkers of response to PD-1/PD-L1 inhibition","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":318,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute","funders":"U.S. Food and Drug Administration; University of Chicago; Bristol-Myers Squibb","keywords":"Medicine; PD-L1; Immunotherapy; Melanoma; Immune system; Oncology; Head and neck squamous-cell carcinoma; Lymphoma; Cytotoxic T cell; Cancer; Renal cell carcinoma; Head and neck cancer; Internal medicine; Cancer research; Antigen; Immunology; Biology","score_opus":0.17863256192961188,"score_gpt":0.5110149956100323,"score_spread":0.3323824336804204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621587943","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013370758,0.99879515,0.00012450063,0.0003256178,0.00014355624,0.000005225516,0.0000340909,0.000005801355,0.0004323747],"genre_scores_gemma":[0.0015745107,0.997203,0.0002551245,0.00031021904,0.00023872197,0.000014872603,0.00007547898,0.0000016679868,0.0003263851],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996063,0.00008636164,0.0000612182,0.00006886585,0.00014632038,0.00003086846],"domain_scores_gemma":[0.99922955,0.0003595317,0.00014793941,0.000018008723,0.00021059382,0.00003440411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011229621,0.0008936262,0.001939568,0.0023601141,0.0001675217,0.0011944826,0.00075543084,0.0008951584,0.0019919863],"category_scores_gemma":[0.0016838072,0.00023053112,0.0007534885,0.0017784939,0.0004538638,0.0009258166,0.0005847327,0.0015201182,0.0013120858],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116032614,0.00005497546,0.0010342299,0.013588246,0.00022136144,0.00012572322,0.000035569843,0.0002669222,0.0015103135,0.0018536117,0.022055455,0.9591376],"study_design_scores_gemma":[0.000047279464,0.0002608244,0.0045931046,0.010881795,0.0006695303,0.0022880929,0.00009995299,0.0002546925,0.0021061096,0.0032282318,0.97551507,0.000055242308],"about_ca_topic_score_codex":0.0006974988,"about_ca_topic_score_gemma":0.0008942765,"teacher_disagreement_score":0.0023601141,"about_ca_system_score_codex":0.0007090664,"about_ca_system_score_gemma":0.0011153707,"threshold_uncertainty_score":0.006663859},"labels":[],"label_agreement":null},{"id":"W2766023480","doi":"10.1016/j.critrevonc.2017.10.009","title":"Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with hematologic or solid neoplasms: A systematic review","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université Laval; McGill University","funders":"","keywords":"Medicine; Concomitant; Clinical trial; Internal medicine; Systematic review; MEDLINE; Oncology; Radiation therapy; Immunotherapy; Hematology; Cancer","score_opus":0.11235881203892009,"score_gpt":0.42442660713128944,"score_spread":0.31206779509236937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766023480","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004899914,0.99915326,0.000027732938,0.00006551337,0.00005162625,0.000026244852,0.00010840243,0.000002193451,0.00007517193],"genre_scores_gemma":[0.008714844,0.9903591,0.00021087598,0.00043692268,0.00007101995,0.00004272744,0.00010452876,0.0000017200299,0.000058284637],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99841166,0.00031316906,0.0007220105,0.0002127772,0.00026783193,0.000072656556],"domain_scores_gemma":[0.99529606,0.0029836418,0.0012863962,0.000055410135,0.000301873,0.00007667498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001620974,0.0010574753,0.005369764,0.0032219542,0.00028400111,0.0014570936,0.001173133,0.0015818186,0.0035619913],"category_scores_gemma":[0.008327761,0.0006366531,0.007010776,0.0042226696,0.0003852098,0.0012071748,0.00081853004,0.0011149904,0.00021907537],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009493812,0.00005165165,0.0028611592,0.8813946,0.035687573,0.00017795303,0.0001086391,0.00020482404,0.00042526747,0.00013910797,0.003808732,0.07419119],"study_design_scores_gemma":[0.0015595522,0.00068375794,0.019102277,0.49432334,0.42862162,0.0012926399,0.0003653826,0.00020759058,0.00043203824,0.00040735144,0.052868944,0.00013547344],"about_ca_topic_score_codex":0.00547333,"about_ca_topic_score_gemma":0.019453214,"teacher_disagreement_score":0.00547333,"about_ca_system_score_codex":0.0011749101,"about_ca_system_score_gemma":0.0032693755,"threshold_uncertainty_score":0.011916101},"labels":[],"label_agreement":null},{"id":"W2768842469","doi":"10.1016/j.critrevonc.2017.11.007","title":"Biomarkers in prostate cancer – Current clinical utility and future perspectives","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Prostate cancer; Liquid biopsy; Medicine; Biomarker; Circulating tumor cell; Cancer; Prostate; Clinical Practice; Oncology; Internal medicine; Intensive care medicine; Metastasis; Biology","score_opus":0.30613549361765446,"score_gpt":0.6113364424185329,"score_spread":0.30520094880087845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768842469","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003863431,0.9991436,0.00005317485,0.000404192,0.00018802383,0.0000019473935,0.000010235365,0.00000283655,0.00015738007],"genre_scores_gemma":[0.00052873173,0.9984509,0.00012996692,0.00038335513,0.00037434653,0.0000040240056,0.000014335321,8.415811e-7,0.00011342319],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932754,0.0001676197,0.00010796251,0.00010725431,0.00022876445,0.000060985672],"domain_scores_gemma":[0.99733824,0.0016038987,0.0003060309,0.000050689476,0.00057706714,0.0001240017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025796904,0.0011445611,0.0024422945,0.0023292056,0.00030441675,0.0024766098,0.0012577411,0.001726911,0.003110821],"category_scores_gemma":[0.0035261684,0.00044485,0.0010388581,0.0026228877,0.0012305182,0.002514582,0.0012529697,0.003247454,0.001233076],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016503857,0.000065012195,0.00072715245,0.01875432,0.0002619374,0.0001621873,0.00008028118,0.00043806277,0.0008006148,0.005439795,0.036922634,0.9361829],"study_design_scores_gemma":[0.00006862941,0.00018853185,0.0018872801,0.012375723,0.00058504415,0.0011676862,0.00018306953,0.00026262744,0.00047176785,0.0064770165,0.9762714,0.000061310966],"about_ca_topic_score_codex":0.0013285303,"about_ca_topic_score_gemma":0.0028462505,"teacher_disagreement_score":0.003110821,"about_ca_system_score_codex":0.00082063134,"about_ca_system_score_gemma":0.002497981,"threshold_uncertainty_score":0.013642848},"labels":[],"label_agreement":null},{"id":"W2769734807","doi":"10.1016/j.critrevonc.2017.11.011","title":"Mind and body practices for fatigue reduction in patients with cancer and hematopoietic stem cell transplant recipients: A systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of Toronto; SickKids Foundation; Pediatric Oncology Group; Hospital for Sick Children; University of Calgary; Institute for Clinical Evaluative Sciences","funders":"Pediatric Oncology Group of Ontario","keywords":"Medicine; Mindfulness; Physical therapy; Psychological intervention; Massage; Acupressure; Randomized controlled trial; Meta-analysis; Strictly standardized mean difference; Acupuncture; Internal medicine; Clinical psychology; Psychiatry; Alternative medicine","score_opus":0.2038610417729056,"score_gpt":0.47208120997224395,"score_spread":0.26822016819933836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769734807","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0100358585,0.9888626,0.0002106238,0.00013732268,0.00013292533,0.000139628,0.00030787126,0.000012385046,0.00016086295],"genre_scores_gemma":[0.2817508,0.7132228,0.0018708457,0.001444338,0.00024296502,0.00045807383,0.00056332117,0.000018980376,0.00042780483],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9975001,0.00086949614,0.00082548265,0.0003779353,0.00027925195,0.00014780156],"domain_scores_gemma":[0.9952199,0.0032862618,0.00092511426,0.00014462696,0.00031625482,0.00010775514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00358823,0.0019331006,0.0106615955,0.0021688545,0.00059148675,0.0019439129,0.0013739282,0.0019532905,0.0041686147],"category_scores_gemma":[0.013618253,0.0011352694,0.026816305,0.0028686544,0.0005295282,0.0012461268,0.0014416593,0.0021561207,0.00024714213],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039494573,0.00011580375,0.009945714,0.3738947,0.58546966,0.00013006439,0.00020467096,0.0003479293,0.0002466538,0.00011830195,0.0007957865,0.024781285],"study_design_scores_gemma":[0.0011747297,0.0003328712,0.008533994,0.021578139,0.966383,0.00008307669,0.00010582145,0.000117485186,0.00007334219,0.0001349932,0.0014466334,0.000035835124],"about_ca_topic_score_codex":0.011012641,"about_ca_topic_score_gemma":0.033676825,"teacher_disagreement_score":0.011012641,"about_ca_system_score_codex":0.0015295313,"about_ca_system_score_gemma":0.0021701336,"threshold_uncertainty_score":0.021897078},"labels":[],"label_agreement":null},{"id":"W2771110982","doi":"10.1016/j.critrevonc.2017.12.009","title":"Systemic treatment in adult uterine sarcomas","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; National Institute for Health and Care Research; Royal Marsden NHS Foundation Trust","keywords":"Endometrial stromal sarcoma; Uterine sarcoma; Leiomyosarcoma; Medicine; Sarcoma; Uterus; Stromal cell; Oncology; Internal medicine; Radiology; Pathology","score_opus":0.17483381086540112,"score_gpt":0.5097559825933041,"score_spread":0.334922171727903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771110982","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011718412,0.9989681,0.000053773074,0.00020453613,0.00010402404,0.0000036735905,0.000012682672,0.0000034564207,0.0005325052],"genre_scores_gemma":[0.0010563184,0.9981824,0.00010724415,0.00025482354,0.00014493911,0.000006911605,0.000023752358,0.0000011422571,0.00022251681],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981254,0.00004592468,0.000037328206,0.000032403976,0.00005808541,0.000013757998],"domain_scores_gemma":[0.999617,0.00025038695,0.000054823187,0.000009510955,0.00005284466,0.000015471822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004356071,0.0004401189,0.0008925718,0.0011493088,0.00019186457,0.00065761607,0.00054481736,0.0007245416,0.002882232],"category_scores_gemma":[0.0010348497,0.00015378717,0.0005838016,0.00081313646,0.00028392696,0.00063756725,0.00040422785,0.0012755394,0.00078284583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073545205,0.000046934772,0.00018379088,0.021305716,0.00013076437,0.00015826912,0.00004747521,0.00025639264,0.0007380156,0.0016287551,0.020403,0.9550273],"study_design_scores_gemma":[0.000048296766,0.00018008905,0.001317223,0.01666915,0.0003907249,0.0025693423,0.00006825677,0.0001279047,0.00061400636,0.0017863681,0.9762081,0.000020393543],"about_ca_topic_score_codex":0.000718636,"about_ca_topic_score_gemma":0.0015594258,"teacher_disagreement_score":0.002882232,"about_ca_system_score_codex":0.00040630286,"about_ca_system_score_gemma":0.0007036549,"threshold_uncertainty_score":0.009642065},"labels":[],"label_agreement":null},{"id":"W2772220088","doi":"10.1016/j.critrevonc.2017.12.011","title":"Physical activity reduces fatigue in patients with cancer and hematopoietic stem cell transplant recipients: A systematic review and meta-analysis of randomized trials","year":2017,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Pediatric Oncology Group; SickKids Foundation; Institute for Clinical Evaluative Sciences; University of Calgary; London Health Sciences Centre","funders":"","keywords":"Medicine; Meta-analysis; Randomized controlled trial; Hematopoietic stem cell transplantation; Confidence interval; Cancer; Strictly standardized mean difference; Physical activity; Physical therapy; Internal medicine; Cancer-related fatigue; Oncology; Transplantation","score_opus":0.24275538187352605,"score_gpt":0.4833647790037403,"score_spread":0.24060939713021426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772220088","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010188144,0.9885416,0.00026149326,0.00015640167,0.00016158447,0.00018180152,0.00032479645,0.000015078811,0.00016906862],"genre_scores_gemma":[0.2624657,0.73224455,0.0020189236,0.0014521849,0.00031317823,0.00042612696,0.00068971363,0.000024506026,0.0003651744],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99564385,0.0018477091,0.0013544899,0.0006142468,0.00036247406,0.00017719247],"domain_scores_gemma":[0.9924851,0.005463209,0.0013136239,0.00023110585,0.00036004177,0.00014695937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055947695,0.0022134548,0.013534612,0.0020728775,0.0005281153,0.0020511525,0.0017212123,0.0022085432,0.004061368],"category_scores_gemma":[0.019024068,0.0012253999,0.027028276,0.0026317704,0.0006590114,0.0013679685,0.0013351166,0.0024415546,0.0002683462],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073194723,0.00008318295,0.0058363657,0.32622218,0.63799155,0.000090780864,0.00012770109,0.000325641,0.00027302056,0.0000996165,0.00063881115,0.020991644],"study_design_scores_gemma":[0.002484428,0.0004522614,0.005987754,0.016601145,0.9726865,0.000074835356,0.00006740789,0.00009808997,0.00008035219,0.00015435192,0.001283001,0.000029829003],"about_ca_topic_score_codex":0.0061990153,"about_ca_topic_score_gemma":0.017430352,"teacher_disagreement_score":0.013534612,"about_ca_system_score_codex":0.001425469,"about_ca_system_score_gemma":0.0019284859,"threshold_uncertainty_score":0.029588342},"labels":[],"label_agreement":null},{"id":"W2791371772","doi":"10.1016/j.critrevonc.2018.01.009","title":"The SWI/SNF complex subunit genes: Their functions, variations, and links to risk and survival outcomes in human cancers","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Gene; Biology; SWI/SNF; Phenotype; Genetics; SMARCA4; ARID1A; Cancer; Protein subunit; Gene expression; Bioinformatics; Cancer research; Computational biology; Mutation","score_opus":0.0852170721346997,"score_gpt":0.42576139986352335,"score_spread":0.34054432772882365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791371772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009538651,0.99903226,0.0000862862,0.00029618217,0.00016603005,0.0000015915415,0.00003059273,0.000004733505,0.000286979],"genre_scores_gemma":[0.0006806483,0.9984163,0.000119382225,0.00019829912,0.0002778305,0.0000028434495,0.00004370555,0.0000012553996,0.00025965594],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998056,0.000026641892,0.000027773498,0.000043773176,0.000075880715,0.000020254962],"domain_scores_gemma":[0.99949,0.00024972414,0.00007808481,0.000013762193,0.00012497758,0.000043391745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074790145,0.0006261417,0.001130899,0.0013349099,0.00016553435,0.0009838167,0.0008857939,0.00088422763,0.0024861346],"category_scores_gemma":[0.001227491,0.0002173087,0.000390169,0.0019146675,0.00056025054,0.0008359828,0.00063494855,0.0016572571,0.0010833122],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011626987,0.0000276421,0.00074892875,0.007958374,0.00011618031,0.000118846205,0.00004721433,0.0003140694,0.001370446,0.0031961135,0.036676716,0.94930935],"study_design_scores_gemma":[0.000025213993,0.000059574242,0.0029403449,0.0028203344,0.00020472621,0.0010139034,0.0000669421,0.00009889675,0.00045826027,0.002896011,0.98938936,0.00002631836],"about_ca_topic_score_codex":0.0012833788,"about_ca_topic_score_gemma":0.0020763592,"teacher_disagreement_score":0.0024861346,"about_ca_system_score_codex":0.0005659933,"about_ca_system_score_gemma":0.0012381203,"threshold_uncertainty_score":0.008316994},"labels":[],"label_agreement":null},{"id":"W2793668795","doi":"10.1016/j.critrevonc.2018.02.010","title":"Effect of anticoagulants on admission rates and length of hospital stay for acute venous thromboembolism: A systematic review of randomized control trials","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The King's University; University of Alberta","funders":"Li Ka Shing Foundation","keywords":"Medicine; Rivaroxaban; Randomized controlled trial; Venous thromboembolism; Low molecular weight heparin; Anticoagulant; Heparin; Meta-analysis; Anticoagulant therapy; Internal medicine; Anesthesia; Warfarin; Thrombosis; Atrial fibrillation","score_opus":0.05674974227454381,"score_gpt":0.47749433214061143,"score_spread":0.4207445898660676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793668795","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038976776,0.9948696,0.00018339398,0.00012032892,0.00014052672,0.00030649948,0.00031991737,0.000012143534,0.00015001006],"genre_scores_gemma":[0.07177576,0.92452234,0.0014488188,0.00084070594,0.00019316036,0.00059825194,0.00040367703,0.000015416066,0.00020192516],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99335206,0.0022966173,0.0026584729,0.00073595095,0.000758157,0.00019882096],"domain_scores_gemma":[0.9789145,0.015523825,0.0040622787,0.0003808408,0.0008866149,0.00023184814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008196081,0.0018873034,0.013303944,0.0026927665,0.00052165566,0.0025502536,0.0019399103,0.0024189937,0.005050424],"category_scores_gemma":[0.036626875,0.0012188124,0.015207778,0.0034794125,0.0009984,0.0016108572,0.0011460339,0.0021762892,0.0002547753],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00688705,0.00007186873,0.0016386335,0.79208523,0.17675754,0.00007051309,0.00010954076,0.00015655579,0.00027683185,0.00013377792,0.0008139338,0.020998431],"study_design_scores_gemma":[0.009155369,0.0009715532,0.0067863003,0.11995181,0.8574039,0.00016685,0.00013074145,0.00011641578,0.00019552914,0.00033471116,0.004728616,0.000058158308],"about_ca_topic_score_codex":0.005217145,"about_ca_topic_score_gemma":0.013324384,"teacher_disagreement_score":0.013303944,"about_ca_system_score_codex":0.0019794388,"about_ca_system_score_gemma":0.0035372793,"threshold_uncertainty_score":0.04334557},"labels":[],"label_agreement":null},{"id":"W2796504850","doi":"10.1016/j.critrevonc.2018.04.001","title":"The influence of genetic variation on late toxicities in childhood cancer survivors: A review","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"British Columbia Children's Hospital","funders":"KWF Kankerbestrijding; European Commission","keywords":"Candidate gene; Genome-wide association study; Medicine; Genetic variation; Genetic predisposition; Cochrane Library; Meta-analysis; Oncology; Biology; Internal medicine; Genetics; Genotype; Gene; Population; Environmental health; Single-nucleotide polymorphism; Disease","score_opus":0.07233568325606497,"score_gpt":0.4488525362974091,"score_spread":0.37651685304134414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796504850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031117903,0.9994116,0.000021235152,0.000084750456,0.000034388566,0.0000062140584,0.000049861534,0.00000140499,0.00007940292],"genre_scores_gemma":[0.0028959573,0.9967804,0.00007199875,0.00010831995,0.000060370316,0.000013996262,0.00004518286,9.55911e-7,0.000022715361],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985532,0.0003298814,0.00054402254,0.0002424239,0.00027759283,0.000052852803],"domain_scores_gemma":[0.9841218,0.013083916,0.001861261,0.00011976844,0.00070614775,0.00010710602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024602637,0.0009085715,0.004101351,0.007777607,0.00035118524,0.0015936177,0.0011960281,0.0015320407,0.0024513295],"category_scores_gemma":[0.010846709,0.0005343291,0.0034737645,0.009485055,0.0006822174,0.0011410437,0.0007011473,0.0006570939,0.0002295855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030576094,0.00004109471,0.0049857926,0.70894545,0.0061465963,0.0003625978,0.00027430803,0.0002580082,0.00032748334,0.00066954124,0.0047461013,0.27293727],"study_design_scores_gemma":[0.00015217961,0.0004198449,0.03744702,0.7788588,0.060493555,0.0036228462,0.0005143299,0.0001854644,0.00040905204,0.00129462,0.116499275,0.000102934915],"about_ca_topic_score_codex":0.0052454905,"about_ca_topic_score_gemma":0.006046427,"teacher_disagreement_score":0.007777607,"about_ca_system_score_codex":0.0011894725,"about_ca_system_score_gemma":0.0035891815,"threshold_uncertainty_score":0.013011217},"labels":[],"label_agreement":null},{"id":"W2804629518","doi":"10.1016/j.critrevonc.2018.05.005","title":"Perioperative chemotherapy for urothelial carcinoma of the upper urinary tract: A systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Urothelial carcinoma; Meta-analysis; Medicine; Perioperative; Urology; Chemotherapy; Upper urinary tract; Urinary system; Carcinoma; Oncology; Internal medicine; Surgery; Cancer; Bladder cancer","score_opus":0.13255033513568734,"score_gpt":0.4548627842880608,"score_spread":0.32231244915237345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804629518","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021379993,0.99731904,0.00012306943,0.00006983154,0.00006801117,0.00006676878,0.00013534848,0.0000054632173,0.00007451067],"genre_scores_gemma":[0.063933074,0.9339643,0.00078087696,0.00059182005,0.00013388105,0.0001925875,0.00024218763,0.000009402605,0.00015184448],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9962452,0.0012397885,0.0013658837,0.00047244618,0.0004879478,0.00018862546],"domain_scores_gemma":[0.9920723,0.0053344797,0.0017001481,0.00020172523,0.00056798453,0.00012338579],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00456578,0.00222357,0.011644535,0.004055775,0.0005352321,0.0020901305,0.0015846827,0.0016701412,0.0028969296],"category_scores_gemma":[0.015652183,0.0010971272,0.02003133,0.004734315,0.0005593091,0.0015052059,0.0013134511,0.0016841039,0.00022121907],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013447595,0.000057988495,0.004639861,0.5810432,0.386865,0.00018125598,0.00012188277,0.00042809077,0.0003950663,0.000118495474,0.00096674054,0.023837566],"study_design_scores_gemma":[0.0004363138,0.00021007122,0.0049524335,0.04214669,0.9487256,0.0001788843,0.00009060816,0.00010309047,0.00015012741,0.00013670872,0.0028327869,0.00003670574],"about_ca_topic_score_codex":0.0069653653,"about_ca_topic_score_gemma":0.022364324,"teacher_disagreement_score":0.98835546,"about_ca_system_score_codex":0.0019257738,"about_ca_system_score_gemma":0.0032540716,"threshold_uncertainty_score":0.024146438},"labels":[],"label_agreement":null},{"id":"W2806460677","doi":"10.1016/j.critrevonc.2018.05.006","title":"Cancer cachexia: Diagnosis, assessment, and treatment","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cachexia; Medicine; Cancer cachexia; Guideline; Cancer; Quality of life (healthcare); Intensive care medicine; Standardization; Cancer treatment; Internal medicine; Pathology; Nursing","score_opus":0.3094995821127756,"score_gpt":0.6011877947690292,"score_spread":0.29168821265625355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806460677","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000036254605,0.9993327,0.000048345308,0.00029256698,0.00013173123,0.000004663108,0.000012665407,0.0000027083063,0.00013831527],"genre_scores_gemma":[0.0004663426,0.9987839,0.00013681184,0.00022322622,0.0002852641,0.0000071669847,0.00001993314,6.487437e-7,0.00007678489],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99934274,0.00014415284,0.00013483877,0.00008860171,0.0002507048,0.000038985923],"domain_scores_gemma":[0.99810445,0.0011142002,0.00028057178,0.000038065056,0.00038557142,0.00007709295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014740925,0.0011355365,0.0029620936,0.0024792608,0.00033586047,0.0017201926,0.0013269394,0.0014010979,0.0023163534],"category_scores_gemma":[0.003989158,0.00038900337,0.0010114147,0.002067851,0.0007515244,0.0013556567,0.0010122827,0.002211535,0.0007916281],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010930308,0.000079841186,0.00062871096,0.028649688,0.00026064971,0.000109556684,0.000053977423,0.0003471128,0.0003174336,0.0018787938,0.035828948,0.93173605],"study_design_scores_gemma":[0.00013507516,0.00025890232,0.005224106,0.049529802,0.0014192043,0.0028457441,0.00023536595,0.00047730043,0.00044669892,0.005254948,0.9340764,0.000096373624],"about_ca_topic_score_codex":0.0029313888,"about_ca_topic_score_gemma":0.0055225906,"teacher_disagreement_score":0.0029620936,"about_ca_system_score_codex":0.0009706481,"about_ca_system_score_gemma":0.002679488,"threshold_uncertainty_score":0.0077958703},"labels":[],"label_agreement":null},{"id":"W2808868283","doi":"10.1016/j.critrevonc.2018.06.009","title":"Imaging predictors of treatment outcomes in rectal cancer: An overview","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Colorectal cancer; Imaging biomarker; Radiology; Neoadjuvant therapy; Medical imaging; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Magnetic resonance imaging","score_opus":0.1934323487675393,"score_gpt":0.5237826760705853,"score_spread":0.3303503273030459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808868283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000110533896,0.9995359,0.000032692176,0.00015278092,0.000043756234,0.000002256339,0.000019391673,0.0000013419753,0.00010145347],"genre_scores_gemma":[0.0013144223,0.998125,0.00014326631,0.00015982757,0.00017820433,0.0000056189756,0.000031420393,7.6231686e-7,0.000041449373],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99942124,0.00014143079,0.0001388754,0.00011296425,0.00014431382,0.00004120611],"domain_scores_gemma":[0.9967272,0.0023456472,0.00048532398,0.000035045814,0.0003402755,0.00006641888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014985643,0.0008313543,0.002218051,0.0026929702,0.00023811677,0.001588936,0.001082905,0.0011283358,0.002096616],"category_scores_gemma":[0.0056725,0.0003808598,0.0016884714,0.0030088252,0.0004971642,0.001308144,0.0006639982,0.001543586,0.00035393544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002623748,0.00009144824,0.00699504,0.06336527,0.0016536515,0.00019037705,0.00010622658,0.00043164205,0.00037532268,0.001388345,0.019604364,0.90553594],"study_design_scores_gemma":[0.00024748087,0.0007096639,0.053604443,0.20515913,0.015787028,0.0071633877,0.0007994572,0.0010266625,0.0010272481,0.0063110236,0.7078988,0.0002655928],"about_ca_topic_score_codex":0.0030489347,"about_ca_topic_score_gemma":0.005086213,"teacher_disagreement_score":0.0030489347,"about_ca_system_score_codex":0.0008278725,"about_ca_system_score_gemma":0.0021244485,"threshold_uncertainty_score":0.007925272},"labels":[],"label_agreement":null},{"id":"W2889067624","doi":"10.1016/j.critrevonc.2018.08.005","title":"The effects of mitochondria-associated long noncoding RNAs in cancer mitochondria: New players in an old arena","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Mitochondrion; Biology; Epigenetics; Cell biology; Function (biology); Mitochondrial DNA; Gene; Genetics; Computational biology","score_opus":0.05287255653739659,"score_gpt":0.4376379375255116,"score_spread":0.384765380988115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889067624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000070415226,0.9980173,0.00018659592,0.0006236828,0.00052057527,0.0000018316263,0.000018211296,0.000010260016,0.0005511548],"genre_scores_gemma":[0.00064533914,0.99754226,0.0002074762,0.00045672373,0.0006313354,0.000003384581,0.000028962986,0.0000024807814,0.0004820485],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997801,0.000034734898,0.000025276804,0.000041337946,0.000092528564,0.00002602273],"domain_scores_gemma":[0.99924743,0.00038805202,0.00007966245,0.000022848435,0.00017589326,0.00008609524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078213523,0.0007396255,0.0012128634,0.0010622835,0.00029097172,0.0014536676,0.00094240636,0.0014355261,0.0037800237],"category_scores_gemma":[0.0011796211,0.00019302683,0.000379123,0.0011931816,0.0008301257,0.0019968096,0.0009565249,0.002392119,0.0018367863],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012692732,0.000041073792,0.00021075908,0.010401085,0.00006364231,0.00023926678,0.00009508349,0.00028546504,0.005976809,0.008959307,0.067596644,0.90600395],"study_design_scores_gemma":[0.000011703814,0.000055235236,0.00041883584,0.001512233,0.00005229672,0.000591148,0.00006648639,0.000062230705,0.0007666983,0.0035615629,0.9928833,0.000018190398],"about_ca_topic_score_codex":0.0004712878,"about_ca_topic_score_gemma":0.00090669486,"teacher_disagreement_score":0.0037800237,"about_ca_system_score_codex":0.0006819155,"about_ca_system_score_gemma":0.0011965157,"threshold_uncertainty_score":0.012645483},"labels":[],"label_agreement":null},{"id":"W2895739306","doi":"10.1016/j.critrevonc.2018.09.017","title":"Crosstalk in cancer resistance and metastasis","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Crosstalk; Metastasis; CD44; Drug resistance; Chemotherapy; Cancer research; Medicine; Cancer; Cancer chemotherapy; Cancer treatment; Cancer cell; Tumor microenvironment; Bioinformatics; Biology; Tumor cells; Internal medicine; Cell; Genetics","score_opus":0.10951879324645543,"score_gpt":0.47477112477453154,"score_spread":0.3652523315280761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895739306","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008439392,0.9973335,0.00022846872,0.00057588576,0.000749297,0.0000040726545,0.000017334443,0.000011996287,0.000995029],"genre_scores_gemma":[0.0010152333,0.99642307,0.0002445203,0.0004912385,0.0007220043,0.0000083699615,0.000033180742,0.0000025044976,0.0010598813],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978465,0.000039890834,0.000022641234,0.000037348564,0.000082087776,0.000033338496],"domain_scores_gemma":[0.9997428,0.00010150835,0.000033998767,0.000009775111,0.000071862356,0.00004009466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006745665,0.0010674761,0.0011965677,0.0014887417,0.0003299655,0.0015285173,0.0008968376,0.001280626,0.00438877],"category_scores_gemma":[0.0007340928,0.00029623572,0.0003717572,0.0014370654,0.00081150356,0.0012778534,0.0010139535,0.002814993,0.0020521092],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100812314,0.00006450406,0.00013945148,0.0077002365,0.00006003582,0.00019877274,0.000050688428,0.00040494298,0.0034034187,0.00941954,0.07798621,0.9004714],"study_design_scores_gemma":[0.000020568732,0.000041368894,0.0003258465,0.0015061738,0.0000664096,0.0005202562,0.00004923916,0.00010002173,0.00062765984,0.003948203,0.99278027,0.000014132895],"about_ca_topic_score_codex":0.000518059,"about_ca_topic_score_gemma":0.0012201262,"teacher_disagreement_score":0.00438877,"about_ca_system_score_codex":0.00072207564,"about_ca_system_score_gemma":0.001198855,"threshold_uncertainty_score":0.014681935},"labels":[],"label_agreement":null},{"id":"W2906204636","doi":"10.1016/j.critrevonc.2018.12.003","title":"Metabolic rewiring beyond Warburg in chronic lymphocytic leukemia: How much do we actually know?","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Leukemia and Lymphoma Society","keywords":"Chronic lymphocytic leukemia; Leukemia; Cancer research; Biology; Metabolism; Immunology; Biochemistry","score_opus":0.09477210235360013,"score_gpt":0.44950691634630763,"score_spread":0.3547348139927075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906204636","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010514407,0.9985821,0.000049167276,0.0006010736,0.00022157868,0.0000019271222,0.000013500398,0.0000052487417,0.00042035434],"genre_scores_gemma":[0.0007281968,0.99829036,0.00007450022,0.00033491274,0.0002108808,0.0000030102342,0.000023237351,0.0000013398264,0.0003335421],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999838,0.000035872745,0.000024773482,0.000028815599,0.000047844856,0.000024675372],"domain_scores_gemma":[0.99966156,0.0001508665,0.00004487233,0.000011611629,0.00009257073,0.000038383387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056753174,0.0005014672,0.0011138115,0.0013241596,0.00030653694,0.0011962673,0.00074456446,0.0011390032,0.0034619425],"category_scores_gemma":[0.0008771811,0.00020500456,0.0005072431,0.0012390664,0.00051570643,0.0018806225,0.0006258988,0.0018597746,0.0016766621],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014943095,0.00005825318,0.00026645095,0.015867284,0.000090267415,0.00024059971,0.00011043037,0.0002436853,0.0017212089,0.005096385,0.04493442,0.9312217],"study_design_scores_gemma":[0.00001655032,0.0001233435,0.0005658566,0.003691163,0.00009703786,0.0010581673,0.000089593304,0.000050884195,0.0004520879,0.002628815,0.99121034,0.000016268918],"about_ca_topic_score_codex":0.0008546668,"about_ca_topic_score_gemma":0.0015063996,"teacher_disagreement_score":0.0034619425,"about_ca_system_score_codex":0.00059525215,"about_ca_system_score_gemma":0.0010504063,"threshold_uncertainty_score":0.011581421},"labels":[],"label_agreement":null},{"id":"W2911141441","doi":"10.1016/j.critrevonc.2018.12.008","title":"Corrigendum to “Imaging predictors of treatment outcomes in rectal cancer: An overview” [Crit. Rev. Oncol./Hematol. 129, (September) (2018), 153–162]","year":2019,"lang":"en","type":"erratum","venue":"Critical Reviews in Oncology/Hematology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Colorectal cancer; Medicine; Cancer; Philosophy; General surgery; Classics; History; Internal medicine","score_opus":0.11888211295658788,"score_gpt":0.45410568855240957,"score_spread":0.3352235755958217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911141441","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032874734,0.0037899555,0.0001551715,0.074654706,0.91686374,0.00002746546,0.0005383398,0.00012094893,0.0038168745],"genre_scores_gemma":[0.0017949631,0.017741045,0.00083209504,0.19015834,0.6907505,0.00015695361,0.0013689247,0.00029416906,0.096902974],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965204,0.00062397943,0.0006755173,0.0004334726,0.0013932213,0.00035341384],"domain_scores_gemma":[0.9674636,0.009640244,0.0018946711,0.0010097105,0.01818338,0.0018083638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033443803,0.002069423,0.0026971945,0.004414443,0.001948317,0.0036490904,0.00279261,0.007459115,0.07872175],"category_scores_gemma":[0.04992187,0.001024566,0.002503824,0.002403651,0.0016567751,0.0021681613,0.0020433792,0.009121757,0.058461428],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010487389,0.000003401255,0.000029970335,0.00006504677,0.0000041300427,0.000060821774,0.0000036571105,0.00000947286,0.000008355314,0.00010413247,0.99594927,0.0037513224],"study_design_scores_gemma":[0.000052936935,0.000023978482,0.000802703,0.0010458254,0.000046557987,0.00040909284,0.000035105593,0.000102799,0.00011827727,0.00088294136,0.9964412,0.00003856713],"about_ca_topic_score_codex":0.017697213,"about_ca_topic_score_gemma":0.027235225,"teacher_disagreement_score":0.07872175,"about_ca_system_score_codex":0.0036585357,"about_ca_system_score_gemma":0.00537163,"threshold_uncertainty_score":0.2633505},"labels":[],"label_agreement":null},{"id":"W2911385124","doi":"10.1016/j.critrevonc.2019.02.005","title":"Impact of exercise on chemotherapy completion rate: A systematic review of the evidence and recommendations for future exercise oncology research","year":2019,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; CINAHL; Randomized controlled trial; Physical therapy; Chemotherapy; MEDLINE; Tolerability; Meta-analysis; Aerobic exercise; Internal medicine; Breast cancer; Clinical trial; Intensive care medicine; Psychological intervention; Cancer; Oncology; Adverse effect","score_opus":0.26506792857307904,"score_gpt":0.5635864499745943,"score_spread":0.29851852140151525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911385124","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008342197,0.9984499,0.00007311268,0.00015538845,0.000070049275,0.00009408091,0.00023019697,0.0000038217736,0.00008922093],"genre_scores_gemma":[0.017500026,0.9810224,0.00047970848,0.00046507895,0.000089049805,0.0001817387,0.00019198729,0.000006975831,0.000063123494],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9919858,0.002868111,0.002805123,0.00085354125,0.0012420657,0.00024537556],"domain_scores_gemma":[0.967963,0.0251288,0.0049406225,0.00038041463,0.001315017,0.00027222006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011940474,0.0017262413,0.011607112,0.005109277,0.0005238588,0.0033595036,0.0017612544,0.0020746852,0.004582587],"category_scores_gemma":[0.051500257,0.0011753404,0.016411442,0.0065847454,0.0009165185,0.0018815768,0.0017491641,0.00232479,0.0002735771],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000836508,0.00004576075,0.0027094807,0.8806378,0.06295915,0.000047391222,0.00012072943,0.00018317308,0.000110034045,0.00018229686,0.0013467949,0.05082083],"study_design_scores_gemma":[0.0008236377,0.0003462532,0.013832908,0.61255246,0.35911125,0.00018788107,0.00022555214,0.00017367215,0.00014047496,0.00050386344,0.012035605,0.00006645148],"about_ca_topic_score_codex":0.012298823,"about_ca_topic_score_gemma":0.03635429,"teacher_disagreement_score":0.012298823,"about_ca_system_score_codex":0.0029042498,"about_ca_system_score_gemma":0.008160184,"threshold_uncertainty_score":0.06314802},"labels":[],"label_agreement":null},{"id":"W2914171857","doi":"10.1016/j.critrevonc.2019.01.008","title":"Biomarkers in Non-Schistosomiasis-related squamous cell carcinoma of the urinary bladder: A review","year":2019,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Clinical trial; Bladder cancer; Oncology; Urinary bladder; Schistosomiasis; Carcinoma; Schistosoma; Urinary system; Internal medicine; Basal cell; Cancer research; Urology; Immunology; Cancer; Schistosoma mansoni","score_opus":0.057432181218545375,"score_gpt":0.395503240123607,"score_spread":0.3380710589050616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914171857","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042366097,0.99963427,0.000027442185,0.00010636148,0.00008817382,0.0000028055063,0.000019771633,0.000002001585,0.00007675118],"genre_scores_gemma":[0.0004314549,0.9991037,0.00009650638,0.00016081781,0.00010679278,0.0000046309415,0.000025088382,4.5272927e-7,0.00007051379],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996536,0.00007208705,0.00008757967,0.00006228425,0.0000992032,0.000025312513],"domain_scores_gemma":[0.99894387,0.00062299473,0.0002015877,0.000015172737,0.00017785523,0.000038486418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010073358,0.00092319516,0.0022846218,0.0030063847,0.00020834724,0.0013913495,0.00085727347,0.0010867293,0.0027002722],"category_scores_gemma":[0.001933592,0.00037466575,0.0013638729,0.002634246,0.00034520103,0.001266629,0.0007335739,0.0012795877,0.00067516946],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023344322,0.00008323936,0.0007546067,0.09523205,0.0008771495,0.00024198742,0.000076120756,0.00034999405,0.0012562082,0.0012828454,0.032971106,0.8666412],"study_design_scores_gemma":[0.00014932161,0.00041662372,0.0052187094,0.05729809,0.0043524993,0.0020821248,0.00023533156,0.00028358618,0.0009565587,0.0023837837,0.92652446,0.00009889661],"about_ca_topic_score_codex":0.0016352253,"about_ca_topic_score_gemma":0.0033775514,"teacher_disagreement_score":0.0030063847,"about_ca_system_score_codex":0.00051270047,"about_ca_system_score_gemma":0.001785864,"threshold_uncertainty_score":0.009033322},"labels":[],"label_agreement":null},{"id":"W2938040477","doi":"10.1016/j.critrevonc.2019.04.009","title":"The landscape of postsurgical recurrence patterns in diffuse low-grade gliomas","year":2019,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital de l'Enfant-Jésus","funders":"","keywords":"Medicine; Glioma; Radiation therapy; Chemotherapy; Malignant transformation; Surgery; Radiology; Pathology","score_opus":0.09265330789770766,"score_gpt":0.43986332450536253,"score_spread":0.3472100166076549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938040477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001386331,0.9992229,0.00003895375,0.00024702525,0.000070468624,0.0000015775229,0.00001797288,0.000002923669,0.00025964648],"genre_scores_gemma":[0.0014459207,0.99788386,0.000109943634,0.00021185521,0.00016557497,0.0000027127592,0.00003144115,8.9159886e-7,0.00014775763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997924,0.000042881235,0.000041925818,0.00004312414,0.000061048384,0.000018644701],"domain_scores_gemma":[0.9994246,0.00029979087,0.0001269542,0.000009460099,0.00011253088,0.00002657985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056803366,0.00044679618,0.0010410377,0.0015930801,0.00014282804,0.0011766154,0.0005537463,0.00063108496,0.0017268964],"category_scores_gemma":[0.0014939216,0.00017621272,0.00054218085,0.0017047356,0.00036041066,0.0008784931,0.00043082747,0.00091644644,0.0004893258],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009404221,0.000021721986,0.00092872913,0.017924681,0.00018501865,0.00017050374,0.00007562055,0.0002388563,0.0005023385,0.0014029912,0.018453883,0.9600017],"study_design_scores_gemma":[0.000043194967,0.00022198157,0.008984447,0.022323923,0.0011360784,0.0034670995,0.000302945,0.00022810466,0.0005151696,0.0034374178,0.9592779,0.00006186879],"about_ca_topic_score_codex":0.0020633985,"about_ca_topic_score_gemma":0.005416178,"teacher_disagreement_score":0.0020633985,"about_ca_system_score_codex":0.0006297256,"about_ca_system_score_gemma":0.0012572722,"threshold_uncertainty_score":0.005777061},"labels":[],"label_agreement":null},{"id":"W2949101873","doi":"10.1016/j.critrevonc.2019.06.004","title":"The microbiome and cancer for clinicians","year":2019,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Microbiome; Cancer; Carcinogenesis; Disease; Pancreatic cancer; Colorectal cancer; Human microbiome; Prostate cancer; Dysbiosis; Medicine; Immunology; Bioinformatics; Biology; Cancer research; Internal medicine","score_opus":0.13038126990205112,"score_gpt":0.5173365347683865,"score_spread":0.38695526486633536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949101873","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018829145,0.992562,0.00007080758,0.0033448527,0.0031543323,0.000002064955,0.000011444506,0.000008359289,0.00082727603],"genre_scores_gemma":[0.00041448473,0.98753536,0.00023213928,0.0035669315,0.006630826,0.000009762194,0.00002788703,0.000004108813,0.0015785501],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99942136,0.00017760084,0.00005182694,0.000074028256,0.00022285292,0.000052287403],"domain_scores_gemma":[0.9983797,0.0008514854,0.00014899806,0.000051610936,0.00037068408,0.00019744682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012686544,0.0011477431,0.0014528878,0.0021581387,0.00043592136,0.0022934286,0.00091208785,0.0030217883,0.0092079425],"category_scores_gemma":[0.0039257146,0.00028245655,0.00050297513,0.0017527404,0.0009393302,0.0024579018,0.0016818822,0.0049365116,0.0034000329],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007766293,0.000039438437,0.0001579454,0.0060928958,0.00006090435,0.00013623082,0.0000643088,0.00016623802,0.0004837221,0.00507959,0.35154185,0.6360992],"study_design_scores_gemma":[0.000016478118,0.000021004322,0.00025902083,0.0038998069,0.000037280206,0.00030169924,0.000049761504,0.000036976933,0.000052061958,0.0030970697,0.99221814,0.000010638221],"about_ca_topic_score_codex":0.0012823407,"about_ca_topic_score_gemma":0.0025159363,"teacher_disagreement_score":0.0092079425,"about_ca_system_score_codex":0.0011388117,"about_ca_system_score_gemma":0.0019686045,"threshold_uncertainty_score":0.03080362},"labels":[],"label_agreement":null},{"id":"W2949176693","doi":"10.1016/j.critrevonc.2019.06.002","title":"Hematologic improvement with iron chelation therapy in myelodysplastic syndromes: Clinical data, potential mechanisms, and outstanding questions","year":2019,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Novartis Pharmaceuticals Canada; Celgene","keywords":"Myelodysplastic syndromes; Medicine; Chelation therapy; Myeloid leukemia; Anemia; Clinical trial; Randomized controlled trial; Intensive care medicine; Internal medicine; Haematopoiesis; Blood transfusion; Oncology; Stem cell; Thalassemia; Bone marrow; Biology","score_opus":0.22302558547096987,"score_gpt":0.5055964256629083,"score_spread":0.28257084019193845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949176693","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032678334,0.9995291,0.000020783602,0.00019654572,0.0001120949,0.0000014725199,0.000007892117,0.0000017918233,0.000097675205],"genre_scores_gemma":[0.0003219669,0.9989711,0.000071902075,0.00030641502,0.0002155716,0.0000035851092,0.000014969173,7.092937e-7,0.00009380231],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996778,0.0000769381,0.000060916816,0.000052889824,0.00010365818,0.00002779729],"domain_scores_gemma":[0.99894696,0.00065164705,0.00012162579,0.000021652168,0.0002067108,0.00005144835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014651652,0.00081089756,0.0024314993,0.0014001356,0.00023885738,0.0013053202,0.001127188,0.0011924976,0.002884908],"category_scores_gemma":[0.0022236293,0.0002272374,0.000759084,0.0016284814,0.0005853505,0.0012129691,0.00069538056,0.00225255,0.0011013839],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023255675,0.000056616045,0.0001940081,0.027739605,0.0002356106,0.00011683855,0.000039916504,0.00019150788,0.00078306074,0.0019681603,0.037044544,0.93139756],"study_design_scores_gemma":[0.00025149473,0.00033727838,0.0018108007,0.019053794,0.0009534591,0.0012772577,0.00012360855,0.00016460617,0.0004901898,0.0038385617,0.97165,0.000048978636],"about_ca_topic_score_codex":0.0007413314,"about_ca_topic_score_gemma":0.001724547,"teacher_disagreement_score":0.002884908,"about_ca_system_score_codex":0.00052287156,"about_ca_system_score_gemma":0.0013686905,"threshold_uncertainty_score":0.009650946},"labels":[],"label_agreement":null},{"id":"W2966782162","doi":"10.1016/j.critrevonc.2019.07.017","title":"Do we still need to study palonosetron for chemotherapy-induced nausea and vomiting? A cumulative meta-analysis","year":2019,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Nausea and vomiting management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; London Health Sciences Centre; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Palonosetron; Meta-analysis; Funnel plot; Publication bias; Medicine; Confidence interval; Odds ratio; Randomized controlled trial; Nausea; Random effects model; Odds; Internal medicine; Logistic regression; Antiemetic","score_opus":0.36153538847355216,"score_gpt":0.5372812469255104,"score_spread":0.17574585845195823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966782162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022396322,0.9958038,0.0005497758,0.00048392132,0.0004247771,0.000068221685,0.0001813473,0.00001684001,0.00023169427],"genre_scores_gemma":[0.14029123,0.8489422,0.0029779703,0.005243785,0.0009077793,0.0002733142,0.00059427775,0.00006171368,0.00070760254],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99581194,0.002122767,0.0010307783,0.00049883674,0.00037936418,0.0001563411],"domain_scores_gemma":[0.990387,0.006849596,0.0014304484,0.00049210415,0.00065086235,0.0001899481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0099223405,0.002072906,0.014264343,0.001772368,0.00033571705,0.0022878468,0.0012917023,0.0017330882,0.005705907],"category_scores_gemma":[0.024548367,0.00123675,0.028665433,0.0023419287,0.00050073926,0.002183163,0.0012316175,0.0029629697,0.0005436012],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056463764,0.000040285235,0.0025101455,0.16469757,0.7816047,0.000069246715,0.00004925326,0.00045722304,0.00034232292,0.0002618126,0.0015365239,0.04278443],"study_design_scores_gemma":[0.0027567996,0.00057806465,0.00341222,0.01587959,0.9711949,0.000067992696,0.000041284395,0.0001687401,0.00007936653,0.0007905209,0.00500015,0.000030278772],"about_ca_topic_score_codex":0.0036682088,"about_ca_topic_score_gemma":0.01225344,"teacher_disagreement_score":0.014264343,"about_ca_system_score_codex":0.0013375182,"about_ca_system_score_gemma":0.0014901664,"threshold_uncertainty_score":0.052474976},"labels":[],"label_agreement":null},{"id":"W2973482359","doi":"10.1016/j.critrevonc.2019.08.006","title":"Integration of palliative, supportive, and nutritional care to alleviate eating-related distress among advanced cancer patients with cachexia and their family members","year":2019,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cachexia; Distress; Cancer; Palliative care; Cancer cachexia; Medicine; Intensive care medicine; Gerontology; Psychology; Nursing; Clinical psychology; Internal medicine","score_opus":0.07629832743797355,"score_gpt":0.4463594489996658,"score_spread":0.37006112156169224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973482359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000082538565,0.99956304,0.000024026598,0.00008761041,0.00007291279,0.0000042720326,0.0000053996855,0.0000011529158,0.00015899274],"genre_scores_gemma":[0.00075324136,0.9987369,0.00014783574,0.00017361378,0.00008928608,0.000008289421,0.000012587314,4.8036264e-7,0.00007780454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975735,0.00006696222,0.000045875833,0.000036044188,0.00007349775,0.000020202071],"domain_scores_gemma":[0.99948657,0.000316536,0.00007146843,0.000008804379,0.000090113695,0.000026449727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089449587,0.0005634677,0.0014885155,0.00094015745,0.00018913654,0.00075522275,0.0007304884,0.00072937156,0.0019617614],"category_scores_gemma":[0.0014301718,0.00016065792,0.00071446225,0.00091410964,0.00023999054,0.0006113473,0.0005040534,0.0013376093,0.00036284266],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014571392,0.00010481455,0.00021555605,0.04470688,0.00040671646,0.000055074226,0.00006515971,0.00012112107,0.0004231421,0.0007761998,0.011269454,0.9417101],"study_design_scores_gemma":[0.0004776094,0.0008714976,0.008331885,0.10260314,0.003515133,0.0017136545,0.00038719008,0.00032749318,0.0007501371,0.0022692026,0.87867403,0.00007901826],"about_ca_topic_score_codex":0.0014104351,"about_ca_topic_score_gemma":0.003780144,"teacher_disagreement_score":0.0019617614,"about_ca_system_score_codex":0.000414851,"about_ca_system_score_gemma":0.001135815,"threshold_uncertainty_score":0.0065627694},"labels":[],"label_agreement":null},{"id":"W2982037555","doi":"10.1016/j.critrevonc.2019.102817","title":"Adjuvant treatment for resected pancreatic adenocarcinoma: A systematic review and network meta-analysis","year":2019,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Kingston Health Sciences Centre; Queen's University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Gemcitabine; Erlotinib; Medicine; Capecitabine; Oncology; Internal medicine; Randomized controlled trial; Meta-analysis; Pancreatic cancer; Adjuvant; Chemotherapy; Cancer; Colorectal cancer; Epidermal growth factor receptor","score_opus":0.3549700768811592,"score_gpt":0.5239913615233373,"score_spread":0.16902128464217803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982037555","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049727974,0.99396133,0.0002167312,0.000111363915,0.00011493866,0.00007571342,0.00038751552,0.0000133215835,0.00014640325],"genre_scores_gemma":[0.21553378,0.7799518,0.0014170934,0.0013453005,0.00025255542,0.00027765316,0.00080333406,0.000034175817,0.00038426774],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9960759,0.0015800224,0.0011783756,0.00059063255,0.00037732392,0.00019761009],"domain_scores_gemma":[0.99360526,0.0041488153,0.0014810017,0.00023262648,0.0003901311,0.00014210033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049012993,0.002137724,0.011685645,0.0034543313,0.00043130553,0.0020529355,0.0016134467,0.0016701986,0.0040129796],"category_scores_gemma":[0.012499954,0.0012633824,0.025362505,0.0045910627,0.0006104259,0.0015429262,0.0015868753,0.0020030397,0.00034881185],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003010036,0.000039784005,0.0071577686,0.34284467,0.6298987,0.00012887275,0.000104797895,0.00048949744,0.0003631435,0.0000956811,0.0010546277,0.014812483],"study_design_scores_gemma":[0.0008665107,0.00018920196,0.0047387546,0.016316218,0.9756836,0.00008149295,0.000054011387,0.00011077133,0.000074159994,0.00013870445,0.0017185389,0.00002800124],"about_ca_topic_score_codex":0.0064141545,"about_ca_topic_score_gemma":0.024336739,"teacher_disagreement_score":0.011685645,"about_ca_system_score_codex":0.0018166327,"about_ca_system_score_gemma":0.0021857833,"threshold_uncertainty_score":0.025920868},"labels":[],"label_agreement":null},{"id":"W3004670172","doi":"10.1016/j.critrevonc.2020.102896","title":"A novel, more reliable approach to use of progression-free survival as a predictor of gain in overall survival: The Ottawa PFS Predictive Model","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Predictive modelling; Progression-free survival; Overall survival; Oncology; Computer science; Medicine; Machine learning","score_opus":0.09157622534961121,"score_gpt":0.4323188863312236,"score_spread":0.34074266098161243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004670172","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020320918,0.5899049,0.3507388,0.014937435,0.0025598442,0.00031872257,0.008107638,0.00094615563,0.012165621],"genre_scores_gemma":[0.42296076,0.40276122,0.14015192,0.007624009,0.0062351315,0.00084221846,0.008351178,0.00037166092,0.01070189],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99864537,0.00051121146,0.00012621241,0.00035905725,0.00028747696,0.00007064631],"domain_scores_gemma":[0.99272174,0.0055421256,0.00053150137,0.00024226292,0.0008398457,0.00012247478],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005243963,0.0025506176,0.003525361,0.0027883959,0.00034218287,0.00256579,0.0032423246,0.0015406763,0.0025121565],"category_scores_gemma":[0.011198331,0.0004654912,0.0023589344,0.0022244968,0.0008666439,0.0022862288,0.0009310082,0.0057427795,0.0012815576],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006546138,0.0002480474,0.032603506,0.0051737865,0.002555039,0.00025730545,0.00015409091,0.046914686,0.0010037101,0.030423708,0.03140599,0.8486054],"study_design_scores_gemma":[0.00045939727,0.0029540618,0.05544355,0.00902513,0.008754085,0.0040652887,0.00036521256,0.44366077,0.0054119574,0.20439187,0.26456037,0.00090830424],"about_ca_topic_score_codex":0.011378517,"about_ca_topic_score_gemma":0.012772415,"teacher_disagreement_score":0.99475604,"about_ca_system_score_codex":0.0021562662,"about_ca_system_score_gemma":0.0028443134,"threshold_uncertainty_score":0.027733028},"labels":[],"label_agreement":null},{"id":"W3009112053","doi":"10.1016/j.critrevonc.2020.102922","title":"Accuracy of the Multinational Association of Supportive Care in Cancer (MASCC) and Clinical Index of Stable Febrile Neutropenia (CISNE) scores for predicting serious complications in adult patients with febrile neutropenia: A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; Ottawa Hospital; University of Toronto; University of Ottawa","funders":"University of Ottawa","keywords":"Medicine; Febrile neutropenia; Internal medicine; Neutropenia; Cancer; Chemotherapy","score_opus":0.07418137858785798,"score_gpt":0.44914023275501785,"score_spread":0.3749588541671599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009112053","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009287869,0.98933756,0.0003561842,0.00013688093,0.00013318984,0.00009871922,0.00044369925,0.000023412367,0.0001824718],"genre_scores_gemma":[0.34419805,0.6496666,0.0028218005,0.0012628607,0.00028982337,0.00038001873,0.0009068042,0.000039988354,0.00043398357],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955308,0.0015739742,0.0015062679,0.0007226012,0.0005088537,0.00015754924],"domain_scores_gemma":[0.9872442,0.009350186,0.0021352817,0.0004642247,0.00064826873,0.00015788396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007998101,0.0020993485,0.0125012435,0.0033373036,0.00046817918,0.0024404132,0.0018063181,0.0020781977,0.0029580686],"category_scores_gemma":[0.023019,0.0014786518,0.033450637,0.004077807,0.0008425114,0.0016179649,0.0016278939,0.0022014587,0.0002989786],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002807741,0.000042006744,0.014113645,0.18152505,0.78278625,0.000072485826,0.00010020851,0.00048505317,0.00022013782,0.00012386472,0.000629208,0.017094426],"study_design_scores_gemma":[0.0006765963,0.0001550307,0.0066059316,0.007928759,0.98335403,0.00005798679,0.000036575435,0.00017073426,0.00005862742,0.00011975195,0.00080651464,0.000029432946],"about_ca_topic_score_codex":0.0076777446,"about_ca_topic_score_gemma":0.022808332,"teacher_disagreement_score":0.0125012435,"about_ca_system_score_codex":0.0015173979,"about_ca_system_score_gemma":0.0020885724,"threshold_uncertainty_score":0.042298496},"labels":[],"label_agreement":null},{"id":"W3024770628","doi":"10.1016/j.critrevonc.2020.102986","title":"Oral potentially malignant disorders: A scoping review of prognostic biomarkers","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Oral Health Pathology and Treatment","field":"Dentistry","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Malignant transformation; Oncology; Medicine; Podoplanin; Confounding; Internal medicine; Population; Pathology; Bioinformatics; Biology; Immunohistochemistry","score_opus":0.11784591354705722,"score_gpt":0.49325303338408716,"score_spread":0.37540711983702996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024770628","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006159599,0.99958736,0.00004264262,0.000114127695,0.00005349277,0.000010597717,0.000041483192,0.0000019134256,0.000086761356],"genre_scores_gemma":[0.0005458446,0.9989318,0.00017916715,0.00018255792,0.000055572727,0.000018605091,0.00004305773,9.850243e-7,0.0000424047],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99771416,0.0004912148,0.0009003963,0.00029188953,0.0005012318,0.000101158716],"domain_scores_gemma":[0.9905067,0.0070641497,0.0014271316,0.00012298401,0.00077519193,0.00010391433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047870865,0.0014317497,0.0048516192,0.009253729,0.00054804416,0.0031762726,0.0017947919,0.0021256125,0.0036196003],"category_scores_gemma":[0.012816122,0.00076866354,0.0036512862,0.008329667,0.0008753425,0.0027219688,0.0017189697,0.0014797061,0.000557036],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022243462,0.000054795775,0.0009722886,0.5035149,0.002507337,0.00021850482,0.00024670793,0.00022997,0.0005390259,0.0014573818,0.013416674,0.47662008],"study_design_scores_gemma":[0.0001195448,0.00015790059,0.0036565866,0.7165097,0.01567068,0.0013314633,0.00039551666,0.00017192875,0.00037646314,0.0019752875,0.25955755,0.000077404766],"about_ca_topic_score_codex":0.004292726,"about_ca_topic_score_gemma":0.009345859,"teacher_disagreement_score":0.009253729,"about_ca_system_score_codex":0.0017249967,"about_ca_system_score_gemma":0.00641299,"threshold_uncertainty_score":0.025316834},"labels":[],"label_agreement":null},{"id":"W3034159339","doi":"10.1016/j.critrevonc.2020.102971","title":"Systemic therapy in metastatic renal cell carcinoma: Emerging challenges in therapeutic choice","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; University Health Network; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canada Research Chairs","keywords":"Medicine; Systemic therapy; Intensive care medicine; Pace; Renal cell carcinoma; Cancer; Oncology; Internal medicine; Breast cancer","score_opus":0.24089697124174567,"score_gpt":0.4453458522876007,"score_spread":0.20444888104585504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034159339","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004993238,0.9984102,0.00010135467,0.0007179104,0.0002341555,0.0000017311114,0.000011019182,0.000004099411,0.00046952086],"genre_scores_gemma":[0.0006940688,0.99777454,0.0001862755,0.0006745995,0.0004298179,0.00000470569,0.000018127583,0.0000017877024,0.00021596407],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996662,0.00011118714,0.00004263765,0.000049788978,0.00010164538,0.00002848097],"domain_scores_gemma":[0.9988422,0.00076565397,0.00011391717,0.000020602876,0.00020211945,0.000055633387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001388212,0.00057158695,0.0018229305,0.0012142874,0.00026426357,0.001657433,0.0008330457,0.0011185106,0.0040199957],"category_scores_gemma":[0.0019455595,0.00021238861,0.0005907847,0.0014632974,0.00064851943,0.001821203,0.00071647577,0.002981383,0.0012221867],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107447195,0.00005377468,0.000173685,0.013978306,0.000120256795,0.00011812003,0.00004760825,0.000475157,0.0007319346,0.007292125,0.048278406,0.9286233],"study_design_scores_gemma":[0.00004497057,0.00014233768,0.0005241119,0.0077269967,0.00019409868,0.000706208,0.00007508692,0.00021239121,0.00022539582,0.004207209,0.98591727,0.000023903583],"about_ca_topic_score_codex":0.0009037421,"about_ca_topic_score_gemma":0.0028749492,"teacher_disagreement_score":0.0040199957,"about_ca_system_score_codex":0.0008337739,"about_ca_system_score_gemma":0.0015064598,"threshold_uncertainty_score":0.013448238},"labels":[],"label_agreement":null},{"id":"W3080495165","doi":"10.1016/j.critrevonc.2020.103085","title":"In reply: Response to letter to the editor","year":2020,"lang":"en","type":"letter","venue":"Critical Reviews in Oncology/Hematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Toronto; University of Ottawa","funders":"","keywords":"Psychology; Computer science","score_opus":0.054668632550273856,"score_gpt":0.41534504348679274,"score_spread":0.36067641093651887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080495165","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001437213,0.0010014412,0.00003765031,0.94286305,0.054180454,0.00001237522,0.000044971668,0.000024050052,0.0016923441],"genre_scores_gemma":[0.001456585,0.0006842775,0.000067000896,0.9459002,0.047189098,0.000029318044,0.00002119358,0.000022598131,0.0046298457],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99528897,0.0014872794,0.0005502074,0.00050830573,0.0014540215,0.00071129506],"domain_scores_gemma":[0.9888543,0.005084101,0.00107315,0.00027264288,0.0025562015,0.0021596076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004279074,0.001303423,0.002255084,0.0013019063,0.004201679,0.005119115,0.0027366024,0.056035653,0.011780457],"category_scores_gemma":[0.034167442,0.0011434272,0.0014475943,0.0009730045,0.0028177947,0.0032811859,0.0020275754,0.03755418,0.010491235],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032372674,0.000010395384,0.00019363259,0.000033829157,0.000009234901,0.0006340004,0.000052440762,0.000019506128,0.000036539514,0.0004095181,0.99731535,0.0012531905],"study_design_scores_gemma":[0.00013833815,0.000059161834,0.00097091025,0.00040026224,0.000049984206,0.0015378405,0.00046809882,0.00025817228,0.00018933557,0.0027349398,0.9931149,0.00007811291],"about_ca_topic_score_codex":0.0062304,"about_ca_topic_score_gemma":0.008553724,"teacher_disagreement_score":0.056035653,"about_ca_system_score_codex":0.0052326056,"about_ca_system_score_gemma":0.007122437,"threshold_uncertainty_score":0.039409578},"labels":[],"label_agreement":null},{"id":"W3080704689","doi":"10.1016/j.critrevonc.2020.103090","title":"The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; McGill University Health Centre","funders":"National Institute for Health and Care Research","keywords":"Medicine; Breast cancer; Radiation therapy; Clinical Practice; Clinical trial; Oncology; Cancer; Medical physics; Radiology; Internal medicine; Physical therapy","score_opus":0.17953776625423248,"score_gpt":0.5333394056239898,"score_spread":0.3538016393697574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080704689","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000036619578,0.99942625,0.000025107518,0.00022753306,0.000119319295,0.0000062746053,0.0000075655585,0.0000016128802,0.00014976744],"genre_scores_gemma":[0.0003019806,0.99930084,0.00008059281,0.00018810868,0.000069768685,0.00000906427,0.000009095556,6.0831917e-7,0.000039967617],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99935454,0.00019225656,0.00017893607,0.00007410779,0.000170338,0.000029815967],"domain_scores_gemma":[0.9966403,0.002373768,0.00032827377,0.00004722742,0.0005435804,0.00006682127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020169618,0.00075982953,0.0017260828,0.002569664,0.00029737185,0.0011831445,0.0013368502,0.0013060129,0.002326248],"category_scores_gemma":[0.0050946777,0.00033660847,0.0010037166,0.0027328234,0.00059135177,0.0012393261,0.0005349799,0.0013466317,0.00066576607],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014771913,0.000047353835,0.00020053869,0.14448887,0.00038308994,0.0001345488,0.00012351578,0.00023799189,0.00047360593,0.0016876861,0.03356337,0.8185117],"study_design_scores_gemma":[0.00007579357,0.000339153,0.0020469085,0.1471856,0.0017543144,0.0013155439,0.0002125813,0.00011106477,0.00039182327,0.001948059,0.8445731,0.000046099056],"about_ca_topic_score_codex":0.0016587497,"about_ca_topic_score_gemma":0.0029598272,"teacher_disagreement_score":0.002569664,"about_ca_system_score_codex":0.0010577197,"about_ca_system_score_gemma":0.0028287948,"threshold_uncertainty_score":0.010666847},"labels":[],"label_agreement":null},{"id":"W3094603587","doi":"10.1016/j.critrevonc.2020.103125","title":"Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"Bayer","keywords":"Medicine; Edoxaban; Rivaroxaban; Apixaban; Intensive care medicine; Low molecular weight heparin; Thrombosis; Anticoagulant therapy; Clinical trial; Anticoagulant; Cancer; Observational study; Surgery; Internal medicine; Warfarin","score_opus":0.1474410475931543,"score_gpt":0.5193484276329743,"score_spread":0.37190738003982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094603587","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031134397,0.99905723,0.00006699488,0.0004916961,0.00017528528,0.0000017473984,0.00000665274,0.00000230738,0.00016689271],"genre_scores_gemma":[0.00045806958,0.9984054,0.00017723089,0.00046178052,0.00039439875,0.0000036831327,0.0000129595965,0.0000012382649,0.000085239866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990765,0.00027374024,0.00018219664,0.00013086975,0.00029091295,0.000045706987],"domain_scores_gemma":[0.9964483,0.0024382744,0.00038207267,0.000058135494,0.00056915253,0.000104186925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022910263,0.00085667905,0.002329474,0.002360075,0.0002552813,0.0022924622,0.0012295574,0.0016472733,0.0027651505],"category_scores_gemma":[0.005352438,0.00030597197,0.0008789427,0.0023912918,0.0008312846,0.0020554878,0.00074020826,0.0033139563,0.0009774887],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012225806,0.000058877114,0.00025674765,0.024869977,0.00021592129,0.00012426259,0.00006353301,0.00040929357,0.0003945797,0.005175409,0.026483933,0.9418253],"study_design_scores_gemma":[0.000099134675,0.00022905032,0.00131717,0.03129372,0.0005482755,0.0015024445,0.00014530901,0.00038205826,0.00025464542,0.006291458,0.9578848,0.000051906132],"about_ca_topic_score_codex":0.0013055669,"about_ca_topic_score_gemma":0.002449685,"teacher_disagreement_score":0.0027651505,"about_ca_system_score_codex":0.0011629066,"about_ca_system_score_gemma":0.0020262867,"threshold_uncertainty_score":0.012116253},"labels":[],"label_agreement":null},{"id":"W3108540679","doi":"10.1016/j.critrevonc.2020.103185","title":"Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Takeda Canada; Merck Sharp and Dohme; Bristol-Myers Squibb Canada; Janssen Biotech; Astellas Pharma; Eisai; AstraZeneca; Pfizer","keywords":"Prostate cancer; Androgen receptor; PTEN; Cancer research; Wnt signaling pathway; Signal transduction; PI3K/AKT/mTOR pathway; Medicine; Tramp; Androgen deprivation therapy; Androgen; Prostate; Cancer; Bioinformatics; Biology; Internal medicine; Hormone; Cell biology","score_opus":0.21749076504914358,"score_gpt":0.5632320503575629,"score_spread":0.3457412853084193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108540679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004263873,0.9990816,0.000049051097,0.00029657132,0.00020012875,0.0000019611273,0.000015708549,0.0000044283743,0.00030793456],"genre_scores_gemma":[0.00027581461,0.9989574,0.00009910707,0.00023916295,0.00021833884,0.000003199301,0.000019315905,6.888227e-7,0.00018691922],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974746,0.00005205649,0.000030440247,0.000044745502,0.00009493903,0.00003041674],"domain_scores_gemma":[0.99928516,0.00040802546,0.00008212544,0.0000124661,0.00015760303,0.000054746273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010964449,0.0009527634,0.0019378979,0.0014029185,0.0002536403,0.0016686297,0.0010405207,0.0011723037,0.006201771],"category_scores_gemma":[0.00129059,0.00026722206,0.000739653,0.002060852,0.0005686794,0.0016269679,0.000822574,0.0023735259,0.0019635425],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001783801,0.000065564884,0.00024161725,0.022069387,0.00020753303,0.0001582894,0.000056802208,0.00043630396,0.001307817,0.0045565073,0.05851154,0.9122103],"study_design_scores_gemma":[0.00006069028,0.0001486822,0.0011259839,0.0066258106,0.00038239846,0.00056458917,0.00011683974,0.00011431376,0.00025351773,0.0035556797,0.98701906,0.00003245912],"about_ca_topic_score_codex":0.0011827445,"about_ca_topic_score_gemma":0.003549909,"teacher_disagreement_score":0.006201771,"about_ca_system_score_codex":0.0008228724,"about_ca_system_score_gemma":0.0019216952,"threshold_uncertainty_score":0.020747006},"labels":[],"label_agreement":null},{"id":"W3116464343","doi":"10.1016/j.critrevonc.2020.103210","title":"The role of tumor suppressor short non-coding RNAs on breast cancer","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Piwi-interacting RNA; microRNA; Suppressor; Biology; Competing endogenous RNA; Malignancy; Metastasis; Breast cancer; Cancer research; Long non-coding RNA; Small nucleolar RNA; RNA; Angiogenesis; Context (archaeology); Tumor progression; Cancer; Non-coding RNA; Bioinformatics; RNA interference; Gene; Genetics","score_opus":0.03982867893960124,"score_gpt":0.41871137723976415,"score_spread":0.3788826983001629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116464343","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000568029,0.9983284,0.00013199239,0.0002663082,0.000539938,0.0000025532106,0.0000131156385,0.000007929314,0.0006530574],"genre_scores_gemma":[0.0003871809,0.99807775,0.00014748225,0.0002968803,0.0004654819,0.000004027277,0.000025860216,0.0000019885501,0.0005932806],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998123,0.00003067475,0.00001829845,0.00003434197,0.00008202784,0.000022392207],"domain_scores_gemma":[0.99960643,0.00020076508,0.00004422935,0.0000129341815,0.00008766427,0.000048010003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076075114,0.0011247532,0.0013811351,0.0012907081,0.00023726241,0.0010579342,0.0009014288,0.0011116142,0.0035633384],"category_scores_gemma":[0.0008130574,0.00025820895,0.0003800394,0.0016442311,0.0007113751,0.0013036714,0.00084071234,0.0022002168,0.0026083223],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011550055,0.000043571225,0.00009997227,0.008407185,0.00006707188,0.00017236765,0.000036072037,0.0004265178,0.0052611646,0.00542442,0.056920078,0.9230261],"study_design_scores_gemma":[0.000022369239,0.00007071928,0.00042672557,0.0014511216,0.00007561688,0.0005113718,0.000033671313,0.00008258135,0.00086606434,0.0029442522,0.993501,0.000014483079],"about_ca_topic_score_codex":0.0005607338,"about_ca_topic_score_gemma":0.0010174284,"teacher_disagreement_score":0.0035633384,"about_ca_system_score_codex":0.00070982194,"about_ca_system_score_gemma":0.0010174797,"threshold_uncertainty_score":0.011920571},"labels":[],"label_agreement":null},{"id":"W3116988381","doi":"10.1016/j.critrevonc.2020.103212","title":"Clinical efficacy and safety of first-line treatments in patients with mantle cell lymphoma: A systematic literature review","year":2020,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Canada","keywords":"Mantle cell lymphoma; Medicine; Randomized controlled trial; Lymphoma; Internal medicine; Systematic review; Clinical trial; Oncology; Transplantation; Surgery; MEDLINE","score_opus":0.04686873006192244,"score_gpt":0.40904868239252035,"score_spread":0.3621799523305979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116988381","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058203895,0.9989525,0.00004106125,0.000070180184,0.000051579165,0.000047356672,0.00016500344,0.0000031049105,0.00008720798],"genre_scores_gemma":[0.0132654635,0.9856511,0.00028402952,0.00045801455,0.000060065173,0.00008031585,0.00014637886,0.0000029084356,0.000051659063],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9968767,0.00082669547,0.0013750115,0.00034063097,0.00047341382,0.0001074881],"domain_scores_gemma":[0.9879297,0.008505633,0.0026394895,0.000145739,0.000636285,0.00014316147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004427579,0.0009731455,0.0066729193,0.0038662346,0.00029842954,0.0018728399,0.0014707757,0.0014778016,0.0043104333],"category_scores_gemma":[0.017902575,0.0007512405,0.008167988,0.0042121084,0.0006404543,0.0014211242,0.0010659001,0.0014279222,0.00027312676],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093326234,0.000032638458,0.0012137829,0.9189168,0.028896065,0.000070046095,0.000103332444,0.00012134583,0.00025307195,0.00014234468,0.0016838863,0.047633268],"study_design_scores_gemma":[0.001600399,0.0007393922,0.010072544,0.58561385,0.37251168,0.000494547,0.00026772692,0.00013088653,0.0003089653,0.0004152287,0.027765797,0.0000790438],"about_ca_topic_score_codex":0.00450703,"about_ca_topic_score_gemma":0.015320296,"teacher_disagreement_score":0.0066729193,"about_ca_system_score_codex":0.0018381788,"about_ca_system_score_gemma":0.003880119,"threshold_uncertainty_score":0.023415565},"labels":[],"label_agreement":null},{"id":"W3124543108","doi":"10.1016/j.critrevonc.2021.103238","title":"Risk of bleeding complications and atrial fibrillation associated with ibrutinib treatment: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Ibrutinib; Atrial fibrillation; Meta-analysis; Medicine; Internal medicine; Cardiology; Leukemia","score_opus":0.19438187720026537,"score_gpt":0.4843117483147941,"score_spread":0.2899298711145287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124543108","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004495193,0.99420035,0.00040013038,0.00014473115,0.00009958826,0.00015276966,0.00033616423,0.000019950672,0.00015112065],"genre_scores_gemma":[0.14688395,0.8482921,0.0019839928,0.00066586054,0.0002681456,0.00085387897,0.00076066836,0.000031268162,0.00026003146],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99046993,0.0038580797,0.0032661667,0.0009564711,0.0011521938,0.00029714615],"domain_scores_gemma":[0.9811968,0.013007567,0.0032725884,0.00056835444,0.001696606,0.00025802763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012909865,0.0027593684,0.018914577,0.008828391,0.0006444191,0.003575082,0.0020919293,0.0021519891,0.0025695844],"category_scores_gemma":[0.027053315,0.0018033863,0.042606805,0.010102626,0.0006572793,0.0015853454,0.0017231053,0.0017906987,0.0002602539],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013035991,0.00002158591,0.004863296,0.29950902,0.6840848,0.00014287957,0.000077611774,0.00045722636,0.00017938502,0.0000848954,0.0004569864,0.008818755],"study_design_scores_gemma":[0.00022888187,0.000088300076,0.0032964272,0.0149198,0.98018676,0.00009608018,0.00003210353,0.00015975666,0.00007687243,0.0001053077,0.0007906254,0.0000191386],"about_ca_topic_score_codex":0.006527866,"about_ca_topic_score_gemma":0.012547035,"teacher_disagreement_score":0.018914577,"about_ca_system_score_codex":0.0025986987,"about_ca_system_score_gemma":0.0035892532,"threshold_uncertainty_score":0.06827468},"labels":[],"label_agreement":null},{"id":"W3143506887","doi":"10.1016/j.critrevonc.2021.103312","title":"Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Mucositis; Meta-analysis; Internal medicine; Medicine; Single-nucleotide polymorphism; Methylenetetrahydrofolate reductase; Methotrexate; Oncology; Cancer; MTRR; Gastroenterology; Bioinformatics; Genetics; Genotype; Chemotherapy; Biology; Gene","score_opus":0.2003460850781804,"score_gpt":0.4925246478094584,"score_spread":0.292178562731278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143506887","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051304144,0.9938828,0.00024928726,0.000117615564,0.00009787557,0.00008250206,0.00031062608,0.000012072904,0.00011682732],"genre_scores_gemma":[0.21750088,0.77817005,0.0017680147,0.0010976252,0.00021170649,0.00031525292,0.00057742733,0.00002625005,0.00033287372],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99524647,0.0019890068,0.0014293022,0.0006646502,0.00045553898,0.0002150431],"domain_scores_gemma":[0.99001336,0.0071844533,0.0018741346,0.00030560928,0.0004893567,0.00013316341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006059526,0.0020086132,0.010331472,0.0030115673,0.00044166067,0.0022256095,0.0015848555,0.0020900636,0.0040498003],"category_scores_gemma":[0.018207362,0.0012597597,0.023625327,0.004876054,0.0005876054,0.0012681052,0.0014005977,0.0016706039,0.00027761696],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018869559,0.00003467761,0.008674138,0.31250778,0.66058385,0.00019112656,0.00012656643,0.0003815538,0.00031357622,0.0001272529,0.00092349155,0.014249042],"study_design_scores_gemma":[0.0005011873,0.000120405435,0.006727314,0.015545659,0.9752917,0.00010272368,0.00005997159,0.00010093703,0.000063915446,0.00012944613,0.001331608,0.000024952094],"about_ca_topic_score_codex":0.0077879904,"about_ca_topic_score_gemma":0.023218002,"teacher_disagreement_score":0.010331472,"about_ca_system_score_codex":0.0016424842,"about_ca_system_score_gemma":0.0023058644,"threshold_uncertainty_score":0.0320462},"labels":[],"label_agreement":null},{"id":"W3152748820","doi":"10.1016/j.critrevonc.2021.103324","title":"Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II- IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Impact; University of Toronto; Queen's University; McMaster University; Cancer Care Ontario; Juravinski Cancer Centre","funders":"","keywords":"Fallopian tube; Medicine; Stage (stratigraphy); Ovary; Adjuvant therapy; Adjuvant; Gynecology; Oncology; Internal medicine; Chemotherapy; Biology","score_opus":0.08088353931758632,"score_gpt":0.4152486905022938,"score_spread":0.33436515118470744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152748820","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007950565,0.9987445,0.00004364743,0.000064896005,0.000057838064,0.000057180532,0.00014630122,0.000003008122,0.00008765001],"genre_scores_gemma":[0.010435331,0.9887072,0.0002070148,0.00034810766,0.000039665618,0.00008729154,0.00010360295,0.0000020519744,0.0000696369],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9986714,0.00039317028,0.0005102015,0.00017017059,0.00018903219,0.00006597906],"domain_scores_gemma":[0.99630797,0.0025109765,0.00083398825,0.000048453792,0.00022130103,0.00007738797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019485339,0.0010006079,0.0056051365,0.0026224137,0.0003180041,0.0012698711,0.0010122451,0.0012053875,0.0034675733],"category_scores_gemma":[0.008336614,0.00066901755,0.0071470984,0.0032804469,0.00046250946,0.001072413,0.0008346186,0.0011921881,0.00021025665],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065638736,0.000030521598,0.0011358892,0.9313666,0.024007246,0.00007725335,0.000089306355,0.00014340352,0.00031214024,0.000111618676,0.0020350085,0.040034555],"study_design_scores_gemma":[0.0018141462,0.00065060105,0.010921689,0.58697736,0.3706508,0.00050526846,0.0003089079,0.00017316523,0.00031242686,0.00034789438,0.027251352,0.00008631966],"about_ca_topic_score_codex":0.00752707,"about_ca_topic_score_gemma":0.03000863,"teacher_disagreement_score":0.00752707,"about_ca_system_score_codex":0.0016114969,"about_ca_system_score_gemma":0.0034906568,"threshold_uncertainty_score":0.0149665475},"labels":[],"label_agreement":null},{"id":"W3154004164","doi":"10.1016/j.critrevonc.2021.103336","title":"Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; Cancer Care Ontario; University of Toronto; Hamilton Health Sciences; Impact","funders":"Cancer Care Ontario","keywords":"Fallopian tube; Ovary; Consolidation (business); Medicine; Gynecology; Ovarian carcinoma; Oncology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.09736373348610841,"score_gpt":0.4254258861202621,"score_spread":0.3280621526341537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154004164","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00096161856,0.99859875,0.000043866636,0.00005545897,0.000054673823,0.00006360713,0.00013042513,0.0000031336842,0.00008857874],"genre_scores_gemma":[0.014117273,0.98498833,0.00022819728,0.00034644213,0.000040664792,0.00008828324,0.00011021101,0.0000022597596,0.00007829111],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99891746,0.00033216146,0.00037932038,0.00015564858,0.00015704433,0.000058359306],"domain_scores_gemma":[0.9970061,0.0020128216,0.00067459344,0.000042214113,0.00019562918,0.00006857153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018393253,0.0008878502,0.0053112553,0.0019989032,0.00034104133,0.0011440461,0.0010732721,0.0010676348,0.0037799983],"category_scores_gemma":[0.007305416,0.00054735143,0.007417489,0.0026156267,0.00044932376,0.0010280253,0.0007425843,0.0011902524,0.0002174847],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010378798,0.000040699968,0.0012344426,0.90371794,0.026917534,0.00008010834,0.0001068775,0.00019683575,0.00037449022,0.00013848768,0.0025600367,0.06359469],"study_design_scores_gemma":[0.0029923366,0.0010421287,0.012958491,0.58765113,0.3631183,0.0005516921,0.00033832187,0.00020587388,0.00039233174,0.00044189589,0.03021698,0.0000906772],"about_ca_topic_score_codex":0.008032569,"about_ca_topic_score_gemma":0.02743224,"teacher_disagreement_score":0.008032569,"about_ca_system_score_codex":0.0015615417,"about_ca_system_score_gemma":0.0031974732,"threshold_uncertainty_score":0.015971601},"labels":[],"label_agreement":null},{"id":"W3165799328","doi":"10.1016/j.critrevonc.2021.103367","title":"Iron overload-induced oxidative stress in myelodysplastic syndromes and its cellular sequelae","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Centre for Blood Research, University of British Columbia; University of British Columbia","keywords":"Oxidative stress; Reactive oxygen species; Myelodysplastic syndromes; DNA damage; Haematopoiesis; Stem cell; Cell biology; Biology; Hematopoietic stem cell; Cellular respiration; Senescence; Oxidative phosphorylation; Membrane permeability; Mitochondrion; Biochemistry; Immunology; Bone marrow; DNA","score_opus":0.12375963500328774,"score_gpt":0.4527460638293274,"score_spread":0.3289864288260397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165799328","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038561237,0.9994417,0.000034090033,0.00013027816,0.0001351543,0.0000017822186,0.000008684751,0.0000024595859,0.00020734203],"genre_scores_gemma":[0.00031079384,0.9990792,0.000062670486,0.00012542437,0.0002425375,0.000002859903,0.000017587161,4.6917748e-7,0.00015841176],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998204,0.000036879184,0.000026228885,0.000028622064,0.00006836973,0.000019438192],"domain_scores_gemma":[0.9995604,0.00020063945,0.00007724518,0.000010504087,0.000111114525,0.00004008654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006557354,0.0008427953,0.0013879674,0.0018663974,0.0002405885,0.0011386658,0.0007531421,0.0010719856,0.002928991],"category_scores_gemma":[0.0009847386,0.0002592502,0.000475919,0.0020483725,0.00042041828,0.0009960172,0.00077814574,0.0015219997,0.0012099048],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013447572,0.00007094337,0.0002537735,0.021764562,0.00015667861,0.00017800364,0.00005816452,0.00027565588,0.0011299283,0.0020035172,0.04523413,0.9287401],"study_design_scores_gemma":[0.000055613134,0.00018638099,0.0016184053,0.00838068,0.0003755926,0.0013347032,0.000105285275,0.00012108096,0.0004334017,0.0030763557,0.98427814,0.00003439879],"about_ca_topic_score_codex":0.0009686438,"about_ca_topic_score_gemma":0.0018903094,"teacher_disagreement_score":0.002928991,"about_ca_system_score_codex":0.00043123937,"about_ca_system_score_gemma":0.0012592203,"threshold_uncertainty_score":0.009798467},"labels":[],"label_agreement":null},{"id":"W3170899709","doi":"10.1016/j.critrevonc.2021.103391","title":"The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic review","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Dalhousie University","funders":"Cancer Research UK","keywords":"Medicine; Radiation therapy; Bolus (digestion); Breast cancer; Medical physics; Mastectomy; Oncology; Radiology; Cancer; Internal medicine","score_opus":0.0864038647895065,"score_gpt":0.4349867527343321,"score_spread":0.3485828879448256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170899709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015899383,0.9995919,0.000023973893,0.000055238666,0.000043142638,0.000016810696,0.00005587493,0.000001701305,0.000052346168],"genre_scores_gemma":[0.0024442975,0.99700576,0.00013271903,0.00027207314,0.00003819084,0.000025700043,0.00004266102,0.0000017521286,0.000036914582],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99851733,0.00043582666,0.00054917554,0.00020379502,0.00023645055,0.000057403973],"domain_scores_gemma":[0.995037,0.0035573556,0.0009910077,0.0000631793,0.00028083747,0.00007050378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002737205,0.0010503933,0.0049678944,0.0032717243,0.00024572463,0.0015784287,0.0013405567,0.001418424,0.0046141734],"category_scores_gemma":[0.010419228,0.0006426689,0.005251578,0.0036840653,0.00053883647,0.001236889,0.0009321674,0.001146374,0.00033796928],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005737087,0.00002815273,0.00064359425,0.86099166,0.0116773,0.00007081215,0.00009009338,0.0001754914,0.00032912046,0.00021730292,0.003947075,0.12125571],"study_design_scores_gemma":[0.00114328,0.00066128466,0.0070095323,0.7378984,0.17224607,0.0006244287,0.00030058567,0.00015405571,0.00040189753,0.000666523,0.07880097,0.00009306547],"about_ca_topic_score_codex":0.005347581,"about_ca_topic_score_gemma":0.016498169,"teacher_disagreement_score":0.005347581,"about_ca_system_score_codex":0.0013881425,"about_ca_system_score_gemma":0.0029994366,"threshold_uncertainty_score":0.015435934},"labels":[],"label_agreement":null},{"id":"W3188155770","doi":"10.1016/j.critrevonc.2021.103430","title":"Prognostic and therapeutic value of somatic mutations in diffuse large B-cell lymphoma: A systematic review","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"Eusko Jaurlaritza","keywords":"Oncology; Diffuse large B-cell lymphoma; Lymphoma; Medicine; Internal medicine; Disease; Clinical trial; Germline mutation; Aggressive lymphoma; Mutation; Bioinformatics; Rituximab; Biology; Genetics; Gene","score_opus":0.05634092512945823,"score_gpt":0.4154295717266789,"score_spread":0.3590886465972207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188155770","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002182075,0.9992804,0.0000348906,0.000110840854,0.0000516147,0.000028043378,0.00013389597,0.0000027657318,0.0001393916],"genre_scores_gemma":[0.0026051013,0.9968844,0.00012052652,0.00016428821,0.00003868483,0.000036687452,0.00009959739,0.000001573669,0.000049007027],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99866354,0.00040425968,0.00050017436,0.00013479839,0.00024495518,0.000052292067],"domain_scores_gemma":[0.9941462,0.0042243875,0.0008706773,0.00006404833,0.00060145324,0.000093210925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022081514,0.0010371662,0.004333882,0.005590932,0.00027641366,0.0013364085,0.0011639822,0.0010071995,0.0044892645],"category_scores_gemma":[0.01022091,0.00046153128,0.0038209008,0.0054279296,0.00037635522,0.0009726102,0.00074495876,0.0006947053,0.0003921898],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032114782,0.000022652906,0.00060929894,0.7966209,0.006696337,0.00009181771,0.000095610165,0.00020876712,0.00029654248,0.0003326434,0.005122126,0.18958214],"study_design_scores_gemma":[0.00032611983,0.00033883197,0.005574607,0.8194795,0.07648719,0.0007921051,0.00019366106,0.00016751308,0.000356685,0.0006593622,0.09556409,0.000060393162],"about_ca_topic_score_codex":0.0042569893,"about_ca_topic_score_gemma":0.011055543,"teacher_disagreement_score":0.005590932,"about_ca_system_score_codex":0.0013245757,"about_ca_system_score_gemma":0.0040212884,"threshold_uncertainty_score":0.0150181055},"labels":[],"label_agreement":null},{"id":"W3189960204","doi":"10.1016/j.critrevonc.2021.103433","title":"Exercise for individuals with bone metastases: A systematic review","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia; Canada Research Chairs; University of Toronto; BC Cancer Agency","funders":"Astellas Pharma; Astellas Pharma Canada","keywords":"Medicine","score_opus":0.09813424377026841,"score_gpt":0.46271266712299436,"score_spread":0.36457842335272594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3189960204","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033040487,0.9989557,0.00004341908,0.00012615114,0.000066393215,0.00016492044,0.00010799966,0.0000047194494,0.00020022152],"genre_scores_gemma":[0.0045014503,0.99459356,0.00022489217,0.00026461246,0.000043558728,0.00021317923,0.0000666515,0.000002170594,0.00008995476],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9971734,0.0010711736,0.00079105544,0.0002249049,0.0006277399,0.00011157484],"domain_scores_gemma":[0.99132204,0.0061736405,0.0016179875,0.000086269916,0.0006667278,0.00013329863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003565864,0.0014179689,0.006124818,0.0057118325,0.00051430735,0.0019470035,0.0012868133,0.0017176707,0.005161983],"category_scores_gemma":[0.017154498,0.0007364907,0.004950494,0.0058714612,0.00060020876,0.001270637,0.0008786919,0.0010865906,0.0003625071],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001744373,0.000016372318,0.00022469586,0.9509633,0.003865623,0.000056730416,0.00007776457,0.00006850902,0.00009992436,0.0001294908,0.0019499409,0.04237324],"study_design_scores_gemma":[0.00036134387,0.00026844832,0.002288905,0.92848605,0.042859882,0.00030043145,0.00015284249,0.000077420096,0.00014507731,0.0002243864,0.024809608,0.000025610963],"about_ca_topic_score_codex":0.0074186786,"about_ca_topic_score_gemma":0.020922031,"teacher_disagreement_score":0.0074186786,"about_ca_system_score_codex":0.0024744703,"about_ca_system_score_gemma":0.0071750954,"threshold_uncertainty_score":0.018858314},"labels":[],"label_agreement":null},{"id":"W3216204715","doi":"10.1016/j.critrevonc.2021.103540","title":"The current landscape of systemic therapy for recurrent glioblastoma: A systematic review of randomized-controlled trials","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Ottawa Hospital; University of British Columbia; University of Ottawa","funders":"","keywords":"Medicine; Lomustine; Temozolomide; Bevacizumab; Oncology; Randomized controlled trial; Internal medicine; Regimen; Progression-free survival; Overall survival; Population; Chemotherapy; Cyclophosphamide; Vincristine","score_opus":0.0924226103081859,"score_gpt":0.47382605870762773,"score_spread":0.38140344839944185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216204715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046868587,0.99897695,0.00008583266,0.00013156045,0.00007073714,0.00008038318,0.00010725779,0.0000053675963,0.00007323797],"genre_scores_gemma":[0.013519818,0.98464787,0.00056332274,0.0007758005,0.000102423975,0.00016686093,0.00014820072,0.0000068300847,0.0000687292],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99358845,0.0024967885,0.0022560004,0.0007021823,0.0007556965,0.00020087484],"domain_scores_gemma":[0.98005944,0.014571206,0.003923274,0.00028243166,0.0009388415,0.00022487994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01035971,0.001781484,0.013459067,0.0034215932,0.0004203636,0.002871983,0.002094817,0.002051454,0.004566335],"category_scores_gemma":[0.032387417,0.0009646823,0.011523331,0.0043907333,0.0009650821,0.0023046646,0.0013901383,0.002080213,0.00029779176],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002172931,0.000030147736,0.0007430424,0.88066435,0.06360988,0.00005534045,0.00009130303,0.0002063364,0.00024355558,0.00023713439,0.0016394128,0.050306536],"study_design_scores_gemma":[0.003892367,0.0007923056,0.0046830587,0.4318977,0.53895956,0.0002295834,0.00021144739,0.00019990245,0.00026985854,0.0009849181,0.017802753,0.000076462464],"about_ca_topic_score_codex":0.004447311,"about_ca_topic_score_gemma":0.01479581,"teacher_disagreement_score":0.013459067,"about_ca_system_score_codex":0.0026080555,"about_ca_system_score_gemma":0.0046433113,"threshold_uncertainty_score":0.054787993},"labels":[],"label_agreement":null},{"id":"W3217756212","doi":"10.1016/j.critrevonc.2021.103534","title":"Immuno-oncology therapy in metastatic bladder cancer: A systematic review and network meta-analysis","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Atezolizumab; Pembrolizumab; Durvalumab; Medicine; Oncology; Regimen; Internal medicine; Avelumab; Adverse effect; Immunotherapy; Cancer","score_opus":0.2226408354437612,"score_gpt":0.5032529699975057,"score_spread":0.28061213455374445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217756212","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027787175,0.99601525,0.00025946044,0.0001271791,0.000100793164,0.00008330458,0.00048188906,0.000014414559,0.00013883878],"genre_scores_gemma":[0.13852277,0.85711694,0.0014986816,0.0012155214,0.00021813394,0.00035218312,0.0007084116,0.000031342628,0.0003359661],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9952642,0.0020112272,0.0013289425,0.00066731015,0.000490188,0.00023809656],"domain_scores_gemma":[0.9914287,0.0058486364,0.001780263,0.0002874786,0.0005093068,0.0001456722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065953145,0.0022836744,0.013079541,0.0037512877,0.0004679269,0.0023096246,0.0017628135,0.0019822773,0.004721008],"category_scores_gemma":[0.015938722,0.0013280666,0.02424329,0.005531365,0.0005943921,0.0016450244,0.0017838717,0.0019891292,0.00040072968],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016723041,0.000029994213,0.005240991,0.38508248,0.5919314,0.00010943317,0.00009483368,0.00041729133,0.00026360256,0.00013208295,0.0011469763,0.013878542],"study_design_scores_gemma":[0.0006542771,0.0001252767,0.004376205,0.022331767,0.96985334,0.00007514863,0.00004501126,0.00011348728,0.00006449841,0.0001617439,0.0021733234,0.000025813504],"about_ca_topic_score_codex":0.0069271354,"about_ca_topic_score_gemma":0.023157645,"teacher_disagreement_score":0.013079541,"about_ca_system_score_codex":0.0018191801,"about_ca_system_score_gemma":0.002724182,"threshold_uncertainty_score":0.034879744},"labels":[],"label_agreement":null},{"id":"W4200071516","doi":"10.1016/j.critrevonc.2021.103566","title":"Radiotherapy and radiosensitization in breast cancer: Molecular targets and clinical applications","year":2021,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Radioresistance; Systemic therapy; Oncology; Cancer; Disease; Internal medicine","score_opus":0.04894730476087189,"score_gpt":0.5086703591717768,"score_spread":0.45972305441090494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200071516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059198457,0.99919385,0.00005890168,0.0001868223,0.00011795743,0.0000028839702,0.000014437066,0.0000047414915,0.00036132993],"genre_scores_gemma":[0.00038738007,0.9989951,0.00009075711,0.00017033763,0.00012127792,0.0000038671897,0.000019496378,8.6999864e-7,0.00021092466],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997974,0.000039854764,0.000023547906,0.000036477624,0.00007688788,0.000025766647],"domain_scores_gemma":[0.99964833,0.00019815056,0.000050183462,0.000009641632,0.000070442235,0.000023268629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007957306,0.0009928505,0.0016209694,0.0017096577,0.00020581167,0.0012002856,0.00086237804,0.0011791207,0.0042918297],"category_scores_gemma":[0.0009435626,0.00030630353,0.0006932185,0.0019465254,0.0004988097,0.0010534478,0.00063548615,0.002125323,0.0017842649],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018468761,0.00008408741,0.00015857455,0.018066915,0.00015744151,0.00011546384,0.00004314655,0.000658599,0.0025897548,0.0030890682,0.036437694,0.9384147],"study_design_scores_gemma":[0.000083556784,0.0002685301,0.00095223443,0.0048272084,0.00034515446,0.000825617,0.00005396226,0.00018851337,0.00095754804,0.0029286079,0.98853546,0.000033532968],"about_ca_topic_score_codex":0.0009602349,"about_ca_topic_score_gemma":0.0019287392,"teacher_disagreement_score":0.0042918297,"about_ca_system_score_codex":0.00065356446,"about_ca_system_score_gemma":0.0012237162,"threshold_uncertainty_score":0.014357626},"labels":[],"label_agreement":null},{"id":"W4210423715","doi":"10.1016/j.critrevonc.2022.103620","title":"A scoping review to map the evidence of physical activity interventions in post-treatment adolescent and young adult cancer survivors","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"CINAHL; Psychological intervention; Medicine; Cochrane Library; MEDLINE; Systematic review; Cancer survivor; Gerontology; Alternative medicine; Cancer; Psychiatry; Internal medicine","score_opus":0.2363290025921716,"score_gpt":0.5449011887916535,"score_spread":0.3085721861994819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210423715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024656454,0.9984938,0.00011714937,0.00025035423,0.00019108276,0.00024961043,0.00019710326,0.000008385812,0.00024587841],"genre_scores_gemma":[0.0021939694,0.99651176,0.00039245925,0.0003927161,0.000049615828,0.00024529113,0.000107962536,0.0000034262418,0.00010271661],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9939892,0.001773222,0.0021922803,0.00048080564,0.0012946499,0.0002699027],"domain_scores_gemma":[0.9790329,0.015646363,0.0029891774,0.00026470612,0.0017627522,0.0003041773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008551544,0.0019968525,0.010256838,0.014149614,0.0009188789,0.0047712536,0.002363288,0.0033003467,0.006999323],"category_scores_gemma":[0.041632064,0.0013917795,0.008920519,0.013236254,0.0010331947,0.0030138332,0.002679683,0.0029369674,0.0006692424],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015556994,0.00002968827,0.00027310094,0.9226275,0.0055022105,0.000068536116,0.00021971566,0.0001268989,0.00016733028,0.00044850723,0.0026013416,0.0677795],"study_design_scores_gemma":[0.00011092755,0.00008217745,0.0009698803,0.9494746,0.025154185,0.000094922085,0.00017571058,0.00004659047,0.00006761357,0.00038426986,0.023419015,0.00002007787],"about_ca_topic_score_codex":0.01685806,"about_ca_topic_score_gemma":0.034961946,"teacher_disagreement_score":0.01685806,"about_ca_system_score_codex":0.004689172,"about_ca_system_score_gemma":0.017921153,"threshold_uncertainty_score":0.04522538},"labels":[],"label_agreement":null},{"id":"W4213232123","doi":"10.1016/j.critrevonc.2022.103638","title":"A systematic review and meta-analysis of adjuvant chemotherapy after chemoradiation for locally advanced cervical cancer","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"International Atomic Energy Agency; Terry Fox Foundation; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Accuray","keywords":"Meta-analysis; Medicine; Publication bias; Funnel plot; Internal medicine; Oncology; Hazard ratio; Randomized controlled trial; Subgroup analysis; Cervical cancer; Adjuvant; Cancer; Confidence interval","score_opus":0.12417699816296195,"score_gpt":0.47165265665990086,"score_spread":0.3474756584969389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213232123","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002677179,0.99595,0.0003353825,0.00017425204,0.00016391177,0.00032963042,0.00018789676,0.000012567426,0.00016918426],"genre_scores_gemma":[0.079071395,0.9151112,0.0027206896,0.0007534914,0.00024678867,0.0014045633,0.00041653792,0.000016995564,0.00025843433],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9866375,0.0073151607,0.0034840351,0.0008372296,0.0013835325,0.00034258893],"domain_scores_gemma":[0.9802761,0.014646087,0.0026743556,0.00048505134,0.0016827626,0.00023556965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018031286,0.0029461095,0.01852448,0.0088012945,0.0007079573,0.0032396086,0.0017439172,0.0023644688,0.0026105398],"category_scores_gemma":[0.042659547,0.0014786589,0.02790622,0.0076262318,0.00070596044,0.0018926555,0.0014314,0.0017581559,0.00029245156],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014871312,0.00003361857,0.0015941486,0.6349016,0.34084058,0.00015338871,0.00010569745,0.0004105587,0.00032133737,0.00017158124,0.0006440106,0.01933637],"study_design_scores_gemma":[0.0007293741,0.00033826448,0.002541362,0.06863386,0.9243089,0.00014707242,0.00005190824,0.00019160451,0.00016396666,0.00023596096,0.0026309018,0.000026742582],"about_ca_topic_score_codex":0.0065051108,"about_ca_topic_score_gemma":0.018328797,"teacher_disagreement_score":0.01852448,"about_ca_system_score_codex":0.003715088,"about_ca_system_score_gemma":0.0066037304,"threshold_uncertainty_score":0.09535968},"labels":[],"label_agreement":null},{"id":"W4221123017","doi":"10.1016/j.critrevonc.2022.103660","title":"Pembrolizumab alone or with chemotherapy for metastatic non-small-cell lung cancer: A systematic review and network meta-analysis","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Canadian Centre for Applied Research in Cancer Control; Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; University Health Network; University of Toronto","funders":"","keywords":"Pembrolizumab; Medicine; Oncology; Lung cancer; Internal medicine; Adverse effect; Meta-analysis; Hazard ratio; Chemotherapy; Randomized controlled trial; Cancer; Immunotherapy; Confidence interval","score_opus":0.13754416683348544,"score_gpt":0.4488775729735346,"score_spread":0.3113334061400491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221123017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004398673,0.99366003,0.00037561482,0.00019766713,0.00017468902,0.00014423911,0.0007934657,0.000022216738,0.00023337528],"genre_scores_gemma":[0.25230646,0.74019486,0.0024308038,0.0021953103,0.00031600182,0.0006587042,0.0011770282,0.00005846773,0.0006624305],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99495465,0.0021386673,0.0013830534,0.00076840946,0.00051509496,0.00024000971],"domain_scores_gemma":[0.99287003,0.0044191247,0.0018403064,0.00026143322,0.00047186643,0.00013729032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065674935,0.002445716,0.011883939,0.003844886,0.00044784424,0.0020598087,0.0015812387,0.0017157781,0.0050867316],"category_scores_gemma":[0.015316542,0.0013545972,0.030251104,0.0046252003,0.0006065461,0.001462855,0.0016291313,0.0017760745,0.00045128935],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024603077,0.00002666297,0.0043890774,0.2533248,0.7251994,0.00008825972,0.000064692824,0.00037526357,0.0002979438,0.00011345057,0.001107984,0.012552002],"study_design_scores_gemma":[0.00082307745,0.00013569307,0.002906089,0.011768208,0.98207724,0.000057764337,0.0000272414,0.000087081506,0.000062059145,0.00011786206,0.0019187991,0.000018900671],"about_ca_topic_score_codex":0.0075460915,"about_ca_topic_score_gemma":0.027808866,"teacher_disagreement_score":0.011883939,"about_ca_system_score_codex":0.0024137672,"about_ca_system_score_gemma":0.0025220707,"threshold_uncertainty_score":0.03473264},"labels":[],"label_agreement":null},{"id":"W4224320263","doi":"10.1016/j.critrevonc.2022.103678","title":"Clinical studies of extended-half-life recombinant FVIII products for prophylaxis in adults and children: A critical review from the physician's perspective","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bayer Canada; Bayer Corporation; Bayer","keywords":"Perspective (graphical); Medicine; Intensive care medicine; Family medicine; Pediatrics; Computer science","score_opus":0.24861790735082723,"score_gpt":0.5435150600523989,"score_spread":0.2948971527015717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224320263","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000065092725,0.9993425,0.0000398004,0.00029093545,0.0001272491,0.000018534802,0.00001771194,0.0000013070239,0.00009679143],"genre_scores_gemma":[0.0013420231,0.99718827,0.00025468195,0.000848027,0.00023422157,0.000059627102,0.000030307185,0.0000017524961,0.00004101876],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935557,0.0019962722,0.0026702995,0.0004570412,0.001190353,0.00013033327],"domain_scores_gemma":[0.9486907,0.041374456,0.004464573,0.00053174,0.004644217,0.00029421103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010267623,0.0010476969,0.0045117904,0.005251747,0.00047968916,0.002476148,0.0017427705,0.0024107597,0.0024740254],"category_scores_gemma":[0.03412569,0.0006005115,0.0029996233,0.0051493556,0.0009475409,0.0023178877,0.00090988225,0.0019218717,0.0004522137],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038737975,0.00004455944,0.00047677974,0.6334582,0.0023000287,0.00018815984,0.00030537485,0.00015017786,0.00050624815,0.0013977579,0.01345754,0.3473278],"study_design_scores_gemma":[0.00021806496,0.00048256057,0.0025391257,0.69356555,0.012896828,0.0009878661,0.0003754714,0.00008826332,0.0004262255,0.0014244311,0.28694463,0.000050954626],"about_ca_topic_score_codex":0.0017721436,"about_ca_topic_score_gemma":0.0036001527,"teacher_disagreement_score":0.010267623,"about_ca_system_score_codex":0.0018205877,"about_ca_system_score_gemma":0.006269659,"threshold_uncertainty_score":0.054301083},"labels":[],"label_agreement":null},{"id":"W4280628647","doi":"10.1016/j.critrevonc.2022.103711","title":"Validity of event-free survival as a surrogate endpoint in haematological malignancy: Review of the literature and health technology assessments","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Clinical endpoint; Medicine; Surrogate endpoint; Overall survival; Oncology; Internal medicine; Clinical trial; Malignancy; Intensive care medicine","score_opus":0.16917668507141453,"score_gpt":0.5136750876270089,"score_spread":0.34449840255559433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280628647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003478546,0.9994629,0.00006262858,0.00023811616,0.00004602755,0.000007938506,0.00001594783,0.0000013495326,0.00013022218],"genre_scores_gemma":[0.001270468,0.9980544,0.00022961912,0.00029394455,0.000073639916,0.000028626546,0.000021107327,0.0000015694828,0.000026636042],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9896674,0.004940648,0.0022790823,0.0007374951,0.0022128294,0.00016251302],"domain_scores_gemma":[0.9147598,0.075897455,0.0052813836,0.00070105254,0.003104561,0.00025567703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018428285,0.0010833576,0.0050393664,0.007124639,0.00030902142,0.0026939064,0.0018862484,0.0025911198,0.0029395826],"category_scores_gemma":[0.053255085,0.00064060447,0.003248839,0.008725725,0.0015888165,0.0024864622,0.0012586466,0.0023896499,0.00056972704],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023937775,0.000040421743,0.00053096225,0.30730984,0.0017840753,0.000056864686,0.00012483755,0.0006724976,0.00017834635,0.0056426357,0.009002631,0.67441744],"study_design_scores_gemma":[0.00022665804,0.0004259518,0.005810542,0.656944,0.009571699,0.0007625927,0.00028448598,0.00067839987,0.00054879923,0.010299614,0.31432882,0.000118385855],"about_ca_topic_score_codex":0.0027405797,"about_ca_topic_score_gemma":0.002961591,"teacher_disagreement_score":0.018428285,"about_ca_system_score_codex":0.0034573723,"about_ca_system_score_gemma":0.006084998,"threshold_uncertainty_score":0.09745926},"labels":[],"label_agreement":null},{"id":"W4281931702","doi":"10.1016/j.critrevonc.2022.103728","title":"Unmet supportive care needs of people with advanced cancer and their caregivers: A systematic scoping review","year":2022,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"CINAHL; Medicine; Psychological intervention; Anxiety; Needs assessment; Distress; Gerontology; MEDLINE; Depression (economics); Social support; Psycho-oncology; Cancer; Family medicine; Nursing; Psychiatry; Psychology; Clinical psychology; Psychotherapist","score_opus":0.09233959939078881,"score_gpt":0.4705893985035747,"score_spread":0.3782497991127859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281931702","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030144595,0.99539196,0.000104121944,0.000464189,0.00014700249,0.0002514838,0.0004105038,0.000004138828,0.00021220489],"genre_scores_gemma":[0.036594305,0.960649,0.000650628,0.0010944307,0.000083656894,0.0005332097,0.00028588632,0.000004762157,0.00010417258],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9893343,0.0031835262,0.0047394927,0.00081153825,0.0015033309,0.0004278134],"domain_scores_gemma":[0.94756854,0.039895482,0.008475548,0.0004736974,0.002944409,0.00064234564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013265215,0.0013881563,0.0058141546,0.010881836,0.0009613878,0.0046003177,0.0014840751,0.003231833,0.0026586207],"category_scores_gemma":[0.07716001,0.0014356963,0.007768445,0.009767213,0.0011002294,0.0036983711,0.00299257,0.0020775315,0.00018829068],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016917924,0.000032414642,0.0033233073,0.9481729,0.014088614,0.0001257755,0.000994304,0.00009725863,0.000109514556,0.00022585441,0.0015532128,0.031107761],"study_design_scores_gemma":[0.000099802084,0.00007758612,0.005275562,0.9422797,0.04285428,0.00023718018,0.0011104232,0.000047289694,0.00005945342,0.00019384391,0.007725001,0.000039909773],"about_ca_topic_score_codex":0.018859055,"about_ca_topic_score_gemma":0.07636383,"teacher_disagreement_score":0.018859055,"about_ca_system_score_codex":0.0049228794,"about_ca_system_score_gemma":0.017788043,"threshold_uncertainty_score":0.07015395},"labels":[],"label_agreement":null},{"id":"W4282961610","doi":"10.1016/j.critrevonc.2022.103747","title":"Assessing the methodological quality of quality-of-life analyses in first-line non-small cell lung cancer trials: A systematic review","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Lung cancer; Clinical trial; Inclusion and exclusion criteria; MEDLINE; Randomized controlled trial; Internal medicine; Systematic review; Oncology; Intensive care medicine; Physical therapy; Alternative medicine; Pathology","score_opus":0.7253479304992632,"score_gpt":0.6936135107392718,"score_spread":0.03173441975999136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282961610","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015542354,0.99327785,0.0023461818,0.00050687435,0.00044053083,0.0011211976,0.0004786064,0.00003142481,0.0002430426],"genre_scores_gemma":[0.13088457,0.84188956,0.014176479,0.0038561549,0.0007181742,0.006806576,0.001104839,0.00011596133,0.00044765035],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.8398339,0.0862784,0.05311413,0.007432221,0.012264381,0.0010769081],"domain_scores_gemma":[0.6424776,0.30691096,0.033138745,0.0073183286,0.009310002,0.0008444667],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.1091184,0.0031812252,0.023217764,0.006512511,0.0009306224,0.007836594,0.0038803183,0.004542033,0.0044195135],"category_scores_gemma":[0.3475907,0.0024670323,0.03096928,0.006876564,0.0027511977,0.0040696603,0.0036704317,0.004133627,0.0004217594],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011946452,0.000022896524,0.0019397193,0.6994701,0.27283457,0.000060562837,0.00018130468,0.00036262753,0.0001631245,0.0005654334,0.00097651687,0.022228459],"study_design_scores_gemma":[0.0023391321,0.0003089528,0.004417893,0.21158454,0.77080226,0.0001732042,0.00018487513,0.0005216075,0.00027654483,0.0024090463,0.0068774032,0.00010460327],"about_ca_topic_score_codex":0.0070608263,"about_ca_topic_score_gemma":0.015075921,"teacher_disagreement_score":0.97678226,"about_ca_system_score_codex":0.0067828614,"about_ca_system_score_gemma":0.010224104,"threshold_uncertainty_score":0.57708013},"labels":[],"label_agreement":null},{"id":"W4293516714","doi":"10.1016/j.critrevonc.2022.103797","title":"Integrating hereditary breast and ovarian cancer genetic counselling and testing into mainstream clinical practice: Legal and ethical challenges","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill University","funders":"Fonds de Recherche du Québec - Santé; Merck Canada; GlaxoSmithKline","keywords":"Genetic testing; Genetic counseling; Confidentiality; Medicine; Mainstream; Informed consent; Service (business); Health care; Family medicine; Alternative medicine; Business; Political science; Genetics; Pathology; Biology","score_opus":0.11370886842590748,"score_gpt":0.476170785487023,"score_spread":0.3624619170611155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293516714","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002886543,0.99178445,0.0002248577,0.0059986906,0.0010764197,0.0000029967118,0.000010803971,0.0000066426646,0.0008662351],"genre_scores_gemma":[0.0007307147,0.9918922,0.0005431912,0.004546489,0.001751829,0.000013392521,0.000020428559,0.000005505996,0.00049624336],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974717,0.0010472615,0.00022698526,0.0002204389,0.0008733415,0.00016023497],"domain_scores_gemma":[0.985495,0.011215504,0.0004726251,0.00025465875,0.002093774,0.0004684771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008773857,0.0008772743,0.0021937098,0.0021330959,0.00077396625,0.0031532987,0.002186219,0.005806376,0.0049448856],"category_scores_gemma":[0.014330065,0.0003865134,0.0007518733,0.002031077,0.0027493003,0.0034741473,0.0022473938,0.008055127,0.0016567247],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049912793,0.000042367956,0.0001853642,0.010499935,0.00009401982,0.00033902947,0.00024783213,0.00033197572,0.00037158196,0.025507446,0.14775424,0.81457615],"study_design_scores_gemma":[0.00002203896,0.000026568548,0.0003732401,0.012895555,0.00007568206,0.0006709166,0.0002553288,0.0000780064,0.000083031824,0.010877005,0.9746181,0.000024453417],"about_ca_topic_score_codex":0.0032621874,"about_ca_topic_score_gemma":0.0062972587,"teacher_disagreement_score":0.008773857,"about_ca_system_score_codex":0.00265039,"about_ca_system_score_gemma":0.0068028164,"threshold_uncertainty_score":0.046401203},"labels":[],"label_agreement":null},{"id":"W4294993163","doi":"10.1016/j.critrevonc.2022.103804","title":"Cancer-related fatigue in childhood cancer survivors: A systematic scoping review on contributors of fatigue and how they are targeted by non-pharmacological interventions","year":2022,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Cancer-related fatigue; Psychological intervention; Checklist; Childhood cancer; Medicine; Physical activity; Intervention (counseling); Cancer; Depression (economics); Systematic review; Clinical psychology; Psychology; Gerontology; MEDLINE; Psychiatry; Physical therapy; Internal medicine","score_opus":0.09497476390225923,"score_gpt":0.45557816698080744,"score_spread":0.3606034030785482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294993163","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010803309,0.9980901,0.0000854113,0.00020763271,0.000097084034,0.00014893211,0.0001866964,0.0000030983774,0.000100721285],"genre_scores_gemma":[0.024571553,0.97320807,0.0006612653,0.0007284654,0.00007760955,0.00050300796,0.0001616786,0.0000041863796,0.000084150255],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9940175,0.0018205361,0.0025509787,0.0005621806,0.0007964642,0.00025242553],"domain_scores_gemma":[0.97341025,0.020606956,0.004139564,0.00031370082,0.0012881164,0.00024134811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008940237,0.001371703,0.0070093824,0.0063887746,0.00070872554,0.003483065,0.0014457151,0.0028591745,0.0027631458],"category_scores_gemma":[0.044943105,0.0014099336,0.014205829,0.0060886187,0.0008739716,0.0022613832,0.0018610114,0.0021759865,0.00018309997],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024067427,0.00003665502,0.0028857263,0.93161595,0.02828304,0.00006414263,0.00039693364,0.00014312504,0.000105969266,0.00021203708,0.0011209538,0.0348947],"study_design_scores_gemma":[0.00024355628,0.00015588196,0.008382962,0.8552885,0.12661372,0.00015242177,0.00040154817,0.00008966422,0.000094101284,0.00021345931,0.008322224,0.0000419639],"about_ca_topic_score_codex":0.023120256,"about_ca_topic_score_gemma":0.0816904,"teacher_disagreement_score":0.023120256,"about_ca_system_score_codex":0.0042848657,"about_ca_system_score_gemma":0.012167929,"threshold_uncertainty_score":0.047281027},"labels":[],"label_agreement":null},{"id":"W4297878040","doi":"10.1016/j.critrevonc.2022.103822","title":"Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: A scoping review","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Vancouver Coastal Health; University Health Network; Toronto General Hospital; University of Toronto; Princess Margaret Cancer Centre","funders":"National Institutes of Health; University of Toronto; National Institute of Nursing Research; Oncology Nursing Foundation","keywords":"PsycINFO; Medicine; MEDLINE; Cancer; Extant taxon; Meta-analysis; Cognition; Systematic review; Breast cancer; Oncology; Bioinformatics; Internal medicine; Psychiatry","score_opus":0.07113327747756361,"score_gpt":0.45638476611455703,"score_spread":0.38525148863699343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297878040","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060446662,0.999689,0.000031426465,0.00006247849,0.000053089476,0.000009738233,0.000039200757,0.0000013886175,0.000053280088],"genre_scores_gemma":[0.0009931936,0.9984646,0.00017555644,0.0001976886,0.000061061975,0.00002356076,0.000049383983,8.7517463e-7,0.00003414865],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9984054,0.00036707267,0.00057760696,0.00025164976,0.00033458287,0.000063694715],"domain_scores_gemma":[0.9907312,0.0072603184,0.0010809009,0.000100408186,0.0007546934,0.00007257037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047769607,0.0013733421,0.0062085697,0.004728243,0.00032392438,0.0027840622,0.0018637966,0.0022141617,0.003251235],"category_scores_gemma":[0.016893327,0.0006616987,0.0056417296,0.0048544584,0.00064516976,0.0018595672,0.0011860315,0.0019725198,0.00049570436],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047052352,0.00008475923,0.0016892194,0.5719117,0.01095102,0.00011647251,0.00013046095,0.00027860957,0.0003344801,0.0010602026,0.008818296,0.4041542],"study_design_scores_gemma":[0.00048515084,0.0004700826,0.01177972,0.71936166,0.077718526,0.0008654743,0.00043264826,0.0003434842,0.0006576842,0.0028866935,0.18481557,0.00018343527],"about_ca_topic_score_codex":0.0058953427,"about_ca_topic_score_gemma":0.011687886,"teacher_disagreement_score":0.0062085697,"about_ca_system_score_codex":0.0012854548,"about_ca_system_score_gemma":0.0040835217,"threshold_uncertainty_score":0.02526325},"labels":[],"label_agreement":null},{"id":"W4306761162","doi":"10.1016/j.critrevonc.2022.103860","title":"A systematic review of contemporary phase I trials in patients with lymphoma","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Adverse effect; Clinical trial; Internal medicine; Oncology","score_opus":0.153472054092088,"score_gpt":0.47553061678527725,"score_spread":0.3220585626931892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306761162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00070009887,0.9979888,0.00014461885,0.00019441487,0.00012919563,0.0003082541,0.0003162148,0.000010432874,0.00020798124],"genre_scores_gemma":[0.015681513,0.98152864,0.0008267273,0.0010600972,0.00010640469,0.00042047948,0.00020607426,0.000010376438,0.00015963748],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99257034,0.0029660873,0.0027954283,0.00058413605,0.00089397025,0.00019005103],"domain_scores_gemma":[0.98259026,0.011300502,0.0044547627,0.00032356262,0.0010762401,0.00025466137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008812996,0.0018306151,0.011323791,0.005303676,0.0004968002,0.0027318178,0.0018310411,0.0018238999,0.005611542],"category_scores_gemma":[0.032611474,0.0010924714,0.008909952,0.0066406373,0.000917629,0.0020173774,0.0016838977,0.0018985306,0.0003627154],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008790905,0.000018252556,0.00044036616,0.93723315,0.032013666,0.000066459135,0.00010605262,0.00010999232,0.00024443786,0.00014537816,0.0016444856,0.027098827],"study_design_scores_gemma":[0.0025121216,0.0005606426,0.0041755848,0.596328,0.36545074,0.00035741425,0.00019671232,0.000102265396,0.00024439694,0.0004920592,0.02951889,0.0000610788],"about_ca_topic_score_codex":0.00439793,"about_ca_topic_score_gemma":0.018909378,"teacher_disagreement_score":0.011323791,"about_ca_system_score_codex":0.0026963367,"about_ca_system_score_gemma":0.0057994933,"threshold_uncertainty_score":0.04660815},"labels":[],"label_agreement":null},{"id":"W4309643713","doi":"10.1016/j.critrevonc.2022.103867","title":"Patient reported outcome measure domains and tools used among adolescents and young adults with cancer: A scoping review","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"CINAHL; PsycINFO; Patient-reported outcome; MEDLINE; Young adult; Medicine; Cancer survivor; Clinical psychology; Cancer; Gerontology; Quality of life (healthcare); Psychiatry; Nursing; Psychological intervention","score_opus":0.15569345566373136,"score_gpt":0.45209914620607505,"score_spread":0.29640569054234367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309643713","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032808824,0.9991443,0.00004769685,0.0000974154,0.00007063949,0.000061202976,0.00015703923,0.0000020362893,0.00009158638],"genre_scores_gemma":[0.0053465297,0.9934871,0.00044567668,0.00029341815,0.000035603574,0.00018881931,0.00015601508,0.0000027156573,0.00004411381],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9914316,0.0027156363,0.0033946293,0.00067514257,0.0015078137,0.00027519336],"domain_scores_gemma":[0.9778426,0.01719874,0.0030842067,0.00023422214,0.0014683389,0.00017190186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013483686,0.001520182,0.0074383677,0.009517562,0.0006610174,0.0042237025,0.0015561803,0.0020534515,0.0027586822],"category_scores_gemma":[0.038623583,0.0010998888,0.008186194,0.009095349,0.0011114076,0.0020883856,0.0021261678,0.002254259,0.00024302608],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002393448,0.00006721665,0.0028629708,0.81332785,0.012896326,0.000066017026,0.00039342337,0.00020597148,0.0001592444,0.00056136283,0.0038993794,0.16532093],"study_design_scores_gemma":[0.00019788677,0.00015223307,0.008547772,0.91485137,0.043679107,0.00023010458,0.00055681146,0.00010766595,0.00015646417,0.0003757017,0.031085294,0.000059526352],"about_ca_topic_score_codex":0.011806704,"about_ca_topic_score_gemma":0.031203808,"teacher_disagreement_score":0.013483686,"about_ca_system_score_codex":0.0040564854,"about_ca_system_score_gemma":0.011354785,"threshold_uncertainty_score":0.07130939},"labels":[],"label_agreement":null},{"id":"W4310018701","doi":"10.1016/j.critrevonc.2022.103880","title":"Three-year disease-free survival in randomized trials of neoadjuvant chemotherapy and HER2-targeted therapy in breast cancer: A meta-analysis","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McGill University; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Trastuzumab; Adjuvant therapy; Neoadjuvant therapy; Sample size determination; Targeted therapy; Randomized controlled trial; Meta-analysis; Trastuzumab emtansine; Chemotherapy; Cancer","score_opus":0.15403272796396347,"score_gpt":0.44466289712837276,"score_spread":0.2906301691644093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310018701","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009239768,0.9882516,0.0011534558,0.00026599786,0.0002880569,0.00006478806,0.00044497935,0.000042133273,0.0002491482],"genre_scores_gemma":[0.4242603,0.5658239,0.0037874514,0.0022549757,0.0007294574,0.00044936372,0.001483979,0.0001254855,0.0010851433],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99175584,0.005099564,0.0013473136,0.0010654831,0.0004635286,0.00026821977],"domain_scores_gemma":[0.9873568,0.010243642,0.0012431428,0.00058017607,0.00038681427,0.00018939996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011855668,0.002472636,0.012574429,0.001408303,0.00028100368,0.0022490069,0.0018398796,0.001804254,0.0037462479],"category_scores_gemma":[0.018692877,0.001176747,0.028493011,0.0024507793,0.00049899967,0.0013616438,0.0011984321,0.003078187,0.00040084828],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010017207,0.000028434277,0.004550283,0.048875082,0.92032766,0.0000657534,0.000030120867,0.00081911066,0.00023190556,0.0001606821,0.0008135711,0.0140801715],"study_design_scores_gemma":[0.0023729762,0.00030888405,0.004495949,0.0025519112,0.9876889,0.000051108695,0.00002699346,0.0003054319,0.00010005347,0.00048005013,0.0015932472,0.000024447709],"about_ca_topic_score_codex":0.0031746936,"about_ca_topic_score_gemma":0.0069759046,"teacher_disagreement_score":0.012574429,"about_ca_system_score_codex":0.0013050112,"about_ca_system_score_gemma":0.0011075737,"threshold_uncertainty_score":0.0626995},"labels":[],"label_agreement":null},{"id":"W4311461682","doi":"10.1016/j.critrevonc.2022.103896","title":"Management of secondary immunodeficiency in hematological malignancies in the era of modern oncology","year":2022,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Malignancy; Intensive care medicine; Cancer; Immunodeficiency; Hematological malignancy; Oncology; Human immunodeficiency virus (HIV); Clinical Practice; Internal medicine; Cancer therapy; Immune system; Immunology; Family medicine","score_opus":0.06335652969341639,"score_gpt":0.37866124238427595,"score_spread":0.3153047126908596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311461682","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011233279,0.9985915,0.00009578854,0.00034116436,0.00019881492,0.0000040694426,0.0000071841337,0.000004884505,0.0006442184],"genre_scores_gemma":[0.0010646945,0.99760026,0.00022296552,0.00039033435,0.0003991858,0.0000065056406,0.0000214288,0.000001345559,0.00029317656],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997645,0.00006952707,0.00003718103,0.000023512079,0.00008360261,0.000021778387],"domain_scores_gemma":[0.9995908,0.00022720189,0.000060999526,0.00000845224,0.00008259275,0.000029963163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000506528,0.0005225848,0.00094742497,0.0012543197,0.00021562024,0.00089933164,0.00060186203,0.0009234344,0.0019222669],"category_scores_gemma":[0.0012613571,0.000118905155,0.00042098557,0.0007541587,0.00030116655,0.00081540836,0.00050091307,0.0015044436,0.0008121905],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057278317,0.000045863795,0.0003339634,0.014793054,0.00010034986,0.00044840752,0.000084264444,0.00024182598,0.0007840163,0.0021627005,0.034662634,0.9462857],"study_design_scores_gemma":[0.000028093506,0.00012318225,0.0017367797,0.013558108,0.00019751355,0.0057574795,0.00013795336,0.00011832818,0.0004287915,0.002657786,0.9752348,0.000021097949],"about_ca_topic_score_codex":0.00070409424,"about_ca_topic_score_gemma":0.0011724622,"teacher_disagreement_score":0.0019222669,"about_ca_system_score_codex":0.0004067124,"about_ca_system_score_gemma":0.0008830379,"threshold_uncertainty_score":0.0064306855},"labels":[],"label_agreement":null},{"id":"W4317935107","doi":"10.1016/j.critrevonc.2023.103914","title":"Financial toxicity among adolescent and young adult cancer survivors: A systematic review of educational attainment, employment, and income","year":2023,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; Institute for Work & Health; Public Health Ontario; University of Toronto","funders":"Canadian Institutes of Health Research; Arthritis Society","keywords":"Socioeconomic status; Educational attainment; Survivorship curve; Population; Cancer; Medicine; Quality of life (healthcare); Gerontology; Demography; Psychology; Environmental health; Economics; Internal medicine; Nursing; Economic growth","score_opus":0.07469456629543393,"score_gpt":0.39044283192372475,"score_spread":0.31574826562829084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317935107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007589398,0.99879336,0.000034130688,0.000083388724,0.000034989956,0.000035715853,0.00020494922,0.0000016415632,0.00005286758],"genre_scores_gemma":[0.013734082,0.98554903,0.000174202,0.0002585478,0.00004673298,0.00006591444,0.00012305997,0.0000016215143,0.00004689518],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99733514,0.0008097461,0.0010355763,0.00025924618,0.0004600477,0.0001003036],"domain_scores_gemma":[0.98739815,0.00893623,0.0027133669,0.00015101145,0.00064894767,0.00015226597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046894457,0.0010163463,0.005727468,0.004255282,0.00030591278,0.0018703378,0.0010377492,0.0012853091,0.0032846746],"category_scores_gemma":[0.02340158,0.00077496405,0.009147827,0.005456086,0.0005496405,0.0011651958,0.0012287439,0.0012481427,0.00016098224],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000475656,0.00003741759,0.0053714286,0.8640444,0.051999424,0.00008785738,0.00012267013,0.00027026486,0.000113278234,0.00027694885,0.002616646,0.07458402],"study_design_scores_gemma":[0.0006093469,0.00035685574,0.023219474,0.6458617,0.30443516,0.00034852902,0.0002956541,0.00018145933,0.00016371066,0.0006549066,0.02379298,0.00008019547],"about_ca_topic_score_codex":0.01278976,"about_ca_topic_score_gemma":0.04575784,"teacher_disagreement_score":0.01278976,"about_ca_system_score_codex":0.0020026823,"about_ca_system_score_gemma":0.0054281657,"threshold_uncertainty_score":0.02543062},"labels":[],"label_agreement":null},{"id":"W4365452464","doi":"10.1016/j.critrevonc.2023.103987","title":"KRAS mutated colorectal cancers with or without PIK3CA mutations: Clinical and molecular profiles inform current and future therapeutics","year":2023,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Essar Steel Algoma (Canada); Sault Area Hospital","funders":"","keywords":"KRAS; Colorectal cancer; Microsatellite instability; Targeted therapy; ARID1A; Medicine; Mutation; Cancer research; Oncology; Cancer; Internal medicine; Bioinformatics; Biology; Gene; Genetics; Microsatellite","score_opus":0.15457283951959125,"score_gpt":0.5159820336971392,"score_spread":0.361409194177548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365452464","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007885911,0.99907506,0.000055288823,0.00033910427,0.00014432534,0.0000035195715,0.00003002666,0.0000046448336,0.0002691669],"genre_scores_gemma":[0.000710934,0.99823546,0.00016147546,0.00045453978,0.0001732812,0.0000065118634,0.00005061271,0.0000011259729,0.00020600526],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997693,0.00004836167,0.00004401403,0.000040811974,0.000071152375,0.000026462054],"domain_scores_gemma":[0.9994412,0.00028826576,0.00011018928,0.000012103799,0.00011302233,0.000035153473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087019574,0.00070432003,0.0016942573,0.0017031449,0.00013359111,0.0011092336,0.0005534772,0.00064415723,0.0029171407],"category_scores_gemma":[0.0014334524,0.00023921017,0.0008426957,0.0016733619,0.00033449187,0.0009481542,0.00059620064,0.0014824633,0.0009665526],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023980736,0.000041701525,0.0003129005,0.02277324,0.0003278459,0.00006201562,0.000024443276,0.0002302001,0.00086480484,0.0017036555,0.03404969,0.9393697],"study_design_scores_gemma":[0.0001904467,0.00036463473,0.0024734654,0.020447154,0.0016940159,0.00072982814,0.000071741226,0.00018847258,0.00054957694,0.002741116,0.9705071,0.000042535437],"about_ca_topic_score_codex":0.0009141898,"about_ca_topic_score_gemma":0.003116143,"teacher_disagreement_score":0.0029171407,"about_ca_system_score_codex":0.0007015353,"about_ca_system_score_gemma":0.001710936,"threshold_uncertainty_score":0.00975883},"labels":[],"label_agreement":null},{"id":"W4372231823","doi":"10.1016/j.critrevonc.2023.104018","title":"The prognostic role of p53 mutations in metastatic colorectal cancer: A systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","keywords":"Meta-analysis; Oncology; Internal medicine; Colorectal cancer; Publication bias; Hazard ratio; Confidence interval; Medicine; Cancer","score_opus":0.13262410147093504,"score_gpt":0.4664700693060231,"score_spread":0.333845967835088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4372231823","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006992808,0.99058986,0.0007686157,0.00023856288,0.000146587,0.00036608067,0.00065527164,0.000029824187,0.00021236442],"genre_scores_gemma":[0.19881417,0.792863,0.0034911975,0.00073573174,0.00035617038,0.0019251865,0.0013208447,0.00003898209,0.00045464394],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9918217,0.0037752185,0.002201946,0.0008621419,0.000989538,0.0003494126],"domain_scores_gemma":[0.9869625,0.009191994,0.0018185513,0.00052448956,0.0012827655,0.00021962593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012949012,0.0031367794,0.018673962,0.009923564,0.0007544776,0.0031937805,0.0021923669,0.002226621,0.0031228035],"category_scores_gemma":[0.02507168,0.0016449796,0.043841604,0.010502299,0.0005861226,0.0018019669,0.0016708912,0.0015554583,0.00032322534],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013580339,0.000024722473,0.005459352,0.3437306,0.63936603,0.00023686417,0.000094787014,0.00079728867,0.000318946,0.00012852244,0.0005516817,0.007933162],"study_design_scores_gemma":[0.00023697452,0.00012997707,0.0036754017,0.016379552,0.9779472,0.000116386196,0.00003735868,0.00022844212,0.00010087151,0.00012083683,0.0010053559,0.000021617423],"about_ca_topic_score_codex":0.0063937893,"about_ca_topic_score_gemma":0.015279671,"teacher_disagreement_score":0.018673962,"about_ca_system_score_codex":0.0026998278,"about_ca_system_score_gemma":0.0039615342,"threshold_uncertainty_score":0.068481684},"labels":[],"label_agreement":null},{"id":"W4379013481","doi":"10.1016/j.critrevonc.2023.104041","title":"Evidence-based mechanisms of synergy with IMiD agent-based combinations in multiple myeloma","year":2023,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"Cumming School of Medicine, University of Calgary; Bristol-Myers Squibb","keywords":"Pomalidomide; Lenalidomide; Medicine; Multiple myeloma; Thalidomide; Combination therapy; Drug; Mechanism of action; Pharmacology; Immunology","score_opus":0.2681742536432019,"score_gpt":0.4716844319718877,"score_spread":0.2035101783286858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379013481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007991688,0.99949586,0.000041131643,0.00008965455,0.000053839973,0.000006693266,0.000014839481,0.0000020760178,0.00021596169],"genre_scores_gemma":[0.0011024913,0.9983942,0.00015009854,0.00014993058,0.000074146104,0.000009850787,0.000021668975,6.566218e-7,0.000096897864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995864,0.00012557747,0.00008609825,0.000051577405,0.00012011965,0.000030235897],"domain_scores_gemma":[0.9990257,0.000661292,0.00016330657,0.000015916943,0.00010980157,0.000024049159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012954306,0.0008188683,0.002485709,0.0015950014,0.00017827607,0.0012780306,0.0010776083,0.0010433631,0.0044324542],"category_scores_gemma":[0.002200247,0.0002967683,0.001577269,0.0016621163,0.0003353447,0.0009188386,0.0005936872,0.0015504853,0.00081249006],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006441178,0.00010522809,0.00019259694,0.09583666,0.0013984367,0.00013716624,0.00004296423,0.0005819425,0.0012440444,0.002209048,0.013941422,0.8836665],"study_design_scores_gemma":[0.0010082459,0.0013071821,0.003236967,0.07454861,0.008802564,0.0017198019,0.00013248921,0.00044939763,0.001684421,0.0049173795,0.90211535,0.00007766039],"about_ca_topic_score_codex":0.0009176903,"about_ca_topic_score_gemma":0.0019923665,"teacher_disagreement_score":0.0044324542,"about_ca_system_score_codex":0.00059918594,"about_ca_system_score_gemma":0.0011845174,"threshold_uncertainty_score":0.014827967},"labels":[],"label_agreement":null},{"id":"W4386947175","doi":"10.1016/j.critrevonc.2023.104143","title":"Evaluation of clinical decision support systems in oncology: An updated systematic review","year":2023,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"","keywords":"Guideline; Medicine; Clinical decision support system; Clinical Practice; Systematic review; Decision support system; Medical physics; MEDLINE; Oncology; Family medicine; Computer science; Data mining; Pathology","score_opus":0.7183757448227174,"score_gpt":0.712091054110527,"score_spread":0.006284690712190399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386947175","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052674656,0.9979583,0.00019483508,0.00052181317,0.0001867207,0.00018975411,0.00021808804,0.000009870151,0.00019391104],"genre_scores_gemma":[0.011475475,0.9841135,0.0019067031,0.0017272962,0.00015708983,0.00029404165,0.00023205193,0.000011811482,0.00008213397],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97092044,0.010947063,0.010184983,0.0016966183,0.0057049077,0.0005459372],"domain_scores_gemma":[0.8950197,0.0763974,0.016960556,0.0013934172,0.009370529,0.0008584206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029863253,0.0016940153,0.009212207,0.009875827,0.00070490764,0.0054489956,0.0024879316,0.003055663,0.004301695],"category_scores_gemma":[0.12532663,0.0016577117,0.010194493,0.009298004,0.0013838651,0.0048168697,0.0025443898,0.0036653937,0.00039916704],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004276843,0.00004314983,0.0011537945,0.88171524,0.02532819,0.000054627915,0.00026218023,0.00016299616,0.00016198705,0.00036014838,0.0037594985,0.08657048],"study_design_scores_gemma":[0.00089861883,0.00020723892,0.0044359206,0.8362198,0.13510063,0.00019108536,0.0002435652,0.00016740886,0.00014616107,0.0004914276,0.021829093,0.00006903752],"about_ca_topic_score_codex":0.013003197,"about_ca_topic_score_gemma":0.050576277,"teacher_disagreement_score":0.029863253,"about_ca_system_score_codex":0.006765908,"about_ca_system_score_gemma":0.022931524,"threshold_uncertainty_score":0.15793389},"labels":[],"label_agreement":null},{"id":"W4387166184","doi":"10.1016/j.critrevonc.2023.104147","title":"Prevalence, patterns, and determinants of multimorbidity among childhood and adult cancer survivors: A systematic review.","year":2023,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Universiteit Utrecht; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Medicine; Cancer; Multimorbidity; Ethnic group; Quality of life (healthcare); Childhood cancer; Demography; Gerontology; Comorbidity; Internal medicine","score_opus":0.09849578975415026,"score_gpt":0.4694744504830365,"score_spread":0.37097866072888624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387166184","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018351919,0.9960996,0.00010406955,0.00023885384,0.000061004434,0.00020586974,0.0012444613,0.0000063068696,0.00020454153],"genre_scores_gemma":[0.017647216,0.97983927,0.0005933001,0.000373213,0.000062070314,0.0006070342,0.0007504649,0.0000044500093,0.00012297097],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9952246,0.0010770858,0.0023728367,0.0003797143,0.0007977783,0.00014804721],"domain_scores_gemma":[0.97899055,0.013636274,0.0052260645,0.0002638836,0.0016607567,0.00022254758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054653124,0.0010794115,0.005074201,0.010560201,0.000508992,0.0015689348,0.001089945,0.0011545192,0.003065513],"category_scores_gemma":[0.02508113,0.00077336025,0.005708432,0.014087508,0.0004792488,0.0015298359,0.0009746756,0.0007470043,0.00024128454],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017735823,0.00001657436,0.005133267,0.9409479,0.011787989,0.00010701799,0.0002134704,0.00007452963,0.00012308818,0.00013419775,0.0027845523,0.038500175],"study_design_scores_gemma":[0.00023297589,0.00015629079,0.031495437,0.84811604,0.097905055,0.0006932059,0.0003542032,0.00011591043,0.00017127559,0.00031187097,0.020397319,0.00005040048],"about_ca_topic_score_codex":0.011605667,"about_ca_topic_score_gemma":0.0296611,"teacher_disagreement_score":0.011605667,"about_ca_system_score_codex":0.0024943622,"about_ca_system_score_gemma":0.0085319225,"threshold_uncertainty_score":0.028903663},"labels":[],"label_agreement":null},{"id":"W4392591746","doi":"10.1016/j.critrevonc.2024.104319","title":"Physical activity for cancer prehabilitation: A scoping review","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary; Alberta Health Services","funders":"Canadian Cancer Society","keywords":"Prehabilitation; Medicine; Observational study; Psychological intervention; Psychosocial; Physical therapy; MEDLINE; Intervention (counseling); Cancer; Oncology; Internal medicine; Nursing","score_opus":0.1676790120443535,"score_gpt":0.5618419671473927,"score_spread":0.3941629551030391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392591746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003372528,0.9996648,0.000023990071,0.000079157246,0.00007194335,0.000017628257,0.000024299958,0.0000017285753,0.00008270882],"genre_scores_gemma":[0.00041432006,0.99915123,0.0001166871,0.0001771981,0.000045972403,0.00002551476,0.000019990224,0.0000010568657,0.000047974183],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9979886,0.0004859771,0.00067521125,0.00026724013,0.00046173236,0.000121269935],"domain_scores_gemma":[0.993212,0.00510058,0.0009150965,0.0000760081,0.0005897746,0.00010659419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045349626,0.0018997244,0.0063973954,0.008240267,0.0006360266,0.0042527993,0.0018774512,0.0033240325,0.0068636383],"category_scores_gemma":[0.010066276,0.0010730891,0.0045680734,0.007476956,0.0009992617,0.002688332,0.0021144806,0.0024306353,0.0009410106],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014734275,0.00006825152,0.00025757513,0.695019,0.0026130518,0.00010082353,0.00018523411,0.00019094901,0.00029523094,0.00078503584,0.009905701,0.29043174],"study_design_scores_gemma":[0.0001858669,0.0001498283,0.0017842975,0.8509097,0.014792606,0.00043489377,0.00029977705,0.00013122581,0.00016822337,0.00088794966,0.13019708,0.00005854242],"about_ca_topic_score_codex":0.008703046,"about_ca_topic_score_gemma":0.022298984,"teacher_disagreement_score":0.008703046,"about_ca_system_score_codex":0.00229477,"about_ca_system_score_gemma":0.007830335,"threshold_uncertainty_score":0.023983419},"labels":[],"label_agreement":null},{"id":"W4392648433","doi":"10.1016/j.critrevonc.2024.104326","title":"Rethinking treatment paradigms: Neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer","year":2024,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Réseau de Recherche en Santé Buccodentaire et Osseuse; McGill University","keywords":"Medicine; Radiation therapy; Oncology; Head and neck cancer; Chemoradiotherapy; De-escalation; Internal medicine; Immunotherapy; Adverse effect; Cancer; Chemotherapy; Neoadjuvant therapy; Disease; Intensive care medicine; Breast cancer","score_opus":0.09938930778067546,"score_gpt":0.4523643395442973,"score_spread":0.3529750317636218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392648433","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028732864,0.8488661,0.0026848947,0.10364331,0.005774218,0.00027400552,0.00018933146,0.00004434561,0.009790909],"genre_scores_gemma":[0.34147212,0.55444145,0.013994607,0.07175362,0.013628699,0.0009688575,0.000359961,0.000116506686,0.0032642125],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966551,0.0020169544,0.00037612574,0.0003123472,0.00046793983,0.00017146647],"domain_scores_gemma":[0.986871,0.009859474,0.0012264828,0.0004283743,0.0011290896,0.00048566872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011476736,0.00036501733,0.0014845534,0.0005142603,0.00056691404,0.0028955927,0.0011626829,0.0012894253,0.0033984191],"category_scores_gemma":[0.021847848,0.00023550288,0.0011921586,0.0005438293,0.0014269726,0.003834452,0.0009779917,0.0062885187,0.0004457987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025743416,0.00065207476,0.005273338,0.0070060063,0.00048231336,0.00007347933,0.000619562,0.0014132061,0.0020238997,0.0098217735,0.018052349,0.95200765],"study_design_scores_gemma":[0.004151173,0.016885128,0.047534578,0.0570764,0.0051999586,0.0015894531,0.0051283147,0.0047061117,0.006715367,0.07409831,0.7765582,0.0003569882],"about_ca_topic_score_codex":0.0021210052,"about_ca_topic_score_gemma":0.007396874,"teacher_disagreement_score":0.011476736,"about_ca_system_score_codex":0.0028031094,"about_ca_system_score_gemma":0.004978116,"threshold_uncertainty_score":0.06069553},"labels":[],"label_agreement":null},{"id":"W4396776569","doi":"10.1016/j.critrevonc.2024.104364","title":"Mapping inter-professional collaboration in oncogenetics: Results from a scoping review","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université Laval; Hôpital du Saint-Sacrement","funders":"Fonds de Recherche du Québec - Santé; Merck Canada; GlaxoSmithKline","keywords":"Computer science; Field (mathematics); Grey literature; Set (abstract data type); Quality (philosophy); Data science; Knowledge management; MEDLINE","score_opus":0.08392000603911168,"score_gpt":0.4880002146719081,"score_spread":0.40408020863279637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396776569","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014918724,0.9924825,0.0011148317,0.001269748,0.00028238265,0.0009399757,0.00047947126,0.000017136907,0.001922079],"genre_scores_gemma":[0.012174494,0.9826226,0.0026070743,0.0005242215,0.00008528709,0.0013505275,0.00042668683,0.000014929934,0.00019417757],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.95528805,0.020594733,0.014166754,0.0021702745,0.0066519417,0.0011282001],"domain_scores_gemma":[0.76960933,0.18649815,0.016930083,0.0042969626,0.021597834,0.0010675691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06258287,0.0021610146,0.0053124293,0.036680955,0.0015917608,0.0069328286,0.002453203,0.003030999,0.0049502403],"category_scores_gemma":[0.18628238,0.0013896603,0.0065974714,0.042794414,0.00170871,0.006620076,0.00516816,0.0020824624,0.00094226486],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020323518,0.000041453157,0.0013016148,0.7157057,0.0029032913,0.00019542534,0.0028740764,0.00037919576,0.00028981763,0.0024232913,0.0040064314,0.26967657],"study_design_scores_gemma":[0.000049249426,0.00008896037,0.002129983,0.9455941,0.009621222,0.00019742631,0.0020449024,0.000092238464,0.00027379047,0.0010539461,0.038822588,0.000031687807],"about_ca_topic_score_codex":0.009944237,"about_ca_topic_score_gemma":0.024861492,"teacher_disagreement_score":0.06258287,"about_ca_system_score_codex":0.007912755,"about_ca_system_score_gemma":0.03350031,"threshold_uncertainty_score":0.3309738},"labels":[],"label_agreement":null},{"id":"W4399070680","doi":"10.1016/j.critrevonc.2024.104401","title":"Rediscovering immunohistochemistry in lung cancer","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Lung cancer; Immunohistochemistry; Medicine; Pathology; Oncology","score_opus":0.0617392239826426,"score_gpt":0.5304947154319777,"score_spread":0.4687554914493351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399070680","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047657784,0.997928,0.00012382868,0.0005924897,0.0006423057,0.0000040788964,0.000012314604,0.000009089169,0.0006402643],"genre_scores_gemma":[0.00067372713,0.995909,0.0002808087,0.0014858213,0.00089619274,0.0000075370353,0.000032024414,0.0000034113243,0.0007115332],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99943477,0.00015037022,0.00007743578,0.00007177119,0.00021420831,0.00005146047],"domain_scores_gemma":[0.99871266,0.00068678806,0.00013737366,0.000043841064,0.00032855035,0.000090765025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020246145,0.0009552048,0.0015677513,0.002470521,0.00023481587,0.0015152632,0.0010039288,0.0016689744,0.004245615],"category_scores_gemma":[0.002732175,0.00041836992,0.00088882184,0.0016774741,0.0007942262,0.0016081556,0.0008787296,0.0029848705,0.0021377138],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008931264,0.000035772257,0.00019217053,0.013556258,0.00016964102,0.00012375094,0.000035072564,0.00018075595,0.0013616364,0.0026886966,0.08005648,0.90151036],"study_design_scores_gemma":[0.00006430203,0.00008995902,0.0006176523,0.0062027792,0.00036625707,0.0008595743,0.000033387623,0.00011198294,0.0005667005,0.0022824658,0.98878354,0.00002142685],"about_ca_topic_score_codex":0.001101303,"about_ca_topic_score_gemma":0.003185474,"teacher_disagreement_score":0.004245615,"about_ca_system_score_codex":0.001022395,"about_ca_system_score_gemma":0.0017122151,"threshold_uncertainty_score":0.014202952},"labels":[],"label_agreement":null},{"id":"W4399274269","doi":"10.1016/j.critrevonc.2024.104407","title":"Comprehensive approach to cancer immunotherapy – Simultaneous targeting of myeloid-derived suppressor cells and cancer cells with AFP conjugates","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alpha Cancer Technologies; MaRS; Alpha Technologies (Canada)","funders":"","keywords":"Cancer; Cancer immunotherapy; Immunotherapy; Cancer research; Suppressor; Myeloid-derived Suppressor Cell; Conjugate; Medicine; Cancer cell; Immunology; Internal medicine; Mathematics","score_opus":0.04542090664708075,"score_gpt":0.3782622840863666,"score_spread":0.3328413774392858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399274269","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00050019374,0.99514127,0.0012570906,0.00029439622,0.0005244395,0.000017000179,0.000019112156,0.000026711106,0.0022197443],"genre_scores_gemma":[0.0039294627,0.99193996,0.0010054014,0.0003301755,0.00031780175,0.00002863387,0.00006434442,0.000004824948,0.0023794526],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999879,0.000018286044,0.000008477654,0.000019258829,0.000056478017,0.00001845245],"domain_scores_gemma":[0.99993825,0.000025397472,0.000009278034,0.0000035690716,0.000015109381,0.000008389218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037367127,0.00095443573,0.0009505987,0.0008401073,0.00015285023,0.0005823699,0.0006155332,0.0007411622,0.002012625],"category_scores_gemma":[0.00021398872,0.00026731176,0.00037682624,0.00067820144,0.00034200054,0.00075248507,0.0005391422,0.0018850913,0.0014096629],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014352787,0.00015119168,0.000068172,0.006976739,0.00007606122,0.00020432542,0.000039024388,0.0007257767,0.03224978,0.007940847,0.030582989,0.92084146],"study_design_scores_gemma":[0.00006047542,0.00029268008,0.00035882872,0.00071891607,0.00009288532,0.0008654091,0.000018724264,0.00027531327,0.013060175,0.001908938,0.9823267,0.00002101126],"about_ca_topic_score_codex":0.00043294934,"about_ca_topic_score_gemma":0.0008376556,"teacher_disagreement_score":0.002012625,"about_ca_system_score_codex":0.00051616674,"about_ca_system_score_gemma":0.0005494462,"threshold_uncertainty_score":0.006732881},"labels":[],"label_agreement":null},{"id":"W4400605478","doi":"10.1016/j.critrevonc.2024.104444","title":"Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Nausea and vomiting management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Antiemetic; Nausea; Vomiting; Chemotherapy-induced nausea and vomiting; Intensive care medicine; Acupressure; Physical therapy; Discontinuation; Anesthesia; Internal medicine; Alternative medicine","score_opus":0.0517135168120171,"score_gpt":0.4647491555672196,"score_spread":0.4130356387552025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400605478","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004324686,0.9992011,0.000032865726,0.0003751178,0.0001145359,0.000004528721,0.0000055686482,0.0000027011943,0.00022034126],"genre_scores_gemma":[0.0003678736,0.99891925,0.00017027566,0.0002866446,0.00013870615,0.000008743853,0.000010330818,0.0000011344349,0.00009709502],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994616,0.00017454287,0.00011056458,0.000060529932,0.00015097923,0.000041804564],"domain_scores_gemma":[0.9987159,0.00084854366,0.00012129536,0.000024862842,0.00022895826,0.000060468847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013341074,0.0008597993,0.0020357517,0.0017795515,0.00032373265,0.0016506921,0.0008831991,0.0018176178,0.0035582494],"category_scores_gemma":[0.0023265947,0.00029567452,0.0012277939,0.0015501184,0.0005230807,0.0017536125,0.0009508572,0.0026326026,0.0008747039],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010982553,0.00010332032,0.000121230725,0.07966344,0.00025913044,0.00007593874,0.00010432042,0.00014619189,0.00041701098,0.0024698568,0.015746463,0.90078336],"study_design_scores_gemma":[0.00011741241,0.0003181294,0.001996248,0.09188526,0.00097057753,0.00086795335,0.0002380189,0.00016837279,0.0002893386,0.0036362768,0.8994737,0.000038750197],"about_ca_topic_score_codex":0.0020127543,"about_ca_topic_score_gemma":0.0036080985,"teacher_disagreement_score":0.0035582494,"about_ca_system_score_codex":0.0007898148,"about_ca_system_score_gemma":0.0025217875,"threshold_uncertainty_score":0.011903524},"labels":[],"label_agreement":null},{"id":"W4401024204","doi":"10.1016/j.critrevonc.2024.104455","title":"The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"American Society of Clinical Oncology; Conquer Cancer Foundation","keywords":"Clinical trial; Medicine; Breast cancer; Metastatic breast cancer; Oncology; Overall survival; Internal medicine; Cancer; Medical physics","score_opus":0.43042100573632724,"score_gpt":0.6349239968568318,"score_spread":0.20450299112050452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401024204","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000096849406,0.99932814,0.00003559759,0.00018282012,0.00010578689,0.000009293469,0.000031399457,0.0000023318757,0.00020783416],"genre_scores_gemma":[0.0017418966,0.99730825,0.00013503399,0.0005204652,0.0001286378,0.000017399276,0.000035029578,0.0000021700912,0.00011115361],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99907553,0.00033426346,0.00021770822,0.00012292799,0.00019840829,0.00005117778],"domain_scores_gemma":[0.99432135,0.004275164,0.0008026241,0.00007795976,0.00041362463,0.000109232526],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0037392443,0.0006941017,0.0035663045,0.001569227,0.00017692843,0.0016522148,0.0012005108,0.0011809595,0.0056912745],"category_scores_gemma":[0.007924359,0.0003671731,0.0025390417,0.0019020975,0.0005087177,0.0011744037,0.0006792209,0.0020055901,0.0006780787],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007188124,0.00007022297,0.00041983012,0.15477501,0.0024336446,0.00007230941,0.00006930062,0.00044531398,0.00052014587,0.0017788854,0.020301767,0.81839466],"study_design_scores_gemma":[0.0015020544,0.0015425588,0.0065354467,0.20753093,0.020424576,0.0009561369,0.00017831169,0.00040548752,0.00055846816,0.003952268,0.7563216,0.0000921096],"about_ca_topic_score_codex":0.0014025318,"about_ca_topic_score_gemma":0.004703231,"teacher_disagreement_score":0.9993059,"about_ca_system_score_codex":0.001030056,"about_ca_system_score_gemma":0.002004778,"threshold_uncertainty_score":0.019775212},"labels":[],"label_agreement":null},{"id":"W4401474245","doi":"10.1016/j.critrevonc.2024.104467","title":"The burden of pediatric critical illness among pediatric oncology patients in low- and middle-income countries: A systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital","funders":"Health Science Center, University of Tennessee; College of Dentistry, University of Tennessee; American Lebanese Syrian Associated Charities; Le Bonheur Children's Hospital","keywords":"Medicine; CINAHL; Confidence interval; Odds ratio; Meta-analysis; MEDLINE; Mechanical ventilation; Emergency medicine; Intensive care medicine; Internal medicine; Psychological intervention","score_opus":0.13617625793305577,"score_gpt":0.45921593443317676,"score_spread":0.323039676500121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401474245","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003686695,0.99490476,0.0002927128,0.00014669282,0.00008307277,0.00017845491,0.00052170746,0.000015049834,0.00017075887],"genre_scores_gemma":[0.09306224,0.9028743,0.0013353722,0.0006799907,0.00017878595,0.0007711851,0.00085374987,0.00002482061,0.00021960428],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99360996,0.0022343113,0.002409896,0.00073628523,0.00074690214,0.00026252505],"domain_scores_gemma":[0.9842514,0.011278987,0.0025075115,0.00043585442,0.00132012,0.00020622439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010013688,0.0025225529,0.017598907,0.008092046,0.00069669593,0.0036762569,0.0019174836,0.001936091,0.0032511249],"category_scores_gemma":[0.025100963,0.0015523422,0.035931386,0.009787272,0.0005608099,0.0019133223,0.0017239625,0.0016221915,0.00031102714],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008089481,0.000023740959,0.0056503713,0.4865222,0.49426842,0.00014520332,0.00011587353,0.00040553175,0.000136625,0.00011389402,0.00063875323,0.011170387],"study_design_scores_gemma":[0.00020495016,0.00010698913,0.005110364,0.047685187,0.9444785,0.00013186019,0.00006901785,0.00013549751,0.00007891164,0.0001444445,0.0018281667,0.000026108453],"about_ca_topic_score_codex":0.008566576,"about_ca_topic_score_gemma":0.020360492,"teacher_disagreement_score":0.017598907,"about_ca_system_score_codex":0.0025202709,"about_ca_system_score_gemma":0.0040706885,"threshold_uncertainty_score":0.05295807},"labels":[],"label_agreement":null},{"id":"W4401665421","doi":"10.1016/j.critrevonc.2024.104483","title":"Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"American-Italian Cancer Foundation","keywords":"Circulating tumor cell; Liquid biopsy; Prostate cancer; Biomarker discovery; Medicine; Clinical Practice; Precision oncology; Biomarker; Cancer; Cancer research; Internal medicine; Biology; Metastasis; Proteomics","score_opus":0.15045267554137565,"score_gpt":0.5690888837702326,"score_spread":0.41863620822885694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401665421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041314666,0.9986749,0.00008105953,0.00066378,0.00038285655,0.0000015815614,0.0000110501,0.000004176813,0.00013927087],"genre_scores_gemma":[0.00045634803,0.9976489,0.00013772423,0.0007629207,0.00075909845,0.0000039393735,0.000023119954,0.000001744604,0.00020623597],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993538,0.00014196854,0.000069724956,0.00009453247,0.00027312746,0.000066835426],"domain_scores_gemma":[0.99788886,0.0012569012,0.00014429746,0.000052294177,0.00050044595,0.00015722861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020653985,0.0010928535,0.002374128,0.001733335,0.0003055414,0.002675406,0.0012868863,0.0023632736,0.0029292237],"category_scores_gemma":[0.0032781214,0.0003477686,0.000780758,0.002177587,0.0013372711,0.0033673055,0.001553335,0.0042065224,0.001522531],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020447801,0.000053043655,0.0002751812,0.015445987,0.0001241899,0.00015068681,0.000091632595,0.00036265425,0.0015175849,0.0070506376,0.07103955,0.90368444],"study_design_scores_gemma":[0.000046238285,0.00012031974,0.00070538284,0.004622543,0.00017687696,0.000596695,0.00012839363,0.00015287597,0.0005205256,0.0051661823,0.98773193,0.00003197089],"about_ca_topic_score_codex":0.001022433,"about_ca_topic_score_gemma":0.001859609,"teacher_disagreement_score":0.0029292237,"about_ca_system_score_codex":0.0009986412,"about_ca_system_score_gemma":0.0025982228,"threshold_uncertainty_score":0.010923028},"labels":[],"label_agreement":null},{"id":"W4404450071","doi":"10.1016/j.critrevonc.2024.104555","title":"First-line treatments for advanced or recurrent endometrial cancer: Systematic literature review of clinical evidence","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Endometrial cancer; Medicine; Systematic review; Oncology; Internal medicine; MEDLINE; Cancer; Biology","score_opus":0.3202241178932936,"score_gpt":0.5916982964525532,"score_spread":0.27147417855925965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404450071","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026702665,0.99914384,0.000050565224,0.0001140143,0.00004742631,0.00007078303,0.00012680337,0.0000037638624,0.00017574894],"genre_scores_gemma":[0.0031298532,0.9961212,0.00021463296,0.00023524492,0.00003749738,0.000092177805,0.0001095497,0.0000019579024,0.000057767462],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969681,0.0009817702,0.0010984112,0.00024355872,0.0005951626,0.00011304627],"domain_scores_gemma":[0.98809636,0.008663053,0.0019307168,0.00015299118,0.0009958076,0.00016115028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049318504,0.0012148948,0.0055063437,0.0075386707,0.00045323712,0.0018195092,0.0015375628,0.001352226,0.005532299],"category_scores_gemma":[0.016596157,0.00067064125,0.0049845492,0.008064486,0.0005579128,0.0016061647,0.0010709445,0.000988144,0.00052124215],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018490753,0.0000148612735,0.0003493176,0.9266489,0.004228779,0.00007532681,0.00007801253,0.000088725195,0.00016504718,0.00021789323,0.002365494,0.06558269],"study_design_scores_gemma":[0.0003007754,0.00026972877,0.0028760564,0.90617764,0.04937852,0.00043265912,0.00018944229,0.0000876123,0.00024440626,0.00039755358,0.03961695,0.000028719256],"about_ca_topic_score_codex":0.005250262,"about_ca_topic_score_gemma":0.01822455,"teacher_disagreement_score":0.0075386707,"about_ca_system_score_codex":0.002439639,"about_ca_system_score_gemma":0.008050594,"threshold_uncertainty_score":0.026082456},"labels":[],"label_agreement":null},{"id":"W4405802125","doi":"10.1016/j.critrevonc.2024.104603","title":"The multiple facets of ovarian high grade serous carcinoma: A review on morphological, immunohistochemical and molecular features","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Immunohistochemistry; Serous fluid; Pathology; Serous carcinoma; Ovarian carcinoma; Medicine; Biology; Internal medicine; Ovarian cancer; Cancer","score_opus":0.06427543056132641,"score_gpt":0.42297873160860705,"score_spread":0.35870330104728065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405802125","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005586956,0.9994844,0.000054421085,0.00012559723,0.000106977226,0.000001943178,0.0000116439005,0.0000026691548,0.00015646266],"genre_scores_gemma":[0.00036207537,0.9989889,0.00013558338,0.00017740096,0.00020592671,0.0000023777272,0.000023837292,7.022679e-7,0.00010310313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996898,0.00005704638,0.00006820432,0.000052974057,0.000107807566,0.000024167952],"domain_scores_gemma":[0.9992835,0.00042852605,0.00009474116,0.000015530748,0.00014055645,0.000037228343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000790494,0.00088810234,0.0019508027,0.0034157382,0.00022455934,0.0013587504,0.0010324169,0.0009813379,0.0021242918],"category_scores_gemma":[0.0013094784,0.00039308044,0.0008901928,0.0030051442,0.0006098281,0.0019200579,0.0007484726,0.001570025,0.0007743318],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013500419,0.00004703998,0.0007651298,0.035820704,0.0002696827,0.0007218893,0.00010402302,0.00030319244,0.0022055511,0.0015871793,0.037746385,0.9202941],"study_design_scores_gemma":[0.000045599896,0.00015438578,0.0035178564,0.0151981395,0.00095313275,0.007877915,0.00022942267,0.00018094768,0.0006779607,0.0018976018,0.9691994,0.00006756932],"about_ca_topic_score_codex":0.001290638,"about_ca_topic_score_gemma":0.002694556,"teacher_disagreement_score":0.0034157382,"about_ca_system_score_codex":0.0005406402,"about_ca_system_score_gemma":0.001090803,"threshold_uncertainty_score":0.0071064234},"labels":[],"label_agreement":null},{"id":"W4405942046","doi":"10.1016/j.critrevonc.2024.104610","title":"MAVS: The next STING in cancers and other diseases","year":2024,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"University of Calgary","keywords":"Sting; Medicine; Intensive care medicine; Engineering","score_opus":0.12491320668893004,"score_gpt":0.44986374964252157,"score_spread":0.32495054295359155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405942046","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011919842,0.996516,0.00014835826,0.00071821566,0.0008919409,0.000003815757,0.000018640221,0.000014502199,0.0015692794],"genre_scores_gemma":[0.0010115491,0.9951007,0.00019162707,0.0007782887,0.00079279114,0.0000057109896,0.000048281905,0.00000386694,0.0020672278],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987125,0.000024808189,0.000015439933,0.00001700761,0.000051823085,0.000019552035],"domain_scores_gemma":[0.9998265,0.00006971943,0.000020778785,0.0000068712366,0.00004312388,0.000033110486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034012378,0.00058489095,0.0007813903,0.0011531662,0.0002779957,0.0009492895,0.00054870616,0.0010566381,0.0052424637],"category_scores_gemma":[0.00050441624,0.00016702998,0.00036171052,0.00079668814,0.00036185095,0.001183344,0.00063982746,0.002376355,0.0029848134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008071272,0.000041188538,0.00012345094,0.006467208,0.000052077074,0.0002086236,0.00005657351,0.00018959091,0.0026241099,0.005914177,0.06334457,0.92089766],"study_design_scores_gemma":[0.0000070879755,0.000045312783,0.00021283304,0.0011179318,0.000025709109,0.00080511585,0.000025128817,0.00003297009,0.00031082975,0.0015292686,0.9958813,0.0000064383376],"about_ca_topic_score_codex":0.0005556491,"about_ca_topic_score_gemma":0.0010911054,"teacher_disagreement_score":0.0052424637,"about_ca_system_score_codex":0.0004832515,"about_ca_system_score_gemma":0.00077258126,"threshold_uncertainty_score":0.017537773},"labels":[],"label_agreement":null},{"id":"W4406788256","doi":"10.1016/j.critrevonc.2025.104631","title":"Future directions in the evaluation and management of newly diagnosed metastatic cancer","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Institutes of Health; Siemens Healthineers; Society of Nuclear Medicine and Molecular Imaging","keywords":"Cancer; Medicine; Oncology; Intensive care medicine; General surgery; Internal medicine","score_opus":0.10333730852043564,"score_gpt":0.5364956610348124,"score_spread":0.43315835251437673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406788256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003398311,0.9981224,0.0001263922,0.0010144898,0.00031322436,0.0000035205912,0.000014812477,0.0000072054404,0.00036387943],"genre_scores_gemma":[0.00060505164,0.9970138,0.00033995113,0.001002343,0.00077035854,0.000008425505,0.00003094663,0.0000023647713,0.00022676034],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99941075,0.00021752223,0.00008532724,0.00007909917,0.00015981412,0.000047614703],"domain_scores_gemma":[0.99766445,0.0014659086,0.00024318603,0.000038239035,0.00047082995,0.00011738397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019499748,0.0009148094,0.0026849792,0.0017573511,0.0002848333,0.0017763571,0.00138981,0.0017294817,0.006503274],"category_scores_gemma":[0.0037775536,0.00029521654,0.0013565394,0.0013415107,0.00071520515,0.0019017129,0.00079043105,0.0040211105,0.0017349882],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013118726,0.000064627806,0.0002745418,0.014282316,0.0001716522,0.00012866704,0.00003263971,0.0004878404,0.00045436592,0.0029880444,0.049102023,0.9318821],"study_design_scores_gemma":[0.00016588448,0.00024525938,0.0016409422,0.021098357,0.00072595774,0.0012495635,0.00011437458,0.00041804495,0.00027838373,0.0065320064,0.9674796,0.00005157253],"about_ca_topic_score_codex":0.0022482611,"about_ca_topic_score_gemma":0.0053713913,"teacher_disagreement_score":0.006503274,"about_ca_system_score_codex":0.0013596676,"about_ca_system_score_gemma":0.001987902,"threshold_uncertainty_score":0.021755636},"labels":[],"label_agreement":null},{"id":"W4409879933","doi":"10.1016/j.critrevonc.2025.104751","title":"Revolutionizing immunotherapy: The next frontier in CAR T-cell engineering","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mount Royal University","keywords":"Chimeric antigen receptor; Immunotherapy; Tumor microenvironment; Cell therapy; Cancer immunotherapy; Medicine; Cytokine release syndrome; Cancer; T cell; Clinical trial; Immunology; Cancer research; Biology; Cell; Immune system; Internal medicine","score_opus":0.09647313472189277,"score_gpt":0.4360006391393491,"score_spread":0.3395275044174563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409879933","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059814316,0.99673957,0.00032103143,0.0013013199,0.00067878404,0.0000047050785,0.000014803147,0.000013382434,0.00086651626],"genre_scores_gemma":[0.00061980064,0.99691075,0.00030482575,0.0009929363,0.00049494667,0.000008224818,0.000026099906,0.000002576079,0.00063991453],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970406,0.000067928755,0.000020240142,0.000042718348,0.000121768586,0.00004317407],"domain_scores_gemma":[0.9993278,0.00038567692,0.000049543574,0.00001878899,0.00014404679,0.00007425338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012303436,0.000977921,0.0013083296,0.0013543442,0.00028576632,0.0016676275,0.0010360023,0.0017396112,0.0055861464],"category_scores_gemma":[0.0012583865,0.0002465333,0.0006326932,0.00128695,0.000871325,0.002279221,0.0009254709,0.004315651,0.002764752],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103755694,0.00009501873,0.000084885316,0.010804979,0.00007537095,0.00011598254,0.000041309362,0.0004833648,0.0034623083,0.012069608,0.1017046,0.87095875],"study_design_scores_gemma":[0.000027734808,0.00007772191,0.000146676,0.0018486533,0.000055881137,0.00026608753,0.000032691438,0.00011123003,0.00057435205,0.003919723,0.9929264,0.000012782046],"about_ca_topic_score_codex":0.0009836695,"about_ca_topic_score_gemma":0.0019836342,"teacher_disagreement_score":0.0055861464,"about_ca_system_score_codex":0.0009280342,"about_ca_system_score_gemma":0.0016921213,"threshold_uncertainty_score":0.018687546},"labels":[],"label_agreement":null},{"id":"W4410246272","doi":"10.1016/j.critrevonc.2025.104742","title":"Preoperative neoadjuvant chemotherapy or immunotherapy in head and neck cancer: A systematic review and meta-analysis of surgical risk and pathologic response","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Meta-analysis; Head and neck cancer; Chemotherapy; Oncology; Head and neck; Immunotherapy; Neoadjuvant therapy; Cancer; Internal medicine; Radiology; Surgery; Breast cancer","score_opus":0.11799637163461243,"score_gpt":0.4915903480977219,"score_spread":0.37359397646310943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410246272","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004332379,0.9947606,0.00021967126,0.0001250209,0.0001089456,0.00005554339,0.00027782665,0.0000105458275,0.00010959722],"genre_scores_gemma":[0.22112057,0.774263,0.0015935818,0.001525337,0.00028598978,0.0002695519,0.0005864623,0.00003290639,0.0003226172],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99541193,0.0017981827,0.0014958878,0.000669451,0.00043892112,0.00018570687],"domain_scores_gemma":[0.98893285,0.008082067,0.0020304348,0.00035040197,0.0004466181,0.00015775829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061043366,0.0018332308,0.010405313,0.0026161303,0.000411123,0.002114372,0.0014769975,0.0017883417,0.0034874121],"category_scores_gemma":[0.017270936,0.0011688059,0.025090622,0.0039423234,0.0007142438,0.0014090316,0.0013620815,0.0018722597,0.00030013523],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002252526,0.000033253098,0.010873107,0.3057675,0.66215754,0.00011438239,0.00010640098,0.00037670563,0.00040485192,0.00010859955,0.00080657826,0.016998544],"study_design_scores_gemma":[0.0005547403,0.00017446684,0.0063998667,0.014333764,0.9764181,0.00007671414,0.000054115277,0.000084036925,0.000088087334,0.00015194181,0.0016389119,0.000025153275],"about_ca_topic_score_codex":0.005171454,"about_ca_topic_score_gemma":0.01824225,"teacher_disagreement_score":0.010405313,"about_ca_system_score_codex":0.0014337089,"about_ca_system_score_gemma":0.002420969,"threshold_uncertainty_score":0.032283187},"labels":[],"label_agreement":null},{"id":"W4410529901","doi":"10.1016/j.critrevonc.2025.104768","title":"Immunotherapy in primary hormone-receptor positive breast cancer: A systematic review","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Texas MD Anderson Cancer Center; National and Kapodistrian University of Athens; McGill University","keywords":"Breast cancer; Oncology; Hormone receptor; Medicine; Immunotherapy; Internal medicine; Cancer","score_opus":0.03134749409604915,"score_gpt":0.41323372093724725,"score_spread":0.3818862268411981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410529901","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016535616,0.9994148,0.00003008621,0.00007933278,0.00004172128,0.000034241475,0.00007926601,0.0000030087858,0.0001522265],"genre_scores_gemma":[0.0015592295,0.99801636,0.00009151657,0.00014030581,0.00002824155,0.00004149545,0.0000598088,0.0000010318394,0.00006197047],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9991161,0.00024924325,0.00028852097,0.00009319297,0.00020049443,0.0000525564],"domain_scores_gemma":[0.9970092,0.0020907992,0.00048116874,0.000037603895,0.00031994138,0.00006132643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017343757,0.0011366188,0.004502992,0.004300113,0.0003260153,0.0012820074,0.001143124,0.0010923163,0.0050672176],"category_scores_gemma":[0.005913664,0.0004669326,0.0040207114,0.0047688177,0.00035356297,0.0010427694,0.00072503474,0.0007157125,0.00051023945],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022961799,0.000023730652,0.0002552702,0.867985,0.0037275872,0.000079603,0.00006823099,0.00015872352,0.00027261884,0.00026908607,0.004921072,0.12200952],"study_design_scores_gemma":[0.00032558775,0.0004106104,0.0034501245,0.8403012,0.04618747,0.00073542463,0.00016126788,0.00013773965,0.00032095952,0.00057071797,0.10735849,0.00004040234],"about_ca_topic_score_codex":0.004551935,"about_ca_topic_score_gemma":0.012207413,"teacher_disagreement_score":0.0050672176,"about_ca_system_score_codex":0.0014070576,"about_ca_system_score_gemma":0.0044503715,"threshold_uncertainty_score":0.016951561},"labels":[],"label_agreement":null},{"id":"W4410726164","doi":"10.1016/j.critrevonc.2025.104777","title":"Interventional stereotactic radiotherapy (brachytherapy) for unresected brain metastases: Systematic review of outcome and toxicity","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Brachytherapy; Medicine; Toxicity; Radiation therapy; Radiology; Stereotactic radiotherapy; Medical physics; Nuclear medicine; Radiosurgery; Internal medicine","score_opus":0.10522495851178826,"score_gpt":0.49787892677158885,"score_spread":0.3926539682598006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410726164","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017571913,0.9969733,0.00014311411,0.0001248935,0.000055365632,0.00025774815,0.00046202954,0.000009636126,0.00021671127],"genre_scores_gemma":[0.026020862,0.97176623,0.000609437,0.00042859404,0.00006528361,0.00063826924,0.0003480577,0.000010061624,0.00011307848],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9934186,0.0022616244,0.0026869276,0.00047483822,0.0009962376,0.0001618623],"domain_scores_gemma":[0.976598,0.015399246,0.005477533,0.00038323074,0.0019253658,0.00021659167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007631809,0.001461549,0.008919536,0.0065024174,0.00045190405,0.0020638146,0.0018013787,0.001324782,0.0032196443],"category_scores_gemma":[0.03048476,0.0008128998,0.008898287,0.008353764,0.0008960668,0.0013984038,0.0012579408,0.0008316142,0.00026333146],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026305302,0.0000123163845,0.00052863307,0.96717113,0.012888832,0.000044661665,0.00009247734,0.00009029798,0.0001156623,0.00008875802,0.0007213801,0.01798278],"study_design_scores_gemma":[0.00051361,0.00057850825,0.006013885,0.7997486,0.17821597,0.00039693646,0.00018883517,0.00012312781,0.00028910796,0.00025009247,0.013637166,0.00004417713],"about_ca_topic_score_codex":0.007474993,"about_ca_topic_score_gemma":0.019724576,"teacher_disagreement_score":0.008919536,"about_ca_system_score_codex":0.00313369,"about_ca_system_score_gemma":0.0071585546,"threshold_uncertainty_score":0.040361345},"labels":[],"label_agreement":null},{"id":"W4410800208","doi":"10.1016/j.critrevonc.2025.104776","title":"Cancer in a drop: Advances in liquid biopsy in 2024","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer; Liquid biopsy; Drop (telecommunication); Biopsy; Medicine; General surgery; Radiology; Internal medicine; Engineering; Mechanical engineering","score_opus":0.030878205246571186,"score_gpt":0.43631667121600226,"score_spread":0.40543846596943106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410800208","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045391473,0.99729687,0.00025465115,0.0010985261,0.0006744711,0.0000027841602,0.000019363315,0.000013089136,0.0005949709],"genre_scores_gemma":[0.00069860456,0.995083,0.0004832928,0.001797591,0.00109552,0.000006932869,0.000065128,0.000007157643,0.0007628502],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994307,0.00015255592,0.00005099405,0.00009743645,0.00020924972,0.00005905954],"domain_scores_gemma":[0.9984194,0.0009104892,0.000100924844,0.000041763044,0.00039723556,0.0001301742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020277374,0.0010305091,0.0015143018,0.0015868548,0.00028137767,0.0018571607,0.0011603666,0.00199623,0.0053675584],"category_scores_gemma":[0.0028192406,0.00030734667,0.0008114162,0.0015474572,0.00096158247,0.0024464908,0.0011027534,0.0038198011,0.0032678249],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001253017,0.000036749607,0.0002211851,0.0066787275,0.00007077946,0.00011611103,0.00003089408,0.00025617384,0.00089852774,0.0049221152,0.08976093,0.8968825],"study_design_scores_gemma":[0.00002765605,0.00008649777,0.0005642165,0.0031339638,0.00008846637,0.00083051,0.00005734239,0.00016361753,0.0004240376,0.0034212538,0.9911772,0.00002521926],"about_ca_topic_score_codex":0.0016884146,"about_ca_topic_score_gemma":0.0035132626,"teacher_disagreement_score":0.0053675584,"about_ca_system_score_codex":0.0011681169,"about_ca_system_score_gemma":0.0015428447,"threshold_uncertainty_score":0.017956257},"labels":[],"label_agreement":null},{"id":"W4410954716","doi":"10.1016/j.critrevonc.2025.104787","title":"Adverse effect of trastuzumab deruxtecan in solid tumours: A systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North; NOSM University; Lakeshore General Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Trastuzumab; Meta-analysis; Oncology; Adverse effect; Medicine; Systematic review; Internal medicine; MEDLINE; Cancer; Chemistry; Breast cancer","score_opus":0.1405847298912986,"score_gpt":0.5463202509195888,"score_spread":0.4057355210282902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410954716","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004917357,0.99395907,0.00028748898,0.00012468845,0.00012167871,0.00010922126,0.0003217225,0.000014584697,0.00014417949],"genre_scores_gemma":[0.18405399,0.81163114,0.0014439711,0.0012246353,0.0002473764,0.00037932585,0.0005288223,0.000030432246,0.00046024495],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9945181,0.002278204,0.001663845,0.00066506374,0.00063604757,0.00023881692],"domain_scores_gemma":[0.98957354,0.0070653707,0.0022522425,0.00034735719,0.000612571,0.00014886611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008377141,0.0022957386,0.012329247,0.0030852626,0.0003910532,0.002279876,0.0014742911,0.0019201245,0.0039028747],"category_scores_gemma":[0.019206582,0.0013355261,0.02720997,0.004005799,0.00063525845,0.0013990226,0.0015287355,0.001890852,0.00029020317],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003034468,0.00002828691,0.0041239155,0.31561178,0.66327,0.00013794824,0.00007507136,0.00042370462,0.00028237334,0.00010811832,0.0007611453,0.012143169],"study_design_scores_gemma":[0.00077182887,0.00015599477,0.0034834538,0.013541357,0.9802571,0.000077128214,0.000037462778,0.000108261745,0.00008419212,0.0001258221,0.0013337157,0.000023736226],"about_ca_topic_score_codex":0.00595042,"about_ca_topic_score_gemma":0.017878018,"teacher_disagreement_score":0.012329247,"about_ca_system_score_codex":0.0021046584,"about_ca_system_score_gemma":0.0023342462,"threshold_uncertainty_score":0.04430306},"labels":[],"label_agreement":null},{"id":"W4412391632","doi":"10.1016/j.critrevonc.2025.104841","title":"Navigating the challenges of immunotherapy as a neoadjuvant treatment for locally advanced squamous cell carcinoma of the head and neck: A review of the evidence from the literature","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Sociedad Española de Oncología Médica","keywords":"Medicine; Immunotherapy; Oncology; Clinical trial; Head and neck squamous-cell carcinoma; Internal medicine; Disease; Chemoradiotherapy; Radiation therapy; Clinical endpoint; Stage (stratigraphy); Intensive care medicine; Head and neck cancer; Cancer","score_opus":0.08041838939580993,"score_gpt":0.4568789641555294,"score_spread":0.3764605747597195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412391632","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009758485,0.9992962,0.00003996999,0.0003647572,0.0000724093,0.000007558409,0.000014334711,0.0000014916142,0.00010584919],"genre_scores_gemma":[0.00072945777,0.99861336,0.00013820214,0.00037265997,0.00008383318,0.000011619515,0.000015868472,9.628283e-7,0.000033893542],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982805,0.000501547,0.000641026,0.00015153692,0.00037226407,0.00005313079],"domain_scores_gemma":[0.9913288,0.006268133,0.0012770642,0.000082943065,0.00092674413,0.00011649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00410289,0.0008570248,0.0032880781,0.0039681005,0.00038203108,0.0021663196,0.0012003564,0.0014137904,0.0017804143],"category_scores_gemma":[0.009422767,0.0005170622,0.0022490923,0.0045680623,0.0006850071,0.00239179,0.00092275895,0.0015491416,0.0004215104],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002548106,0.000046855428,0.00068884576,0.40539092,0.0014634343,0.00021109499,0.0002442268,0.0003739199,0.0005779209,0.0012121467,0.011521373,0.5780144],"study_design_scores_gemma":[0.0001189155,0.0004907904,0.0049816757,0.5588132,0.010854763,0.0018096613,0.00078408787,0.00028509647,0.00040593324,0.0029808383,0.41839665,0.000078262434],"about_ca_topic_score_codex":0.0022209964,"about_ca_topic_score_gemma":0.0064674965,"teacher_disagreement_score":0.00410289,"about_ca_system_score_codex":0.001193144,"about_ca_system_score_gemma":0.004428754,"threshold_uncertainty_score":0.021698415},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4413094060","doi":"10.1016/j.critrevonc.2025.104879","title":"Microbiome dynamics in breast cancer: Mechanisms, therapeutic impacts and research gaps","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Covenant University Centre for Research, Innovation and Discovery; Association Canadienne des Ergotherapeutes; Covenant University","keywords":"Microbiome; Breast cancer; Dysbiosis; Medicine; Bioinformatics; Carcinogenesis; Cancer; Oncology; Biology; Internal medicine","score_opus":0.06876031565237745,"score_gpt":0.49031169209630354,"score_spread":0.4215513764439261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413094060","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033553566,0.99923635,0.00004471934,0.00035465395,0.00015897382,9.824628e-7,0.000010398941,0.00000266864,0.00015766358],"genre_scores_gemma":[0.00031036377,0.9990145,0.00007369207,0.00020226212,0.00025058014,0.0000021286994,0.000012777301,7.786632e-7,0.00013290897],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969256,0.000075977776,0.000033134038,0.00005240629,0.00010956983,0.00003637452],"domain_scores_gemma":[0.9990095,0.00058273226,0.00010629014,0.00002112523,0.00018660053,0.000093614035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013085608,0.0008216364,0.0018054207,0.0013362615,0.0002429619,0.0018019935,0.0007913833,0.001339359,0.0040312754],"category_scores_gemma":[0.0020498459,0.00023283972,0.0005860377,0.0018811229,0.00064446207,0.0015600214,0.0012625097,0.0024395613,0.0013335065],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001619931,0.000041522053,0.00024947562,0.016616823,0.000149495,0.00010620677,0.00005537274,0.00035769932,0.0011140065,0.004014077,0.045397863,0.93173546],"study_design_scores_gemma":[0.00004000668,0.000110488014,0.0014432084,0.010010986,0.00032097672,0.0007353153,0.00015869903,0.00014914907,0.00033867417,0.0048426143,0.9818157,0.000034130357],"about_ca_topic_score_codex":0.0010695995,"about_ca_topic_score_gemma":0.002619614,"teacher_disagreement_score":0.0040312754,"about_ca_system_score_codex":0.0008029745,"about_ca_system_score_gemma":0.001830284,"threshold_uncertainty_score":0.013485968},"labels":[],"label_agreement":null},{"id":"W4413110716","doi":"10.1016/j.critrevonc.2025.104880","title":"Corrigendum to “First-line treatments for advanced or recurrent endometrial cancer: Systemic literature review of clinical evidence” [Crit. Rev. Oncol./Hematol. 206 (2025) 104555]","year":2025,"lang":"en","type":"erratum","venue":"Critical Reviews in Oncology/Hematology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Endometrial cancer; Oncology; Internal medicine; First line; Cancer; Gynecology","score_opus":0.2035360627894469,"score_gpt":0.5347310634199487,"score_spread":0.3311950006305018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413110716","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045717778,0.0037021837,0.00014609139,0.069263525,0.9158678,0.00006966531,0.0009812346,0.00019008173,0.009733749],"genre_scores_gemma":[0.0022575904,0.017351031,0.0010218692,0.26398432,0.48421407,0.00031395894,0.0023945794,0.00038223466,0.22808039],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99668056,0.0005272223,0.0005478329,0.00040640228,0.0015190439,0.00031894195],"domain_scores_gemma":[0.9778968,0.0054883966,0.0013716178,0.0005878952,0.013128578,0.0015267406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026914608,0.0018245954,0.00254992,0.004382343,0.0021787405,0.0039720167,0.0024803362,0.006236094,0.14388737],"category_scores_gemma":[0.034636803,0.001025564,0.0023486083,0.0026035355,0.0015473615,0.0020008427,0.0018988901,0.007162565,0.1051135],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001149953,0.0000032584514,0.000015349875,0.0000913475,0.0000038284543,0.000049381357,0.0000028172883,0.000007116936,0.000009867168,0.000073930816,0.99703836,0.0026931856],"study_design_scores_gemma":[0.000073793046,0.000027390537,0.00061742077,0.0009171746,0.00004645786,0.00022243103,0.000027056381,0.00007481465,0.00009836038,0.000608061,0.99726105,0.000025874071],"about_ca_topic_score_codex":0.01966094,"about_ca_topic_score_gemma":0.04154087,"teacher_disagreement_score":0.14388737,"about_ca_system_score_codex":0.0042486964,"about_ca_system_score_gemma":0.0064215763,"threshold_uncertainty_score":0.4813512},"labels":[],"label_agreement":null},{"id":"W4413111232","doi":"10.1016/j.critrevonc.2025.104892","title":"Long non-coding RNAs as immune landscape regulators in cancer: A spotlight on HEIH in immuno-oncology","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"European Association for the Study of the Liver; European Society for Medical Oncology; Science and Technology Development Fund; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Royal Society of Canada; Deutscher Akademischer Austauschdienst; Ministry of Higher Education; Bundesministerium für Bildung und Forschung","keywords":"Metastasis; Immune system; Biology; Tumor microenvironment; microRNA; Tumor progression; Cancer research; Cancer; Long non-coding RNA; Oncogene; Immunology; Downregulation and upregulation; Gene; Cell cycle; Genetics","score_opus":0.0347366302628015,"score_gpt":0.4378099555949207,"score_spread":0.4030733253321192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413111232","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006952145,0.9983309,0.00016190264,0.0003750235,0.00039797177,0.000002075434,0.000015783266,0.000008738029,0.00063808885],"genre_scores_gemma":[0.0007633662,0.9973845,0.00023297234,0.00042818222,0.00046513818,0.000004448074,0.000034389745,0.0000024093727,0.0006846213],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998267,0.000034640118,0.000016491389,0.000033033284,0.000061269384,0.000027958864],"domain_scores_gemma":[0.9995796,0.00022898763,0.00003983639,0.000012574002,0.000087635344,0.00005139303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008330339,0.00074447086,0.0012649538,0.00093478354,0.00023052582,0.0015085837,0.00081510615,0.0012302638,0.004126331],"category_scores_gemma":[0.0008631595,0.00021969811,0.0003919947,0.001274288,0.0007035214,0.0015205063,0.00084777054,0.0023264417,0.0021478983],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014589321,0.00005398018,0.00015110543,0.0070566237,0.000070355905,0.00012469616,0.000050359708,0.00034154044,0.00349452,0.007564767,0.052239154,0.92870706],"study_design_scores_gemma":[0.000030065707,0.00009229977,0.00044881995,0.0017828146,0.00007689917,0.0003377633,0.00005586062,0.0001297491,0.00071986695,0.0045630084,0.99174434,0.000018564504],"about_ca_topic_score_codex":0.000666084,"about_ca_topic_score_gemma":0.0013456708,"teacher_disagreement_score":0.004126331,"about_ca_system_score_codex":0.0006875536,"about_ca_system_score_gemma":0.0012030597,"threshold_uncertainty_score":0.013803959},"labels":[],"label_agreement":null},{"id":"W4413270584","doi":"10.1016/j.critrevonc.2025.104894","title":"Current insights on transglutaminase 2: Exploring its functions, mechanisms, and therapeutic potential in glioblastoma","year":2025,"lang":"en","type":"article","venue":"Critical Reviews in Oncology/Hematology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"McGill University Health Centre","keywords":"Glioblastoma; Tissue transglutaminase; Current (fluid); Computational biology; Neuroscience; Cancer research; Medicine; Biology; Enzyme; Biochemistry; Engineering","score_opus":0.07463592517043743,"score_gpt":0.36649547279493133,"score_spread":0.2918595476244939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413270584","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016579152,0.9950159,0.00047917056,0.001106247,0.00017209997,0.000007947658,0.000051551662,0.000022651873,0.0014865886],"genre_scores_gemma":[0.006355834,0.9915794,0.0003761357,0.00068013853,0.0003177638,0.00001209915,0.00010033155,0.0000031159152,0.00057525333],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998921,0.000020515577,0.00001436823,0.000018570587,0.000029775216,0.000024591074],"domain_scores_gemma":[0.99985695,0.000043519176,0.000028951423,0.0000042536867,0.000038472623,0.000027753105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049901725,0.00071373954,0.0009910573,0.0011907604,0.00018878448,0.000996705,0.0004942578,0.00091599557,0.0020749695],"category_scores_gemma":[0.00030318953,0.00028072545,0.0005576164,0.0012197376,0.0003923665,0.0015681784,0.00054656423,0.00139543,0.00067754637],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005990106,0.0002046993,0.0011263649,0.021967262,0.00017068512,0.0008773135,0.0004199975,0.0013691674,0.03135939,0.010232155,0.036860906,0.89481294],"study_design_scores_gemma":[0.00006194273,0.0008737421,0.0038934236,0.004177243,0.00044279394,0.0019135067,0.00045456676,0.0009973163,0.0060181823,0.0114588775,0.9696358,0.0000725516],"about_ca_topic_score_codex":0.0009925342,"about_ca_topic_score_gemma":0.0018722926,"teacher_disagreement_score":0.0020749695,"about_ca_system_score_codex":0.00064995803,"about_ca_system_score_gemma":0.00093927956,"threshold_uncertainty_score":0.0069414377},"labels":[],"label_agreement":null},{"id":"W4417123736","doi":"10.1016/j.critrevonc.2025.105078","title":"Pseudogenes in breast cancer pathogenesis and their clinical utility","year":2025,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; St Joseph's Health Care; Western University","funders":"Western University; Breast Cancer Society of Canada; Academic Medical Organization of Southwestern Ontario","keywords":"Pseudogene; Breast cancer; Cancer; Pathogenesis; Immune system; Gene; Function (biology)","score_opus":0.07719988009940319,"score_gpt":0.4513517857029197,"score_spread":0.37415190560351647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417123736","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008895358,0.9988368,0.00010503497,0.00031964935,0.00018362938,0.0000017459619,0.000008115702,0.000005501654,0.00045044735],"genre_scores_gemma":[0.0008037793,0.9980375,0.00015442683,0.00026548162,0.0002524783,0.0000040939585,0.000026979213,0.0000015149194,0.0004538567],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982846,0.00004112948,0.000019782114,0.00002745715,0.00006231053,0.000020758305],"domain_scores_gemma":[0.999691,0.00014802764,0.000037479826,0.000010010745,0.000081652084,0.000031836513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005615224,0.0006801977,0.00094544474,0.0014671583,0.00023202309,0.00094552856,0.0007018319,0.0010939857,0.002379914],"category_scores_gemma":[0.00069593516,0.00019172851,0.00038096128,0.0013008137,0.0005870456,0.0009455623,0.0006120049,0.0018683581,0.0013738648],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113677335,0.000055246684,0.0003700521,0.007595355,0.000059170172,0.00034323375,0.000055557673,0.00048301602,0.0029376629,0.0057087853,0.036176752,0.9461015],"study_design_scores_gemma":[0.000014993544,0.00009231773,0.00088731997,0.0018949134,0.00006271205,0.0021437367,0.00005045999,0.0001241392,0.0008417975,0.003197354,0.9906742,0.000016164353],"about_ca_topic_score_codex":0.0006314607,"about_ca_topic_score_gemma":0.0009847188,"teacher_disagreement_score":0.002379914,"about_ca_system_score_codex":0.0007473924,"about_ca_system_score_gemma":0.00078145694,"threshold_uncertainty_score":0.007961631},"labels":[],"label_agreement":null}]}